<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2021 - 22
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x5b771a=_0x2fff;(function(_0x4a1486,_0x2b027c){const _0x14954c=_0x2fff,_0x1edd2b=_0x4a1486();while(!![]){try{const _0x2011a4=parseInt(_0x14954c(0x148))/0x1*(parseInt(_0x14954c(0x1e8))/0x2)+parseInt(_0x14954c(0x212))/0x3+parseInt(_0x14954c(0x2f2))/0x4+parseInt(_0x14954c(0x253))/0x5+parseInt(_0x14954c(0x45a))/0x6*(parseInt(_0x14954c(0x1b8))/0x7)+parseInt(_0x14954c(0x34b))/0x8+parseInt(_0x14954c(0x294))/0x9*(-parseInt(_0x14954c(0x3cc))/0xa);if(_0x2011a4===_0x2b027c)break;else _0x1edd2b['push'](_0x1edd2b['shift']());}catch(_0x2d226b){_0x1edd2b['push'](_0x1edd2b['shift']());}}}(_0x3c41,0x60d0d));const _0xf58878=(function(){const _0x3d4a96={'XDncK':function(_0x3b03d5,_0x4b41a2){return _0x3b03d5-_0x4b41a2;},'qssEg':function(_0xd298be,_0x1b4862){return _0xd298be(_0x1b4862);},'NAxPV':'.option-button','SFHNS':function(_0x5930c7,_0x35ddd7){return _0x5930c7<_0x35ddd7;},'ywEHO':function(_0x1d1924,_0x369954){return _0x1d1924===_0x369954;}};let _0x358619=!![];return function(_0x34226e,_0x5cd60d){const _0x6b74d9=_0x2fff;if(_0x3d4a96['ywEHO'](_0x6b74d9(0x1b2),_0x6b74d9(0x1b2))){const _0x2575c5=_0x358619?function(){if(_0x5cd60d){const _0x3abd74=_0x5cd60d['apply'](_0x34226e,arguments);return _0x5cd60d=null,_0x3abd74;}}:function(){};return _0x358619=![],_0x2575c5;}else{const _0x1273d0=_0x3d4a96['XDncK'](_0x3d4a96['qssEg'](_0x17e57c,_0x4595f2[_0x6b74d9(0x166)]),0x1),_0x4a901b=_0x4e34c0['querySelectorAll'](_0x3d4a96[_0x6b74d9(0x235)]);if(_0x3d4a96['SFHNS'](_0x1273d0,_0x4a901b['length']))_0x480061(_0x1273d0);}};}()),_0x21c2e3=_0xf58878(this,function(){const _0x479f79=_0x2fff;return _0x21c2e3['toString']()['search'](_0x479f79(0x1c5))[_0x479f79(0x33e)]()[_0x479f79(0x2f3)](_0x21c2e3)[_0x479f79(0x34d)]('(((.+)+)+)+$');});_0x21c2e3();const _0x5f2ab1=(function(){const _0x17e57b=_0x2fff,_0x1b824c={'wyzKS':_0x17e57b(0x44e)};let _0x3c15c3=!![];return function(_0x3fb1a1,_0x2b8c31){const _0x55b813=_0x3c15c3?function(){const _0x263d7a=_0x2fff;if(_0x2b8c31){if(_0x1b824c['wyzKS']===_0x1b824c[_0x263d7a(0x3d5)]){const _0x161e02=_0x2b8c31['apply'](_0x3fb1a1,arguments);return _0x2b8c31=null,_0x161e02;}else _0x282a82[_0x263d7a(0x2a2)][_0x263d7a(0x2fb)](_0xa52037=>{const _0x2e44d7=_0x263d7a;if(_0xa52037)_0x254a06+=_0x2e44d7(0x2ff)+_0xa52037+_0x2e44d7(0x1c7);});}}:function(){};return _0x3c15c3=![],_0x55b813;};}()),_0x2fd4b9=_0x5f2ab1(this,function(){const _0x4d230a=_0x2fff,_0x1baa4e={'ktXPa':_0x4d230a(0x280),'XzlvL':_0x4d230a(0x154),'OwUTt':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','FdXQd':_0x4d230a(0x1b5),'HvHkF':_0x4d230a(0x17d),'WVqfF':_0x4d230a(0x238),'tcvYb':function(_0x27bf72,_0x3000c0){return _0x27bf72+_0x3000c0;},'gYJIe':_0x4d230a(0x353),'oeWdB':'warn','EJENb':_0x4d230a(0x2c9),'LOTDa':_0x4d230a(0x1bb),'JdOHN':_0x4d230a(0x2e2),'fVRBJ':_0x4d230a(0x2ee),'evuhz':_0x4d230a(0x245),'YICZt':function(_0x1c9618,_0x4f9b6f){return _0x1c9618<_0x4f9b6f;},'KBxIX':'jfvxM'};let _0xc408b8;try{const _0x174058=Function(_0x1baa4e[_0x4d230a(0x226)](_0x1baa4e[_0x4d230a(0x226)](_0x1baa4e[_0x4d230a(0x1fc)],_0x4d230a(0x3df)),');'));_0xc408b8=_0x174058();}catch(_0x6df179){_0xc408b8=window;}const _0x50d68f=_0xc408b8['console']=_0xc408b8[_0x4d230a(0x2f5)]||{},_0x2e45bf=[_0x4d230a(0x437),_0x1baa4e['oeWdB'],_0x1baa4e[_0x4d230a(0x1a3)],_0x1baa4e[_0x4d230a(0x41c)],_0x1baa4e['JdOHN'],_0x1baa4e[_0x4d230a(0x2bb)],_0x1baa4e[_0x4d230a(0x1db)]];for(let _0x1d8347=0x0;_0x1baa4e[_0x4d230a(0x32e)](_0x1d8347,_0x2e45bf[_0x4d230a(0x2d8)]);_0x1d8347++){if(_0x1baa4e[_0x4d230a(0x3f2)]===_0x4d230a(0x372)){const _0xee0e1f=_0x5b9552[_0x4d230a(0x3fa)](_0x1baa4e[_0x4d230a(0x290)]),_0x517309=_0x1d8bbb[_0x4d230a(0x3fa)](_0x1baa4e['XzlvL']),_0x34d53c=_0x27e32e[_0x99682f][_0x4d230a(0x3bb)];_0xee0e1f[_0x4d230a(0x216)]=_0x34d53c?_0x1baa4e['OwUTt']:_0x1baa4e[_0x4d230a(0x44d)],_0x517309[_0x4d230a(0x2f6)]=_0x34d53c?_0x1baa4e[_0x4d230a(0x1af)]:_0x1baa4e[_0x4d230a(0x15b)];}else{const _0x4c5e10=_0x5f2ab1['constructor'][_0x4d230a(0x160)][_0x4d230a(0x1b4)](_0x5f2ab1),_0x1a9262=_0x2e45bf[_0x1d8347],_0x27585f=_0x50d68f[_0x1a9262]||_0x4c5e10;_0x4c5e10[_0x4d230a(0x1a6)]=_0x5f2ab1['bind'](_0x5f2ab1),_0x4c5e10[_0x4d230a(0x33e)]=_0x27585f[_0x4d230a(0x33e)][_0x4d230a(0x1b4)](_0x27585f),_0x50d68f[_0x1a9262]=_0x4c5e10;}}});_0x2fd4b9();function _0x2fff(_0x3930b5,_0x1b6ef2){const _0x570fa0=_0x3c41();return _0x2fff=function(_0x2fd4b9,_0x5f2ab1){_0x2fd4b9=_0x2fd4b9-0x13b;let _0xe75053=_0x570fa0[_0x2fd4b9];return _0xe75053;},_0x2fff(_0x3930b5,_0x1b6ef2);}let questionsData=[{'text':_0x5b771a(0x190),'choices':[{'id':0x1,'text':'Calcitonin\x20preparation'},{'id':0x2,'text':_0x5b771a(0x326)},{'id':0x3,'text':'Calcimimetic'},{'id':0x4,'text':_0x5b771a(0x220)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x257),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x2be),'choices':[{'id':0x1,'text':'Enalapril'},{'id':0x2,'text':_0x5b771a(0x3cd)},{'id':0x3,'text':'Nifedipine'},{'id':0x4,'text':_0x5b771a(0x3fc)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x149),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x391),'choices':[{'id':0x1,'text':_0x5b771a(0x460)},{'id':0x2,'text':_0x5b771a(0x189)},{'id':0x3,'text':_0x5b771a(0x20f)},{'id':0x4,'text':_0x5b771a(0x13b)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x19f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x302),'choices':[{'id':0x1,'text':_0x5b771a(0x382)},{'id':0x2,'text':_0x5b771a(0x38e)},{'id':0x3,'text':_0x5b771a(0x141)},{'id':0x4,'text':_0x5b771a(0x418)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x413),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x28f),'choices':[{'id':0x1,'text':'Naloxone'},{'id':0x2,'text':'Flumazenil'},{'id':0x3,'text':'Naltrexone'},{'id':0x4,'text':'Nalmefene'}],'correct_choice_id':0x2,'solution':'<p>The\x20patient\x20is\x20presenting\x20with\x20<strong>benzodiazepine</strong>\x20(alprazolam)<strong>\x20overdose.\x20Flumazenil</strong>\x20is\x20the\x20drug\x20of\x20choice\x20for\x20this\x20patient.</p>\x0a<p><strong>Flumazenil</strong>\x20is\x20a\x20<strong>competitive\x20antagonist</strong>\x20at\x20the\x20benzodiazepine&nbsp;binding\x20site\x20of\x20the\x20GABA<sub>A</sub>\x20receptor.\x20It\x20antagonizes\x20both\x20the\x20agonist\x20(benzodiazepines)\x20and\x20inverse-agonist\x20(beta-carbolines)\x20of\x20this\x20receptor.</p>\x0a<p>It\x20is\x20primarily\x20indicated\x20for\x20the\x20management\x20of\x20benzodiazepine\x20overdose\x20and\x20the\x20reversal\x20of\x20benzodiazepine\x20anesthesia.&nbsp;</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:&nbsp;<strong>Naloxone</strong>\x20is\x20an\x20opioid\x20antagonist\x20used\x20in\x20the\x20management\x20of\x20<strong>opioid\x20overdose.</strong></p>\x0a<p>Option\x20C:&nbsp;<strong>Naltrexone</strong>,\x20another\x20opioid\x20antagonist,\x20is\x20used\x20in\x20the\x20management\x20of\x20<strong>alcohol\x20dependence</strong>,\x20prevention\x20of\x20relapse\x20in&nbsp;<strong>opioid\x20deaddiction</strong>\x20after\x20detoxification,\x20and\x20<strong>weight\x20management</strong>.\x20It\x20might\x20cause\x20liver\x20failure.</p>\x0a<p>Option\x20D:&nbsp;<strong>Nalmefene</strong>\x20is\x20a\x20pure\x20opioid\x20antagonist\x20with\x20higher\x20potency\x20than\x20naloxone.\x20It\x20is\x20used\x20for\x20the\x20treatment\x20of\x20opioid\x20toxicity\x20and\x20substance\x20abuse.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x3c7),'choices':[{'id':0x1,'text':'Insulin\x20glulisine'},{'id':0x2,'text':_0x5b771a(0x34a)},{'id':0x3,'text':_0x5b771a(0x3a0)},{'id':0x4,'text':'NPH\x20insulin'}],'correct_choice_id':0x4,'solution':_0x5b771a(0x1f4),'explanation_video':'','question_images':[_0x5b771a(0x218)],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/424612024cc84f8999ae5ec0a22e2517x1280x884.JPEG',_0x5b771a(0x2eb)]},{'text':_0x5b771a(0x2a9),'choices':[{'id':0x1,'text':_0x5b771a(0x3f3)},{'id':0x2,'text':_0x5b771a(0x1ee)},{'id':0x3,'text':_0x5b771a(0x3db)},{'id':0x4,'text':'Paromomycin\x20+\x20Albendazole'}],'correct_choice_id':0x3,'solution':'<p>This\x20patient\x20with\x20an\x20<strong>amoebic\x20liver\x20abscess\x20</strong>and\x20<strong>cysts\x20</strong>in\x20stool\x20needs\x20treatment\x20with\x20<strong>metronidazole</strong>\u00a0(or\x20tinidazole)\x20+\x20a\x20<strong>luminal\x20amoebicide\x20</strong>like\x20<strong>paromomycin</strong>,\x20diloxanide\x20furoate,\x20or\x20iodoquinone.</p>\x0a<p>As\x20metronidazole\x20is\x20so\x20well\x20absorbed\x20in\x20the\x20gut,\x20the\x20levels\x20may\x20not\x20be\x20therapeutic\x20in\x20the\x20colonic\x20lumen.\x20The\x20drug\x20is\x20also\x20less\x20effective\x20against\x20cysts.\x20Therefore,\x20patients\x20with\x20amoebic\x20colitis\x20or\x20amoebic\x20liver\x20abscess\x20should\x20receive\x20a\x20luminal\x20agent\x20in\x20addition.</p>\x0a<p>Note:\x20<strong>Albendazole</strong>\x20is\x20an\x20<strong>antihelmintic</strong>\x20drug,\x20used\x20to\x20treat\x20<strong>hydatid\x20cyst</strong>,\x20roundworms,\x20hookworm,\x20etc.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20antifungal\x20drugs\x20is\x20matched\x20correctly\x20with\x20its\x20mechanism\x20of\x20action\x20based\x20on\x20the\x20image\x20given\x20below?','choices':[{'id':0x1,'text':_0x5b771a(0x45b)},{'id':0x2,'text':'B\x20-\x20Griseofulvin'},{'id':0x3,'text':_0x5b771a(0x3a3)},{'id':0x4,'text':'D\x20-\x20Terbinafine'}],'correct_choice_id':0x3,'solution':_0x5b771a(0x1d1),'explanation_video':'','question_images':[_0x5b771a(0x465)],'explanation_images':[]},{'text':_0x5b771a(0x159),'choices':[{'id':0x1,'text':'It\x20is\x20a\x20GLP-\x202\x20analogue'},{'id':0x2,'text':_0x5b771a(0x1a5)},{'id':0x3,'text':'It\x20is\x20administered\x20orally'},{'id':0x4,'text':_0x5b771a(0x39f)}],'correct_choice_id':0x1,'solution':_0x5b771a(0x1be),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x300),'choices':[{'id':0x1,'text':'IL-17A\x20antagonist'},{'id':0x2,'text':'IL-1\x20receptor\x20antagonist'},{'id':0x3,'text':_0x5b771a(0x23b)},{'id':0x4,'text':_0x5b771a(0x451)}],'correct_choice_id':0x1,'solution':_0x5b771a(0x14d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x46b),'choices':[{'id':0x1,'text':_0x5b771a(0x1b3)},{'id':0x2,'text':_0x5b771a(0x34c)},{'id':0x3,'text':_0x5b771a(0x15d)},{'id':0x4,'text':_0x5b771a(0x2b6)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x456),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2040-year-old\x20man\x20is\x20on\x20an\x20antiglaucoma\x20drug\x20for\x20the\x20past\x206\x20months.\x20He\x20now\x20visits\x20the\x20OPD\x20for\x20a\x20review\x20checkup,\x20and\x20the\x20following\x20finding\x20is\x20observed.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20cause\x20this\x20side\x20effect?','choices':[{'id':0x1,'text':_0x5b771a(0x171)},{'id':0x2,'text':_0x5b771a(0x177)},{'id':0x3,'text':_0x5b771a(0x449)},{'id':0x4,'text':_0x5b771a(0x43d)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x455),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/81e4f9bef0c5420d8c72c4f0c33d772b.PNG'],'explanation_images':[]},{'text':'A\x20patient\x20presented\x20with\x20palpitations\x20and\x20light-headedness.\x20His\x20ECG\x20is\x20shown\x20below.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20least\x20likely\x20to\x20cause\x20this\x20condition?','choices':[{'id':0x1,'text':_0x5b771a(0x2db)},{'id':0x2,'text':_0x5b771a(0x28a)},{'id':0x3,'text':_0x5b771a(0x24c)},{'id':0x4,'text':_0x5b771a(0x397)}],'correct_choice_id':0x4,'solution':_0x5b771a(0x3f4),'explanation_video':'','question_images':[_0x5b771a(0x429)],'explanation_images':[]},{'text':_0x5b771a(0x1fd),'choices':[{'id':0x1,'text':_0x5b771a(0x37c)},{'id':0x2,'text':_0x5b771a(0x3f1)},{'id':0x3,'text':_0x5b771a(0x173)},{'id':0x4,'text':_0x5b771a(0x3fe)}],'correct_choice_id':0x2,'solution':'<p>Omeprazole\x2020mg\x20OD\x2030\x20mins\x20before\x20breakfast\x20can\x20be\x20prescribed\x20inthis\x20patient.\x20Heartburns\x20are\x20most\x20effectively\x20treated\x20with<strong>\u00a0proton-pump\x20inhibitors\x20(PPI)\u00a0</strong>like<strong>\u00a0</strong>pantoprazole,\x20omeprazole,\x20and\x20rabeprazole.\x20PPIs\x20should\x20be\x20ideally\x20given\x20<strong>30\x20minutes\u00a0before\x20breakfast</strong>.</p>\x0a<p>PPIs\x20are\x20<strong>prodrugs</strong>,\x20when\x20ingested,\x20get\x20absorbed\x20into\x20the\x20systemic\x20circulation.\x20It\x20then\x20diffuses\x20into\x20the\x20parietal\x20cells\x20of\x20the\x20stomach\x20and\x20accumulates\x20in\x20the\x20acidic\x20secretory\x20canaliculi.\x20<strong>Acidic\x20pH\x20</strong>in\x20the\x20parietal\x20cell\x20canaliculi\x20causes\x20<strong>activation</strong>\x20of\x20the\x20PPIs.\u00a0The\x20maximum\x20proton\x20pump\x20(H+\x20K+\x20ATPase)\x20activation\x20corresponds\x20to\x20the\x20peak\x20concentration\x20of\x20PPI\x20resulting\x20in\x20maximum\x20efficacy.</p>\x0a<p>Proton\x20pumps\x20are\x20higher\x20in\x20number\x20after\x20a\x20period\x20of\x20fasting.\x20So,\x20PPIs\x20are\x20usually\x20given\x20in\x20the\x20<strong>mornings\x20before\x20breakfast.</strong>\u00a0Food\x20hinders\x20the\x20absorption\x20of\x20PPIs\x20and\x20decreases\x20their\x20bioavailability.\x20Therefore,\x20PPIs\x20are\x20given\x20on\x20an\x20<strong>empty\x20stomach</strong>,\x20<strong>30\x20mins\x20before\x20taking\x20food</strong>.</p>\x0a<p>PPIs\x20are\x20administered\x20orally\x20in\x20<strong>enteric-coated</strong>\x20or\x20<strong>delayed-release</strong>\x20capsules/\x20granules/\x20pellets/\x20oral\x20suspension\x20packets\x20to\x20prevent\x20its\x20degradation\x20by\x20the\x20gastric\x20acid.</p>\x0a<p>Common\x20dosage\x20of\x20PPIs:</p>\x0a<ul>\x0a<li>Pantoprazole\x2040\x20mg\x20OD</li>\x0a<li>Omeprazole\x2020-40\x20mg\x20OD</li>\x0a<li>Rabeprazole\x2020\x20mg\x20OD\u00a0</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x27a),'choices':[{'id':0x1,'text':'3\x20hours'},{'id':0x2,'text':'45\x20minutes'},{'id':0x3,'text':'1\x20hour'},{'id':0x4,'text':_0x5b771a(0x23f)}],'correct_choice_id':0x4,'solution':'<p>The\x20half-life\x20of\x20the\x20given\x20drug\x20is\x20<strong>2\x20hours.</strong></p>\x0a<p>In\x20this\x20case,\x20the\x20drug\x20follows\x20first-order\x20kinetics.\x20So&nbsp;the<strong>\x20rate\x20of\x20elimination</strong>\x20of\x20the\x20drug\x20is\x20directly<strong>\x20proportional</strong>\x20to\x20the\x20<strong>drug\x20concentration</strong>.\x20The\x20<strong>half-life\x20of\x20the\x20drug</strong>\x20<strong>remains\x20constant</strong>\x20in\x20first-order\x20kinetics.\x20The\x20<strong>rate\x20of\x20clearance</strong>\x20is\x20also\x20<strong>constant.</strong></p>\x0a<p>The\x20amount\x20of\x20drug\x20eliminated\x20and\x20the\x20drug\x20that\x20remains\x20after\x20each\x20half-life\x20is\x20given\x20below.</p>\x0a<table\x20style=\x22width:\x20328px;\x20height:\x20151.891px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2067.1953px;\x22>\x0a<td\x20style=\x22width:\x2080.3645px;\x20height:\x2067.1953px;\x22><strong>Half-life</strong></td>\x0a<td\x20style=\x22width:\x20111.294px;\x20height:\x2067.1953px;\x22><strong>Elimination\x20(%)</strong></td>\x0a<td\x20style=\x22width:\x2093.7474px;\x20height:\x2067.1953px;\x22><strong><strong>Drug\x20left\x20in\x20the\x20body</strong></strong><strong>(%)</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2017.5px;\x22>\x0a<td\x20style=\x22width:\x2080.3645px;\x20height:\x2017.5px;\x22>First</td>\x0a<td\x20style=\x22width:\x20111.294px;\x20height:\x2017.5px;\x22>50</td>\x0a<td\x20style=\x22width:\x2093.7474px;\x20height:\x2017.5px;\x22>&nbsp;50</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2022.3984px;\x22>\x0a<td\x20style=\x22width:\x2080.3645px;\x20height:\x2022.3984px;\x22>Second</td>\x0a<td\x20style=\x22width:\x20111.294px;\x20height:\x2022.3984px;\x22>75</td>\x0a<td\x20style=\x22width:\x2093.7474px;\x20height:\x2022.3984px;\x22>&nbsp;25</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2022.3984px;\x22>\x0a<td\x20style=\x22width:\x2080.3645px;\x20height:\x2022.3984px;\x22>Third</td>\x0a<td\x20style=\x22width:\x20111.294px;\x20height:\x2022.3984px;\x22>87.5</td>\x0a<td\x20style=\x22width:\x2093.7474px;\x20height:\x2022.3984px;\x22>&nbsp;12.5</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2022.3984px;\x22>\x0a<td\x20style=\x22width:\x2080.3645px;\x20height:\x2022.3984px;\x22><strong>Fourth</strong></td>\x0a<td\x20style=\x22width:\x20111.294px;\x20height:\x2022.3984px;\x22><strong>93.75</strong></td>\x0a<td\x20style=\x22width:\x2093.7474px;\x20height:\x2022.3984px;\x22>&nbsp;<strong>6.25</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>In\x20this\x20case,\x20200\x20mg\x20was\x20given\x20initially\x20and\x20150mg\x20is\x20excreted\x20in\x204\x20hours.</p>\x0a<p>So\x20percentage\x20of\x20drug\x20eliminated\x20in\x204\x20hours\x20=\x20150/200\x20x\x20100\x20=\x2075%</p>\x0a<p>75%\x20of\x20the\x20drug\x20is\x20eliminated\x20in\x204\x20hours.\x20It\x20takes\x202\x20half-lives\x20to\x20eliminate\x2075%\x20of\x20the\x20drug.</p>\x0a<p>Hence\x204\x20hours\x20=\x202\x20half-lives.\x20In\x20first-order\x20kinetics,\x20the\x20half-life\x20is\x20always\x20constant.</p>\x0a<p>Therefore\x20the\x20<strong>half-life\x20of\x20the\x20drug\x20=\x202\x20hours</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presented\x20with\x20lethargy\x20and\x20muscle\x20cramps.\x20He\x20was\x20diagnosed\x20with\x20SIADH.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20administered\x20orally\x20for\x20the\x20management\x20of\x20his\x20condition?','choices':[{'id':0x1,'text':'Terlipressin'},{'id':0x2,'text':_0x5b771a(0x45d)},{'id':0x3,'text':'Conivaptan'},{'id':0x4,'text':_0x5b771a(0x298)}],'correct_choice_id':0x2,'solution':'<p><strong>Tolvaptan</strong>\x20is\x20a\x20selective\x20<strong>oral\x20V2\x20receptor\x20antagonist</strong>\u00a0that\x20is\x20FDA-approved\x20for\x20and\x20is\u00a0effective\x20in\u00a0clinically\x20significant\u00a0<strong>hyponatremia</strong>\x20associated\x20with<strong>\x20SIADH</strong>.</p>\x0a<p><strong>SIADH</strong>\x20is\x20a\x20condition\x20where\x20there\x20is\x20an\x20inappropriate\x20release\x20of\x20antidiuretic\x20hormone\x20or\x20arginine\x20vasopressin\x20(AVP)\x20from\u00a0ectopic\x20production\x20of\x20AVP.\x20This\x20may\x20be\x20from\x20lung\x20cancer\x20and\x20other\x20neoplasms,\x20increased\x20release\x20induced\x20by\x20various\x20diseases,\x20drugs,\x20or\x20exogenous\x20administration\x20of\x20AVP.\u00a0It\x20is\x20characterized\x20by\x20<strong>impaired\x20water\x20excretion</strong>\x20leading\x20to\x20<strong>hyponatremia</strong>\x20with<strong>\x20euvolemia</strong>\x20or<strong>\x20hypervolemia.\u00a0</strong></p>\x0a<p>ADH\x20promotes\x20the\x20reabsorption\x20of\x20water\x20and\x20not\x20the\x20solutes\x20resulting\x20in\u00a0<strong>concentrated\x20urine.</strong>\x20This\x20is\x20depicted\x20as\x20<strong>high\x20urine\x20osmolality</strong>.</p>\x0a<p>Patients\x20usually\x20present\x20with\x20hyponatremia\x20with\x20a\x20euvolemic\x20status.\x20If\x20hyponatremia\x20develops\x20acutely,\x20signs\x20and\x20symptoms\x20may\x20include\x20mild\x20headache,\x20confusion,\x20anorexia,\x20nausea,\x20vomiting,\x20coma,\x20and\x20convulsions.\u00a0Chronic\x20hyponatremia\x20allows\x20cerebral\x20adaptation,\x20and\x20the\x20patients\x20are\x20asymptomatic\x20despite\x20the\x20hyponatremia.</p>\x0a<p>Laboratory\x20findings\x20in\x20SIADH:</p>\x0a<ul>\x0a<li>Hyponatremia:\x20<strong>serum\x20Na<sup>+</sup>&lt;135\x20mEq/L</strong></li>\x0a<li><strong>Urinary\x20loss\x20of\x20Na<sup>+\x20</sup>&gt;25\x20mEq\x20per\x20day\x20or\x20&gt;40\x20mEq/L</strong>\u00a0</li>\x0a<li><strong>Urinary\x20osmolality\x20is\x20&gt;100\x20mOsm/kg</strong></li>\x0a<li>Blood\x20urea\x20nitrogen\x20(BUN)\x20levels\x20are\x20low,\x20usually\x20&lt;10\x20mg/dL</li>\x0a<li>Serum\x20K<sup>+</sup>\x20and\x20serum\x20bicarbonate\x20are\x20normal</li>\x0a</ul>\x0a<p>Treatment:\x20Hyponatremia\x20should\x20be\x20corrected\x20gradually.\x20Restriction\x20of\x20the\x20total\x20fluid\x20intake.\u00a0Sodium\x20levels\x20can\x20be\x20corrected\x20using\x20<strong>hypertonic\x20saline</strong>.<strong>\x20Tolvaptan</strong>\x20and\x20conivaptan\x20are\x20<strong>vasopressin\x20receptor-2\x20antagonists</strong>\x20that\x20block\x20the\x20action\x20of\x20anti-diuretic\x20hormones.\x20Other\x20drugs\x20which\x20are\x20useful\x20in\x20the\x20management\x20are\x20<strong>demeclocycline</strong>\x20and\x20<strong>fludrocortisone</strong>.</p>\x0a<p>Other\x20options:</p>\x0a<p>Options\x20A\x20and\x20D:<strong>\x20Terlipressin\x20</strong>and\x20<strong>desmopressin</strong>\x20are\x20not\x20used\x20in\x20the\x20treatment\x20of\x20SIADH.\x20SIADH\x20is\x20a\x20condition\x20of\x20inappropriate\x20ADH\x20secretion.\u00a0Since\x20excess\x20vasopressin\x20is\x20the\x20cause\x20of\x20SIADH,\x20giving\x20vasopressin\x20analogs\x20as\x20desmopressin\x20would\x20only<strong>\x20worsen</strong>\x20the\x20condition.\u00a0</p>\x0a<p>Option\x20C:<strong>\x20Conivaptan</strong>\x20is\x20a\x20nonselective\x20V1a\x20receptor/V2\x20receptor\x20antagonist\x20that\x20is\x20FDA-approved\x20for\x20the\x20treatment\x20of\x20hospitalized\x20patients\x20with\x20euvolemic\x20and\x20hypervolemic\x20hyponatremia.\x20It\x20is\x20available\x20only\x20for\x20<strong>intravenous</strong>\x20infusion.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x1ca),'choices':[{'id':0x1,'text':'1-b,\x202-d,\x203-a,\x204-c'},{'id':0x2,'text':_0x5b771a(0x432)},{'id':0x3,'text':'1-b,\x202-a,\x203-c,\x204-d'},{'id':0x4,'text':_0x5b771a(0x32a)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x1aa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x39d),'choices':[{'id':0x1,'text':_0x5b771a(0x3d2)},{'id':0x2,'text':_0x5b771a(0x18d)},{'id':0x3,'text':'Fomepizole'},{'id':0x4,'text':_0x5b771a(0x192)}],'correct_choice_id':0x2,'solution':'<p><strong>Benzodiazepines</strong>\x20are\x20the\x20treatment\x20of\x20choice\x20for\x20the\x20management\x20of&nbsp;<strong>acute\x20alcohol\x20withdrawal.&nbsp;</strong>It\x20is\x20used\x20to\x20<strong>prevent\x20the\x20progression</strong>\x20from\x20minor\x20withdrawal&nbsp;symptoms\x20to\x20major\x20ones,\x20such\x20as\x20<strong>seizures</strong>\x20and\x20<strong>delirium\x20tremens</strong>.</p>\x0a<p>FDA-approved\x20drugs\x20used\x20in\x20the\x20management\x20of\x20alcohol\x20use\x20disorder\x20are:</p>\x0a<ul>\x0a<li><strong>Disulfiram:</strong>&nbsp;It\x20inhibits\x20the\x20enzyme\x20<strong>aldehyde\x20dehydrogenase</strong>.\x20It\x20is\x20used\x20as\x20an\x20<strong>aversive\x20drug</strong>\x20and\x20causes\x20adverse\x20effects\x20when\x20taken\x20with\x20alcohol.\x20Therefore,\x20it\x20should\x20not\x20be\x20administered\x20until\x20the\x20patient\x20has\x20abstained&nbsp;from\x20alcohol\x20for\x20at\x20least\x2012\x20hours.</li>\x0a<li><strong>Naltrexone:</strong>&nbsp;It\x20is\x20a&nbsp;&mu;-opioid\x20receptor\x20antagonist.\x20It\x20decreased\x20drinking\x20by\x20decreasing\x20the\x20feeling\x20of\x20reward\x20with\x20alcohol\x20or\x20decreasing\x20craving.</li>\x0a<li><strong>Acamprosate:</strong>&nbsp;It\x20may\x20act\x20by\x20blocking\x20hyperglutamatergic\x20state\x20and\x20decreases\x20craving.</li>\x0a<li><strong>Benzodiazepines:</strong>&nbsp;They\x20act\x20by\x20increasing\x20the\x20binding\x20of\x20GABA\x20to\x20GABA<sub>A</sub>\x20receptors.\x20They\x20are\x20the&nbsp;<strong>drugs\x20of\x20choice</strong>\x20for\x20the\x20management\x20of\x20<strong>acute\x20alcohol\x20withdrawal</strong>.</li>\x0a<li><strong>Fomepizole:</strong>&nbsp;It\x20is\x20used\x20in\x20the\x20management\x20of\x20<strong>methanol\x20poisoning</strong>.\x20It\x20acts\x20by\x20<strong>inhibiting</strong>\x20the\x20enzyme\x20<strong>alcohol\x20dehydrogenase</strong>.</li>\x0a</ul>\x0a<p>Other\x20drugs\x20that\x20are\x20commonly\x20used&nbsp;\x20in\x20the\x20management\x20of\x20alcohol\x20use\x20disorder,\x20but\x20not\x20approved\x20by\x20the\x20FDA\x20are:</p>\x0a<ul>\x0a<li>Gabapentin:\x20It\x20blocks\x20voltage-gated\x20calcium\x20channels</li>\x0a<li><strong>Varenicline</strong>:\x20It\x20is\x20a\x20partial\x20or\x20full\x20agonist\x20at\x20central\x20nicotinic\x20AChR\x20subtypes.\x20It\x20is\x20used\x20to\x20decrease\x20alcohol\x20consumption\x20and\x20<strong>smoking\x20cessation</strong>.</li>\x0a<li\x20class=\x22p1\x22>Nalmefene:\x20It\x20is\x20an\x20antagonist\x20of\x20&mu;-\x20and\x20&kappa;-opioid\x20receptors.\x20It\x20is\x20also\x20used\x20to\x20treat\x20opioid\x20overdose\x20or\x20dependence.</li>\x0a<li\x20class=\x22p1\x22><strong>Baclofen</strong>:\x20It\x20is\x20a\x20GABA<sub>B\x20</sub>receptor\x20agonist.\x20It\x20acts\x20as\x20a\x20<strong>skeletal\x20muscle\x20relaxant</strong>\x20and\x20is\x20used\x20in\x20the\x20management\x20of\x20spasticity.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20not\x20true\x20about\x20beta-blockers?','choices':[{'id':0x1,'text':_0x5b771a(0x224)},{'id':0x2,'text':_0x5b771a(0x1f0)},{'id':0x3,'text':_0x5b771a(0x430)},{'id':0x4,'text':_0x5b771a(0x1c0)}],'correct_choice_id':0x3,'solution':'<p><strong>Celiprolol&nbsp;</strong>is\x20excreted\x20predominantly\x20through\x20the\x20<strong>renal</strong>\x20route.\x20It\x20is\x20excreted\x20unchanged\x20in\x20the\x20urine.</p>\x0a<p>Option\x20A:\x20Atenolol\x20is\x20longer\x20acting\x20with\x20a\x20longer\x20half-life\x20than\x20metoprolol.\x20It\x20is\x20usually\x20administered\x20once\x20daily.</p>\x0a<p>Option\x20C:\x20Labetalol\x20is\x20a\x20non-selective\x20&beta;-blocker\x20with\x20&alpha;<sub>1</sub>\x20blocking\x20action\x20similar\x20to\x20carvedilol.</p>\x0a<p>Option\x20D:\x20Nadolol\x20has\x20the\x20longest\x20half-life\x20of\x2020\x20hours\x20and\x20is\x20administered\x20once\x20daily.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x414),'choices':[{'id':0x1,'text':'Chloramphenicol'},{'id':0x2,'text':_0x5b771a(0x1cb)},{'id':0x3,'text':'Erythromycin'},{'id':0x4,'text':_0x5b771a(0x186)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x21f),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/8601d74ed10f4206ba871098f231f1db.JPEG'],'explanation_images':[]},{'text':'A\x2020-year-old\x20male\x20patient\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20complaints\x20of\x20breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting.\x20He\x20was\x20immediately\x20given\x20an\x20intramuscular\x20injection\x20of\x20a\x20drug\x20in\x201:1000\x20dilution.\x20The\x20drug\x20acts\x20on\x20which\x20of\x20the\x20following\x20receptor\x20to\x20improve\x20the\x20patient\x27s\x20breathing\x20difficulty?','choices':[{'id':0x1,'text':_0x5b771a(0x2d7)},{'id':0x2,'text':'Beta\x201'},{'id':0x3,'text':_0x5b771a(0x3d6)},{'id':0x4,'text':'Alpha\x201'}],'correct_choice_id':0x1,'solution':_0x5b771a(0x339),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x420),'choices':[{'id':0x1,'text':_0x5b771a(0x17e)},{'id':0x2,'text':_0x5b771a(0x25d)},{'id':0x3,'text':_0x5b771a(0x313)},{'id':0x4,'text':_0x5b771a(0x205)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x248),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x2ed),'choices':[{'id':0x1,'text':_0x5b771a(0x333)},{'id':0x2,'text':_0x5b771a(0x2ec)},{'id':0x3,'text':'1-c.\x202-b,\x203-a,\x204-d'},{'id':0x4,'text':'1-c.\x202-d,\x203-b,\x204-a'}],'correct_choice_id':0x2,'solution':'<p>Option\x20<strong>B</strong>\x20is\x20correctly\x20matched.</p>\x0a<table\x20style=\x22height:\x20173px;\x20width:\x20387.28125px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20149px;\x20text-align:\x20center;\x20height:\x2018px;\x22><strong>Antiretroviral\x20drug</strong></td>\x0a<td\x20style=\x22width:\x20240.28125px;\x20text-align:\x20center;\x20height:\x2018px;\x22><strong>Adverse\x20effect</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2024px;\x22>\x0a<td\x20style=\x22width:\x20149px;\x20height:\x2024px;\x22>\x0a<p><strong>1.\u00a0</strong>Didanosine</p>\x0a</td>\x0a<td\x20style=\x22width:\x20240.28125px;\x20height:\x2024px;\x22>\x0a<p><strong>c.\u00a0</strong>Peripheral\x20neuropathy</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2045px;\x22>\x0a<td\x20style=\x22width:\x20149px;\x20height:\x2045px;\x22>\x0a<p><strong>2.\u00a0</strong>Abacavir</p>\x0a</td>\x0a<td\x20style=\x22width:\x20240.28125px;\x20height:\x2045px;\x22>\x0a<p><strong>a.\u00a0</strong>Hypersensitivity\x20syndrome\u00a0</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20149px;\x20height:\x2018px;\x22>\x0a<p><strong>3.\u00a0</strong>Indinavir</p>\x0a</td>\x0a<td\x20style=\x22width:\x20240.28125px;\x20height:\x2018px;\x22>\x0a<p><strong>b.\u00a0</strong>Nephrolithiasis</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20149px;\x20height:\x2018px;\x22>\x0a<p><strong>4.\u00a0</strong>Enfuvirtide</p>\x0a</td>\x0a<td\x20style=\x22width:\x20240.28125px;\x20height:\x2018px;\x22><strong>d.\u00a0</strong>Injection-site\x20reactions</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Didanosine</strong>\u00a0is\x20a\x20<strong>nucleoside\x20reverse\x20transcriptase\x20inhibitor</strong>\x20(NRTI)\x20used\x20in\x20the\x20treatment\x20of\x20HIV-1,\x20HIV-2,\x20and\x20HTLV-1.\x20<strong>Peripheral\x20neuropathy</strong>\x20characterized\x20by\x20pain,\x20numbness,\x20and\x20tingling\x20in\x20glove\x20and\x20stock\x20pattern,\x20and\x20<strong>pancreatitis</strong>\x20are\x20the\x20most\x20adverse\x20effects\x20of\x20this\x20drug.\x20<strong>Stavudine</strong>,\x20another\x20NRTI,\x20also\x20causes\x20similar\x20adverse\x20effects.\u00a0</p>\x0a<p><strong>Abacavir</strong>\x20is\x20also\x20an\x20NRTI\x20approved\x20for\x20the\x20treatment\x20of\x20HIV-1\x20infection.\x20The\x20most\x20serious\x20adverse\x20effect\x20of\x20abacavir\x20is\x20a\x20<strong>hypersensitivity\x20syndrome</strong>\x20characterized\x20by\x20fever,\x20maculopapular\x20rash,\x20abdominal\x20pain,\x20gastrointestinal\x20upset,\x20malaise,\x20and\x20fatigue.</p>\x0a<p><strong>Indinavir</strong>\x20is\x20a\x20<strong>protease\x20inhibitor</strong>\u00a0that\x20has\x20a\x20unique\x20adverse\x20effect\x20of\x20<strong>nephrolithiasis</strong>\x20and\x20<strong>crystalluria</strong>.\x20It\x20is\x20also\x20associated\x20with\x20asymptomatic\x20unconjugated\x20<strong>hyperbilirubinemia</strong>,\x20<strong>hyperglycemia</strong>,\x20and\x20insulin\x20resistance.</p>\x0a<p><strong>Enfuvirtide</strong>\x20is\x20an\x20<strong>entry\x20(fusion)\x20inhibitor</strong>\x20that\x20binds\x20to\x20the\x20transmembrane\x20gp41\x20of\x20HIV-1\x20and\x20blocks\x20its\x20entry\x20into\x20the\x20host\x20cells.\x20It\x20is\x20the\x20only\x20approved<strong>\x20parenteral</strong>\x20antiretroviral\x20drug\x20and\x20therefore,<strong>\x20injection-site\x20reactions</strong>\x20like\x20pain,\x20erythema,\x20induration,\x20and\x20nodules/cysts\x20development\x20are\x20most\x20frequently\x20seen.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x146),'choices':[{'id':0x1,'text':_0x5b771a(0x24a)},{'id':0x2,'text':_0x5b771a(0x206)},{'id':0x3,'text':_0x5b771a(0x2d4)},{'id':0x4,'text':_0x5b771a(0x20a)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x288),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x1fb),'choices':[{'id':0x1,'text':'1'},{'id':0x2,'text':'2'},{'id':0x3,'text':'3'},{'id':0x4,'text':'4'}],'correct_choice_id':0x3,'solution':'<p\x20style=\x22text-align:\x20left;\x22>The\x20device\x20in\x20image\x203\x20is\x20a\u00a0<strong>spacer\x20device\x20</strong>that\x20can\x20be\x20prescribed\x20to<strong>\u00a0</strong><strong>decrease\u00a0</strong>the\x20incidence\x20of\x20propellant-mediated\x20<strong>oropharyngeal\x20adverse\x20effects</strong>.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Spacers\x20reduce\x20the\x20velocity\x20and\x20size\x20of\x20particles\x20entering\x20the\x20upper\x20airways.\u00a0This<strong>\u00a0</strong>reduces\x20the\x20amount\x20of\x20drug\x20depositing\x20in\x20the\x20oropharynx\x20and\x20increases\x20the\x20proportion\x20of\x20drugs\x20inhaled\x20into\x20the\x20lower\x20airways.\x20Thus,\x20a\x20less\x20amount\x20of\x20the\x20drug\x20gets\x20swallowed\x20and\x20absorbed\x20from\x20the\x20GI\x20tract\x20and\x20limits\x20local\x20side\x20effects.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Spacer\x20devices\x20are\x20<strong>useful</strong>\x20in\x20delivering\x20inhaled\x20drugs\x20to\x20<strong>children</strong>\u00a0who\x20are\x20not\x20able\x20to\x20use\x20a\x20pMDI\x20alone\x20but\x20can\x20also\x20be\x20used\x20by\x20<strong>adults</strong>\x20for\x20better\x20drug\x20delivery.\x20The\x20image\x20below\x20shows\x20the\x20use\x20of\x20a\x20spacer\x20device\x20with\x20a\x20face\x20mask\x20which\x20is\x20preferred\x20in\x20children\x20younger\x20than\x203\x20years\x20of\x20age.</p>','explanation_video':'','question_images':[_0x5b771a(0x219)],'explanation_images':[_0x5b771a(0x2a3),'https://dhmbxeygs57ff.cloudfront.net/uploads/c79334e432384464a4db8f878ca4023bx720x540.JPEG','https://dhmbxeygs57ff.cloudfront.net/uploads/cf3ec9228e96415da2ec3c3932577099x596x600.JPEG',_0x5b771a(0x19a),_0x5b771a(0x468)]},{'text':_0x5b771a(0x42a),'choices':[{'id':0x1,'text':_0x5b771a(0x197)},{'id':0x2,'text':_0x5b771a(0x43b)},{'id':0x3,'text':_0x5b771a(0x1b6)},{'id':0x4,'text':_0x5b771a(0x442)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x461),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x22f),'choices':[{'id':0x1,'text':_0x5b771a(0x366)},{'id':0x2,'text':_0x5b771a(0x354)},{'id':0x3,'text':_0x5b771a(0x21b)},{'id':0x4,'text':'Grapefruit\x20juice'}],'correct_choice_id':0x1,'solution':_0x5b771a(0x2df),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x239),'choices':[{'id':0x1,'text':_0x5b771a(0x140)},{'id':0x2,'text':_0x5b771a(0x351)},{'id':0x3,'text':_0x5b771a(0x2f4)},{'id':0x4,'text':_0x5b771a(0x2bc)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x33b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x2c1),'choices':[{'id':0x1,'text':'Phosphodiesterase\x20inhibition'},{'id':0x2,'text':_0x5b771a(0x35a)},{'id':0x3,'text':_0x5b771a(0x225)},{'id':0x4,'text':'Activation\x20of\x20histone\x20deacetylase'}],'correct_choice_id':0x4,'solution':_0x5b771a(0x1eb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20pregnant\x20woman\x20presents\x20to\x20your\x20OPD\x20with\x20severe\x20constipation.\x20After\x20ruling\x20out\x20pathological\x20causes,\x20which\x20of\x20the\x20following\x20is\x20the\x20safest\x20to\x20prescribe?','choices':[{'id':0x1,'text':_0x5b771a(0x210)},{'id':0x2,'text':_0x5b771a(0x258)},{'id':0x3,'text':_0x5b771a(0x22c)},{'id':0x4,'text':'Lactulose'}],'correct_choice_id':0x4,'solution':_0x5b771a(0x2f9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x2d5),'choices':[{'id':0x1,'text':_0x5b771a(0x3e4)},{'id':0x2,'text':_0x5b771a(0x43a)},{'id':0x3,'text':_0x5b771a(0x16d)},{'id':0x4,'text':'Topiramate'}],'correct_choice_id':0x4,'solution':_0x5b771a(0x283),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2035-year-old\x20woman,\x20diagnosed\x20with\x20bipolar\x20disorder\x20is\x20under\x20treatment\x20with\x20lithium\x20for\x20the\x20past\x202\x20months.\x20She\x20now\x20presents\x20with\x20excessive\x20thirst\x20and\x20frequent\x20urination\x20and\x20a\x20diagnosis\x20of\x20nephrogenic\x20diabetes\x20insipidus\x20was\x20made.\x20The\x20administration\x20of\x20desmopressin\x20did\x20not\x20increase\x20the\x20specific\x20gravity\x20of\x20urine.\x20Which\x20is\x20the\x20most\x20appropriate\x20treatment\x20in\x20this\x20case?','choices':[{'id':0x1,'text':_0x5b771a(0x310)},{'id':0x2,'text':'Amiloride'},{'id':0x3,'text':_0x5b771a(0x3cd)},{'id':0x4,'text':_0x5b771a(0x1da)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x29d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x14c),'choices':[{'id':0x1,'text':_0x5b771a(0x443)},{'id':0x2,'text':_0x5b771a(0x394)},{'id':0x3,'text':_0x5b771a(0x271)},{'id':0x4,'text':'It\x20is\x20a\x20monoclonal\x20antibody\x20containing\x20only\x20human\x20component'}],'correct_choice_id':0x2,'solution':'<p><strong>Trastuzumab</strong>\x20is\x20a\x20<strong>humanized\x20monoclonal\x20antibody</strong>\x20against\x20the\x20external\x20domain\x20of\x20<strong>HER2/neu.</strong>\x20In\x20humanized\x20antibodies,\x20all\x20components\x20are\x20identical\x20to\x20human\x20antibodies\x20(95%\x20human\x20component),\x20except\x20the\x20complementary\x20region\x20of\x20the\x20variable\x20chain\x20that\x20<strong>contains\x20sequences</strong>\x20from<strong>\x20other\x20species</strong>.</p>\x0a<p>It&nbsp;is\x20indicated\x20in\x20the\x20management\x20of\x20<strong>adjuvant\x20therapy</strong>\x20in\x20<strong>early</strong>\x20and\x20<strong>metastatic\x20HER-2\x20positive\x20breast\x20cancer.</strong>&nbsp;</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201213\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Human\x20epidermal\x20growth\x20factor\x20receptor\x202\x20tyrosine\x20kinase\x20receptor\x20(<strong>HER-2-TK</strong>)\x20<strong>inhibitors</strong>\x20are:</p>\x0a<ul>\x0a<li>Lapatinib</li>\x0a<li>Neratinib</li>\x0a</ul>\x0a<p><strong>Anti-Her-2\x20monoclonal\x20antibodies</strong>\x20are:</p>\x0a<ul>\x0a<li>Trastuzumab</li>\x0a<li>Pertuzumab</li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x370),'choices':[{'id':0x1,'text':'Enalapril'},{'id':0x2,'text':'Telmisartan'},{'id':0x3,'text':_0x5b771a(0x2a7)},{'id':0x4,'text':_0x5b771a(0x356)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x22a),'explanation_video':'','question_images':[_0x5b771a(0x3b7)],'explanation_images':[]},{'text':'Among\x20the\x20following\x20antimuscarinic\x20drugs\x20used\x20in\x20the\x20treatment\x20of\x20overactive\x20bladder,\x20which\x20one\x20shows\x20direct\x20spasmolytic\x20activity\x20on\x20smooth\x20muscles?','choices':[{'id':0x1,'text':'Tolterodine'},{'id':0x2,'text':_0x5b771a(0x336)},{'id':0x3,'text':_0x5b771a(0x285)},{'id':0x4,'text':_0x5b771a(0x36a)}],'correct_choice_id':0x3,'solution':_0x5b771a(0x347),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x43f),'choices':[{'id':0x1,'text':_0x5b771a(0x227)},{'id':0x2,'text':_0x5b771a(0x417)},{'id':0x3,'text':_0x5b771a(0x2c7)},{'id':0x4,'text':_0x5b771a(0x35d)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x33a),'explanation_video':'','question_images':[],'explanation_images':[_0x5b771a(0x36f)]},{'text':_0x5b771a(0x28e),'choices':[{'id':0x1,'text':_0x5b771a(0x1d2)},{'id':0x2,'text':_0x5b771a(0x3b0)},{'id':0x3,'text':_0x5b771a(0x341)},{'id':0x4,'text':_0x5b771a(0x419)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x1a9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x1a1),'choices':[{'id':0x1,'text':'Gemfibrozil'},{'id':0x2,'text':_0x5b771a(0x221)},{'id':0x3,'text':'Digoxin'},{'id':0x4,'text':_0x5b771a(0x452)}],'correct_choice_id':0x2,'solution':'<p\x20style=\x22text-align:\x20left;\x22><strong>Atenolol</strong>\x20is\x20a\x20<strong>beta-blocker</strong>\x20and\x20an\x20anti-hypertensive\x20medication\x20that\x20can\x20be\x20<strong>safely</strong>\x20prescribed\x20along\x20<strong>with\x20statins</strong>\x20like\x20atorvastatin\x20because\x20atenolol\x20does\x20not\x20have\x20much\x20interaction\x20with\x20statin\x20metabolism.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22><strong>Statins</strong>\x20are\x20hypolipidemic\x20drugs\x20that\x20act\x20by\x20<strong>competitively</strong>\x20<strong>inhibiting</strong>\x20the\x20enzyme\x20<strong>HMG-CoA\x20reductase</strong>.\x20This\x20allows\x20for\x20a\x20compensatory\x20increase\x20in\x20LDL\x20receptors\x20in\x20the\x20liver\x20and\x20thereby\x20<strong>increases\x20LDL\x20catabolism</strong>.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>They\x20are\x20well\x20tolerated.\x20However,\x20they\x20can\x20cause\x20notable\x20<strong>side\x20effects</strong>\x20such\x20as\x20<strong>myopathy\x20</strong>and\x20<strong>liver\x20injury</strong>.\x20They\u00a0occur\x20commonly\x20when\x20<strong>statins</strong>\x20are\x20<strong>concurrently</strong>\x20given\x20with\x20<strong>nicotinic\x20acid</strong>,\u00a0<strong>gemfibrozil</strong>,\x20or\u00a0<strong>CYP3A4</strong>\x20<strong>inhibitors</strong>\x20such\x20as:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20left;\x22><strong>Macrolide\x20antibiotics\x20(erythromycin/clarithromycin)</strong></li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Ketoconazole</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Cyclosporine</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>HIV\x20protease\x20inhibitors</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Warfarin</li>\x0a<li\x20style=\x22text-align:\x20left;\x22><strong>Digoxin</strong></li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Azole\x20antifungals</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Amiodarone</li>\x0a</ul>\x0a<p>Other\x20options:\u00a0</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20A:\x20<strong>Gemfibrozil</strong>\x20is\x20a\x20fibrate\x20that<strong>\x20inhibits\x20</strong>the<strong>\u00a0hepatic\x20uptake\x20of\x20statins</strong>\x20by\x20the\x20organic\x20anion\x20transporter\x20OATP1B1\x20and\x20prevents\x20its\x20metabolism,\x20thereby\x20increasing\x20its\x20bioavailability.\x20Thus,\x20the\x20risk\x20of\x20toxicity\x20of\x20statins\x20increases.\x20Concurrent\x20use\x20of\x20gemfibrozil\x20with\x20statins\x20most\x20commonly\x20causes\x20myopathy\x20(<strong>rhabdomyolysis</strong>).\u00a0</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20C:\u00a0<strong>Digoxin</strong>\u00a0used\x20concurrently\x20with\x20a\x20statin\x20can\x20increase\x20the\x20risk\x20of\x20myopathy.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20D:\x20<strong>Nicotinic\x20acid</strong>\x20(Niacin)\x20used\x20concurrently\x20with\x20statins\x20can\x20cause\x20myopathy\x20due\x20to\x20inhibition\x20of\x20skeletal\x20muscle\x20cholesterol\x20synthesis.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x304),'choices':[{'id':0x1,'text':'Ceftazidime'},{'id':0x2,'text':_0x5b771a(0x38b)},{'id':0x3,'text':_0x5b771a(0x152)},{'id':0x4,'text':_0x5b771a(0x41b)}],'correct_choice_id':0x4,'solution':'<p><strong>Cefpodoxime</strong>\x20<strong>does\x20not\x20have\x20anti-<em>Psedumonas</em>\x20activity</strong>\x20and\x20so\x20<strong>cannot\x20be\x20used\x20for</strong>\x20pneumonia\x20caused\x20by\x20<em><strong>Pseudomonas</strong></em>.</p>\x0a<p>The\x20<strong>antipseudomonal\x20cephalosporins</strong>\x20include\x20<strong>ceftazidime</strong>,\x20<strong>ceftolozane</strong>,\x20<strong>cefepime</strong>,\x20and\x20<strong>cefpirome</strong>.\x20<strong>Cefepime</strong>\x20and\x20<strong>cefpirome</strong>\x20also\x20have\x20excellent\x20action\x20against\x20organisms\x20that\x20might\x20be\x20resistant\x20to\x20other\x20cephalosporins\x20such\x20as\x20<em>Enterobacter</em>.\x20Thus,\x20they\x20are\x20also\x20called\x20<strong>fourth-generation\x20cephalosporins</strong>.</p>\x0a<p>Other\x20cell-wall\x20inhibitors\x20that\x20are\x20active\x20against\x20<em>Pseudomonas</em>\x20are:</p>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li><strong>Extended-spectrum\x20penicillins:</strong>\x0a<ul>\x0a<li>Carboxypenicillins:\x20carbenicillin,\x20ticarcillin&nbsp;</li>\x0a<li>Ureidopenicillins:\x20piperacillin,\x20mezlocillin</li>\x0a</ul>\x0a</li>\x0a<li><strong>Carbapenams:\x20</strong>imipenem,\x20carbapenem,\x20doripenem</li>\x0a<li><strong>Monobactum:\x20</strong>aztreonam</li>\x0a</ul>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x1c6),'choices':[{'id':0x1,'text':_0x5b771a(0x35b)},{'id':0x2,'text':_0x5b771a(0x241)},{'id':0x3,'text':'Rho-kinase\x20inhibitor'},{'id':0x4,'text':'K+\x20ATP\x20channel\x20agonist'}],'correct_choice_id':0x2,'solution':_0x5b771a(0x471),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x38f),'choices':[{'id':0x1,'text':_0x5b771a(0x41a)},{'id':0x2,'text':_0x5b771a(0x1a2)},{'id':0x3,'text':_0x5b771a(0x375)},{'id':0x4,'text':'GABA\x20transporter\x20inhibitor'}],'correct_choice_id':0x1,'solution':_0x5b771a(0x1ce),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x29c),'choices':[{'id':0x1,'text':_0x5b771a(0x203)},{'id':0x2,'text':'Doxorubicin'},{'id':0x3,'text':_0x5b771a(0x2c8)},{'id':0x4,'text':_0x5b771a(0x27b)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x327),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x3ec),'choices':[{'id':0x1,'text':'Radical\x20cure\x20of\x20plasmodium\x20vivax'},{'id':0x2,'text':'Prophylaxis\x20of\x20malaria\x20in\x20pregnancy'},{'id':0x3,'text':_0x5b771a(0x1c9)},{'id':0x4,'text':_0x5b771a(0x346)}],'correct_choice_id':0x1,'solution':_0x5b771a(0x287),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Your\x20friend\x20is\x20planning\x20a\x20trip\x20to\x20the\x20mountains\x20but\x20is\x20concerned\x20because\x20of\x20her\x20history\x20of\x20severe\x20nausea\x20and\x20vomiting\x20while\x20traveling\x20anywhere.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20be\x20the\x20least\x20effective\x20in\x20managing\x20her\x20condition?','choices':[{'id':0x1,'text':_0x5b771a(0x454)},{'id':0x2,'text':'Ondansetron'},{'id':0x3,'text':_0x5b771a(0x19b)},{'id':0x4,'text':'Diphenhydramine'}],'correct_choice_id':0x2,'solution':_0x5b771a(0x412),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x26f),'choices':[{'id':0x1,'text':_0x5b771a(0x3cd)},{'id':0x2,'text':_0x5b771a(0x3a7)},{'id':0x3,'text':_0x5b771a(0x43d)},{'id':0x4,'text':_0x5b771a(0x45d)}],'correct_choice_id':0x1,'solution':_0x5b771a(0x142),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x404),'choices':[{'id':0x1,'text':_0x5b771a(0x270)},{'id':0x2,'text':_0x5b771a(0x459)},{'id':0x3,'text':_0x5b771a(0x156)},{'id':0x4,'text':_0x5b771a(0x323)}],'correct_choice_id':0x2,'solution':_0x5b771a(0x2fa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2060-year-old\x20female\x20patient\x20was\x20diagnosed\x20with\x20parkinsonism.\x20She\x20was\x20commenced\x20on\x20combination\x20therapy\x20with\x20co-careldopa.\x20What\x20is\x20the\x20rationale\x20behind\x20this\x20combination\x20therapy?','choices':[{'id':0x1,'text':_0x5b771a(0x17a)},{'id':0x2,'text':_0x5b771a(0x467)},{'id':0x3,'text':_0x5b771a(0x250)},{'id':0x4,'text':_0x5b771a(0x296)}],'correct_choice_id':0x4,'solution':_0x5b771a(0x2d2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x30d),'choices':[{'id':0x1,'text':_0x5b771a(0x42f)},{'id':0x2,'text':_0x5b771a(0x399)},{'id':0x3,'text':_0x5b771a(0x41d)},{'id':0x4,'text':_0x5b771a(0x343)}],'correct_choice_id':0x3,'solution':'<p><strong>Radioactive\x20iodine\x20therapy</strong>\x20is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.\x20Therefore,\x20it\x20is\x20not\x20a\x20treatment\x20option\x20in\x20this\x20patient.</p>\x0a<p>Thyrotoxicosis\x20in\x20pregnancy:</p>\x0a<p>The\x20<strong>drug\x20of\x20choice</strong>\x20for\x20the\x20treatment\x20of\x20thyrotoxicosis\x20during\x20the<strong>\x20first\x20trimester\x20</strong>of\x20pregnancy\x20is\x20<strong>propylthiouracil\x20(PTU).</strong></p>\x0a<p>Methimazole\x20and\x20its\x20prodrug\x20(carbimazole)\x20are\x20usually\x20avoided\x20in\x20the\x20first\x20trimester\x20due\x20to\x20<strong>teratogenic\x20risk.</strong>&nbsp;However,\x20methimazole\x20is\x20used\x20for\x20the\x20remainder\x20of\x20the\x20pregnancy\x20due\x20to\x20the\x20concern\x20for\x20<strong>PTU-associated\x20liver\x20failure.</strong>&nbsp;</p>\x0a<p><strong>Subtotal\x20thyroidectomy</strong>\x20can\x20be\x20performed\x20during\x20the\x20<strong>mid-trimester.</strong></p>\x0a<p><strong>Radioactive\x20iodine\x20</strong>crosses\x20the\x20placenta\x20and\x20causes\x20the\x20destruction\x20of\x20the\x20fetal\x20thyroid.\x20Therefore,\x20it&nbsp;is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.</p>\x0a<p>Treatment\x20of\x20thyrotoxicosis\x20in\x20pregnancy</p>\x0a<table\x20style=\x22height:\x20108px;\x20width:\x20381px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Treatment\x20for\x20thyrotoxicosis</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x22><strong>First\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x22>\x0a<ul>\x0a<li>Propylthiouracil</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2064px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2064px;\x22><strong>Second\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2064px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a<li>Subtotal\x20thyroidectomy</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20137.828125px;\x22><strong>Third\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5b771a(0x1bd),'choices':[{'id':0x1,'text':_0x5b771a(0x368)},{'id':0x2,'text':_0x5b771a(0x376)},{'id':0x3,'text':_0x5b771a(0x30f)},{'id':0x4,'text':_0x5b771a(0x3d3)}],'correct_choice_id':0x1,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>The\x20given\x20scenario\x20of\x20deviation\x20of\x20the\x20eyes\x20(<strong>oculogyric\x20crisis</strong>),\u00a0inability\x20to\x20open\x20the\x20mouth\x20(<strong>trismus</strong>),\x20asymmetric\x20position\x20of\x20the\x20head\x20and\x20neck\x20(<strong>torticollis</strong>)\x20are\x20pointing\x20towards\x20a\x20diagnosis\x20of\x20haloperidol-induced\x20<strong>acute\x20dystonia</strong>.\x20The\x20first-line\x20treatment\x20for\x20antipsychotic-induced\x20acute\x20dystonia\x20is\x20<strong>diphenhydramine.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Acute\x20muscular\x20dystonia:</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>This\x20is\x20an\x20extrapyramidal\x20symptom\x20(EPS)\x20that\x20occurs\x20due\x20to\x20the\x20<strong>antagonism\x20of</strong>\x20dopamine\x20<strong>D2</strong>\x20receptors.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Acute\x20dystonia\x20is\x20more\x20commonly\x20associated\x20with\x20high\x20potency\x20<strong>typical\x20antipsychotics</strong>\x20like\x20<strong>haloperidol</strong>\x20and\x20occurs\x20within\u00a01\x20to\x205\x20days\x20of\x20initiation\x20of\x20therapy.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20occurs\x20most\x20commonly\x20among\x20<strong>younger</strong>\x20patients\x20and\x20is\x20characterized\x20by\x20<strong>muscle\x20spasms</strong>\x20involving\x20linguo-facial\x20muscles\x20causing\x20torticollis,\x20locked\x20jaw\x20or\x20trismus,\x20grimacing,\x20tongue\x20thrusting,\x20and\x20oculogyric\x20crisis\x20in\x20severe\x20form.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Treatment:</p>\x0a<ol>\x0a<li>Anticholinergic\x20agents\x20like\x20<strong>benztropine</strong>\u00a0or<strong>\x20diphenhydramine</strong>,\x20by\x20blocking\x20striatal\x20cholinergic\x20receptors,\x20balance\x20the\x20dopaminergic\x20activity\x20and\x20is\x20given\x20as\x20<strong>first-line\x20treatment</strong>\x20for\x20dystonia.\u00a0</li>\x0a<li><strong>Benzodiazepines\x20(diazepam)</strong>\x20antagonizes\x20the\x20excitatory\x20dopaminergic\x20neurons\x20by\x20their\x20GABA\x20agonist\x20action\x20and\x20are\x20used\x20in<strong>\x20refractory</strong>\x20cases\x20or\x20when\x20anticholinergic\x20use\x20is\x20contraindicated.</li>\x0a</ol>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20Propranolol\x20is\x20used\x20for\x20the\x20management\x20of\x20<strong>akathisia.</strong></p>\x0a<p>Option\x20C:\x20Dantrolene\x20is\x20used\x20in\x20the\x20management\x20of\x20<strong>neuroleptic\x20malignant\x20syndrome.</strong></p>\x0a<p>Option\x20D:\x20Lorazepam\x20is\x20used\x20for\x20treating\x20anxiety\x20disorders,\x20alcohol\x20withdrawal,\x20and\x20anesthetic\x20medication.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2045-year-old\x20man\x20has\x20chronic\x20hypertension\x20since\x2010\x20years.\x20He\x20has\x20tried\x20three\x20different\x20drugs\x20A,\x20B,\x20and\x20C\x20to\x20control\x20his\x20hypertension\x20over\x20the\x20years.\x20The\x20graph\x20below\x20shows\x20the\x20relationship\x20between\x20the\x20log[Dose]\x20and\x20the\x20response\x20of\x20three\x20drugs\x20A,\x20B,\x20and\x20C.\x20Which\x20of\x20the\x20following\x20options\x20is\x20true\x20in\x20regards\x20to\x20the\x20drugs\x27\x20efficacy?','choices':[{'id':0x1,'text':_0x5b771a(0x463)},{'id':0x2,'text':_0x5b771a(0x360)},{'id':0x3,'text':_0x5b771a(0x13c)},{'id':0x4,'text':_0x5b771a(0x2e9)}],'correct_choice_id':0x1,'solution':_0x5b771a(0x172),'explanation_video':'','question_images':[_0x5b771a(0x34e)],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/31dc380ad3314fbc84b8312c08dd272cx1280x1165.JPEG',_0x5b771a(0x31c)]}],quizName=_0x5b771a(0x1d8);const quizFilename=_0x5b771a(0x26d);let hierarchy=[_0x5b771a(0x29b),'NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise',_0x5b771a(0x14f)];if(window['location'][_0x5b771a(0x41e)][_0x5b771a(0x3a4)](_0x5b771a(0x436))){const customData=JSON[_0x5b771a(0x2dc)](localStorage[_0x5b771a(0x275)](_0x5b771a(0x2cb)));if(customData){const mXOxGj=_0x5b771a(0x312)['split']('|');let GDhrOK=0x0;while(!![]){switch(mXOxGj[GDhrOK++]){case'0':document[_0x5b771a(0x3fa)](_0x5b771a(0x384))[_0x5b771a(0x2f6)]=hierarchy[_0x5b771a(0x416)]('\x20>\x20');continue;case'1':quizName=customData[_0x5b771a(0x2ea)];continue;case'2':hierarchy=customData['hierarchy'];continue;case'3':questionsData=customData[_0x5b771a(0x1e0)];continue;case'4':document['getElementById']('totalQuestions')[_0x5b771a(0x2f6)]=questionsData[_0x5b771a(0x2d8)];continue;case'5':document[_0x5b771a(0x445)]=quizName+_0x5b771a(0x187);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x5b771a(0x188),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x5b771a(0x3e3)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])[_0x5b771a(0x315)](null)[_0x5b771a(0x27c)](()=>({'status':_0x5b771a(0x1ff),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x5b771a(0x2d8)]};function saveProgress(){const _0x2688c7=_0x5b771a,_0x10b1a4={'bXdCa':_0x2688c7(0x1f8)};if(isQuizCompleted)return;const _0xfb5a62=JSON['parse'](localStorage[_0x2688c7(0x275)](_0x10b1a4['bXdCa']))||{};_0xfb5a62[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x2688c7(0x1a7),'lastSeen':new Date()[_0x2688c7(0x193)]()},localStorage[_0x2688c7(0x251)](_0x10b1a4[_0x2688c7(0x18a)],JSON[_0x2688c7(0x45f)](_0xfb5a62));}function loadProgress(){const _0x704365=_0x5b771a,_0x1aca93={'lUMLJ':function(_0x5589b9,_0x49feb3){return _0x5589b9!==_0x49feb3;},'dYoYi':_0x704365(0x438),'GXYnV':_0x704365(0x183),'vWRjU':_0x704365(0x3e5)},_0x4208e4=JSON[_0x704365(0x2dc)](localStorage[_0x704365(0x275)]('userHistory'))||{},_0x1420b0=_0x4208e4[quizFilename];if(_0x1420b0){if(_0x1aca93[_0x704365(0x147)](_0x1aca93[_0x704365(0x26a)],_0x1aca93[_0x704365(0x45c)])){const _0x51c765=_0x704365(0x44f)[_0x704365(0x3bd)]('|');let _0x168c1b=0x0;while(!![]){switch(_0x51c765[_0x168c1b++]){case'0':console['log'](_0x1aca93['vWRjU']);continue;case'1':return!![];case'2':currentMode=_0x1420b0[_0x704365(0x293)];continue;case'3':currentQuestionIndex=_0x1420b0[_0x704365(0x3f0)];continue;case'4':stats=_0x1420b0[_0x704365(0x3b4)];continue;case'5':questionStates=_0x1420b0[_0x704365(0x264)];continue;}break;}}else{if(_0x41d734[_0x704365(0x447)]()){const _0xf28248=new _0x57bfad();_0xf28248[_0x704365(0x214)](_0x5863ed),_0xf28248['attachMedia'](_0x1c9109);}else _0x206fed[_0x704365(0x3e7)](_0x704365(0x1ec))&&(_0x349658[_0x704365(0x2ef)]=_0xf4375f);}}return![];}function clearProgress(){const _0x45caea=_0x5b771a,_0x11e77d={'BtBOg':function(_0x554877){return _0x554877();},'jxInT':function(_0x13a3a5,_0x2fde9d){return _0x13a3a5===_0x2fde9d;},'vwKPD':_0x45caea(0x37f),'VkLCK':_0x45caea(0x1f8),'IySdU':_0x45caea(0x41f)},_0x50276d=JSON[_0x45caea(0x2dc)](localStorage[_0x45caea(0x275)](_0x45caea(0x1f8)))||{};_0x50276d[quizFilename]&&(_0x11e77d[_0x45caea(0x2f0)](_0x11e77d[_0x45caea(0x40c)],'uDuqo')?(delete _0x50276d[quizFilename],localStorage[_0x45caea(0x251)](_0x11e77d[_0x45caea(0x24b)],JSON[_0x45caea(0x45f)](_0x50276d)),console[_0x45caea(0x437)](_0x11e77d[_0x45caea(0x316)])):_0x11e77d['BtBOg'](_0x260e04));}function markQuizAsCompleted(){const _0x36c43c=_0x5b771a,_0x26e7d7={'xRJWd':_0x36c43c(0x3e9)},_0x2520bf=JSON[_0x36c43c(0x2dc)](localStorage['getItem'](_0x36c43c(0x1f8)))||{},_0x1ac7c1=questionsData[_0x36c43c(0x2d8)],_0x3ed0a6=stats[_0x36c43c(0x16f)]||0x0;_0x2520bf[quizFilename]={'score':_0x3ed0a6,'total':_0x1ac7c1,'status':_0x26e7d7[_0x36c43c(0x1f6)],'completedOn':new Date()[_0x36c43c(0x193)]()},localStorage[_0x36c43c(0x251)]('userHistory',JSON[_0x36c43c(0x45f)](_0x2520bf));}const urlParams=new URLSearchParams(window[_0x5b771a(0x22b)][_0x5b771a(0x34d)]),startAt=parseInt(urlParams['get'](_0x5b771a(0x44c))),resume=urlParams[_0x5b771a(0x305)]('resume')===_0x5b771a(0x470);function goBack(){const _0x3b9dc1=_0x5b771a,_0x40d840={'WXpBH':_0x3b9dc1(0x369)};if(!isQuizCompleted)saveProgress();window[_0x3b9dc1(0x22b)]['href']=document['referrer']||_0x40d840[_0x3b9dc1(0x32c)];}function selectMode(_0x10993d){const _0x67a65a=_0x5b771a,_0xff52a8={'NrEwm':_0x67a65a(0x2e4),'CnTmP':_0x67a65a(0x38a)};currentMode=_0x10993d,document[_0x67a65a(0x3fa)](_0xff52a8[_0x67a65a(0x457)])[_0x67a65a(0x40f)][_0x67a65a(0x3a9)]=_0xff52a8[_0x67a65a(0x389)],initializeQuiz();}function initializeQuiz(){const _0x4daeb2=_0x5b771a,_0x30d314={'KbgIc':_0x4daeb2(0x423),'lYsat':'timed_exam','OwmXi':_0x4daeb2(0x434),'sohvY':_0x4daeb2(0x38a),'xsOsl':_0x4daeb2(0x3b8),'mjWsR':_0x4daeb2(0x2a8),'QYRRk':'testModeLegend','CpGDc':_0x4daeb2(0x22e),'XMfWd':_0x4daeb2(0x318),'kNuVB':function(_0x15d1e1,_0xdc496f){return _0x15d1e1===_0xdc496f;},'zoTyg':function(_0x3de127,_0x32ad8f){return _0x3de127===_0x32ad8f;},'YsEID':function(_0x336fee,_0x52f0d8){return _0x336fee===_0x52f0d8;},'USdXl':_0x4daeb2(0x3bc),'TJPSJ':_0x4daeb2(0x17f),'FJuyq':function(_0x1d063c,_0x376d91){return _0x1d063c(_0x376d91);},'TGiWO':function(_0x4596c4,_0x4c4a5c){return _0x4596c4>=_0x4c4a5c;},'eXqPF':function(_0x11ac6a){return _0x11ac6a();},'UcQdL':function(_0x5b4645){return _0x5b4645();}};quizStartTime=Date[_0x4daeb2(0x3e3)]();const _0x46f332=document[_0x4daeb2(0x3fa)](_0x4daeb2(0x280)),_0x2f9e74=document[_0x4daeb2(0x3fa)]('markReviewBtn'),_0x3532d5=document[_0x4daeb2(0x3fa)]('testModeReviewLegend'),_0x1e55a3=currentMode===_0x30d314[_0x4daeb2(0x433)]||currentMode===_0x30d314[_0x4daeb2(0x25a)];document[_0x4daeb2(0x3fa)](_0x30d314[_0x4daeb2(0x19c)])['style'][_0x4daeb2(0x3a9)]=_0x1e55a3?_0x30d314[_0x4daeb2(0x262)]:_0x30d314[_0x4daeb2(0x1ba)],document['getElementById'](_0x30d314['mjWsR'])[_0x4daeb2(0x40f)]['display']=_0x1e55a3?_0x30d314[_0x4daeb2(0x262)]:_0x30d314[_0x4daeb2(0x1ba)],document['getElementById'](_0x30d314[_0x4daeb2(0x311)])[_0x4daeb2(0x40f)][_0x4daeb2(0x3a9)]=_0x1e55a3?_0x30d314['xsOsl']:_0x30d314['sohvY'],document['getElementById'](_0x30d314[_0x4daeb2(0x3c9)])[_0x4daeb2(0x40f)]['display']=_0x1e55a3?'block':_0x30d314[_0x4daeb2(0x262)],_0x46f332[_0x4daeb2(0x40f)][_0x4daeb2(0x3a9)]=_0x1e55a3?_0x30d314[_0x4daeb2(0x262)]:_0x30d314['XMfWd'],_0x2f9e74[_0x4daeb2(0x40f)]['display']=_0x1e55a3?_0x30d314[_0x4daeb2(0x3a5)]:_0x30d314[_0x4daeb2(0x262)],_0x3532d5['style'][_0x4daeb2(0x3a9)]=_0x1e55a3?_0x30d314[_0x4daeb2(0x3a5)]:_0x30d314[_0x4daeb2(0x262)],(_0x30d314[_0x4daeb2(0x37b)](currentMode,_0x4daeb2(0x317))||_0x30d314['zoTyg'](currentMode,_0x30d314['lYsat']))&&(_0x30d314[_0x4daeb2(0x30e)](_0x30d314[_0x4daeb2(0x15f)],'GawAG')?document[_0x4daeb2(0x3fa)](_0x30d314[_0x4daeb2(0x458)])[_0x4daeb2(0x3ce)][_0x4daeb2(0x2f1)](_0x4daeb2(0x291)):_0x5c87b6=_0xaef39a[_0x4daeb2(0x42e)](_0x822d5a=>!(_0x822d5a[_0x4daeb2(0x198)][_0x4daeb2(0x23c)](_0x31e708[_0x4daeb2(0x266)]()[_0x4daeb2(0x163)](/ /g,'-'))&&_0x822d5a[_0x4daeb2(0x14b)]===_0x32f205))),!_0x30d314[_0x4daeb2(0x18c)](isNaN,startAt)&&_0x30d314[_0x4daeb2(0x15e)](startAt,0x0)&&startAt<questionsData[_0x4daeb2(0x2d8)]&&(currentQuestionIndex=startAt),_0x30d314[_0x4daeb2(0x161)](loadBookmarkedQuestions),_0x30d314[_0x4daeb2(0x393)](generateQuestionNav),_0x30d314[_0x4daeb2(0x393)](updateStats),displayQuestion();}function generateQuestionNav(){const _0x3da900=_0x5b771a,_0x153a0a={'JLrIg':_0x3da900(0x1f3),'iboaa':function(_0x295a17,_0x4955bd){return _0x295a17===_0x4955bd;},'idKxy':_0x3da900(0x1cf),'tBYwY':function(_0x31f0f2,_0x189ad2){return _0x31f0f2+_0x189ad2;},'tzQQf':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200'},_0x323704=document[_0x3da900(0x3fa)](_0x3da900(0x1de));_0x323704[_0x3da900(0x3a8)]='';for(let _0x4edbd8=0x0;_0x4edbd8<questionsData['length'];_0x4edbd8++){if(_0x153a0a[_0x3da900(0x2bd)](_0x153a0a[_0x3da900(0x3ad)],_0x3da900(0x1cf))){const _0x39dc95=document[_0x3da900(0x334)](_0x3da900(0x306));_0x39dc95['textContent']=_0x153a0a['tBYwY'](_0x4edbd8,0x1),_0x39dc95[_0x3da900(0x216)]=_0x153a0a[_0x3da900(0x168)],_0x39dc95['onclick']=()=>jumpToQuestion(_0x4edbd8),_0x39dc95['id']='navBtn_'+_0x4edbd8,_0x323704[_0x3da900(0x37d)](_0x39dc95);}else _0x4693e3[_0x3da900(0x3fa)](_0x153a0a[_0x3da900(0x185)])['classList'][_0x3da900(0x246)](_0x3da900(0x291));}updateQuestionNav();}function updateQuestionNav(){const _0x4907cc=_0x5b771a,_0x2d891a={'lIHXS':_0x4907cc(0x27f),'OLhmg':_0x4907cc(0x1e1),'nYuiO':'Incorrect','frwPh':'userHistory','iKKle':'Progress\x20loaded.','xkEWW':function(_0x2cf984,_0x8094c8){return _0x2cf984<_0x8094c8;},'SOitN':function(_0x5825df,_0x2e30e2){return _0x5825df!==_0x2e30e2;},'KbMQi':_0x4907cc(0x179),'YbolI':_0x4907cc(0x3f9),'yXUOo':'nav-btn-bookmarked','UirYB':_0x4907cc(0x279),'YtIVN':_0x4907cc(0x188),'WwNES':function(_0x5d1ea4,_0x4b7d1e){return _0x5d1ea4===_0x4b7d1e;},'xaHkh':function(_0x2c3b16,_0x1b48ea){return _0x2c3b16!==_0x1b48ea;},'gSJdR':_0x4907cc(0x2ca),'OzleO':function(_0xd61c81,_0x3f4914){return _0xd61c81===_0x3f4914;},'qyGJv':'nav-btn-correct','wMLQO':_0x4907cc(0x440),'sgapT':_0x4907cc(0x44b),'DTHaH':_0x4907cc(0x340),'cVXtl':function(_0x192ce8,_0x2f4a0e){return _0x192ce8!==_0x2f4a0e;},'UpOLh':_0x4907cc(0x1c4)};for(let _0x2f4122=0x0;_0x2d891a[_0x4907cc(0x167)](_0x2f4122,questionsData[_0x4907cc(0x2d8)]);_0x2f4122++){const _0x379d61=document[_0x4907cc(0x3fa)](_0x4907cc(0x377)+_0x2f4122),_0x44cc9e=questionStates[_0x2f4122];let _0x38b6b9='';if(_0x2f4122===currentQuestionIndex){if(_0x2d891a[_0x4907cc(0x3aa)](_0x2d891a[_0x4907cc(0x46c)],_0x2d891a[_0x4907cc(0x164)]))_0x38b6b9=_0x4907cc(0x3a2);else{const _0x520a07=_0x2790bd[_0x4907cc(0x1ea)][_0x29d392[_0x4907cc(0x314)]];_0x520a07['id']===_0x108d43?(_0x701de2=_0x2d891a['lIHXS'],_0x4ff31c=_0x2d891a[_0x4907cc(0x431)]):(_0x992529=_0x4907cc(0x440),_0x4c22a2=_0x2d891a['nYuiO']);}}else{if(_0x44cc9e[_0x4907cc(0x3bb)])_0x38b6b9=_0x2d891a[_0x4907cc(0x33f)];else{if(_0x44cc9e[_0x4907cc(0x170)])_0x38b6b9=_0x2d891a['UirYB'];else{if(currentMode===_0x2d891a[_0x4907cc(0x329)]||_0x2d891a[_0x4907cc(0x145)](currentMode,'timed_study')){if(_0x2d891a[_0x4907cc(0x1cc)](_0x4907cc(0x2ca),_0x2d891a[_0x4907cc(0x2cd)])){const _0x3aa5c1=_0x4942ae[_0x4907cc(0x2dc)](_0x372d3e[_0x4907cc(0x275)](_0x2d891a['frwPh']))||{},_0x267bc3=_0x3aa5c1[_0x3ba582];if(_0x267bc3){const _0x28b7ec=_0x4907cc(0x388)[_0x4907cc(0x3bd)]('|');let _0x105ad9=0x0;while(!![]){switch(_0x28b7ec[_0x105ad9++]){case'0':_0x460b22=_0x267bc3[_0x4907cc(0x264)];continue;case'1':_0xb26eb7=_0x267bc3['currentQuestionIndex'];continue;case'2':_0x4b64da=_0x267bc3['currentMode'];continue;case'3':_0xc9456b[_0x4907cc(0x437)](_0x2d891a[_0x4907cc(0x157)]);continue;case'4':_0x362789=_0x267bc3[_0x4907cc(0x3b4)];continue;case'5':return!![];}break;}}return![];}else{if(_0x2d891a[_0x4907cc(0x408)](_0x44cc9e[_0x4907cc(0x200)],_0x4907cc(0x27f)))_0x38b6b9=_0x2d891a[_0x4907cc(0x1ab)];else{if(_0x44cc9e[_0x4907cc(0x200)]===_0x2d891a[_0x4907cc(0x2e0)])_0x38b6b9=_0x2d891a[_0x4907cc(0x25b)];else _0x38b6b9=_0x2d891a['DTHaH'];}}}else{if(_0x2d891a[_0x4907cc(0x1e2)](_0x44cc9e[_0x4907cc(0x314)],null))_0x38b6b9=_0x2d891a[_0x4907cc(0x240)];else _0x38b6b9=_0x4907cc(0x340);}}}}_0x379d61['className']=_0x4907cc(0x34f)+_0x38b6b9;}}function jumpToQuestion(_0x3e4e46){const _0x180d75=_0x5b771a,_0x1a6d90={'wlgKO':function(_0x2fb544,_0x135eaa){return _0x2fb544>=_0x135eaa;},'MNTJZ':function(_0x92e50f,_0x531626){return _0x92e50f<_0x531626;},'ApZMY':function(_0x3bbb05,_0x545cb8){return _0x3bbb05===_0x545cb8;},'gRoeP':_0x180d75(0x29e),'TvOGK':'qBraO','IcHTH':function(_0x543ed9,_0x1c3432){return _0x543ed9-_0x1c3432;},'QpcPP':function(_0x5ccf7e){return _0x5ccf7e();}};_0x1a6d90[_0x180d75(0x281)](_0x3e4e46,0x0)&&_0x1a6d90[_0x180d75(0x2af)](_0x3e4e46,questionsData[_0x180d75(0x2d8)])&&(_0x1a6d90[_0x180d75(0x1d3)](_0x1a6d90[_0x180d75(0x3a1)],_0x1a6d90[_0x180d75(0x17b)])?_0x55929e[_0x180d75(0x3a8)]+=_0x180d75(0x215)+_0x94f105[_0x180d75(0x2ac)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':(questionStartTime&&(questionStates[currentQuestionIndex][_0x180d75(0x26c)]+=_0x1a6d90[_0x180d75(0x295)](Date['now'](),questionStartTime)),currentQuestionIndex=_0x3e4e46,displayQuestion(),_0x1a6d90['QpcPP'](saveProgress)));}function updateStats(){const _0x395d2c=_0x5b771a,_0x54b712={'nEHzF':_0x395d2c(0x188),'aRwQz':function(_0x5e506d,_0x3aa1af){return _0x5e506d===_0x3aa1af;},'AkdtP':'timed_study','WFEIG':_0x395d2c(0x249),'GqPmS':function(_0x2aec30,_0x1f1ee3){return _0x2aec30*_0x1f1ee3;},'UQMPd':function(_0x35028b,_0x5f390b){return _0x35028b/_0x5f390b;},'GFwBT':_0x395d2c(0x1f5),'nmlmF':function(_0x47a928,_0x482118){return _0x47a928+_0x482118;},'SCfIN':function(_0x219614,_0x5c99ff){return _0x219614/_0x5c99ff;},'SDmfa':_0x395d2c(0x26c),'ViQyj':function(_0x5321b1,_0x3ef629){return _0x5321b1+_0x3ef629;}};if(currentMode===_0x54b712[_0x395d2c(0x3f8)]||_0x54b712[_0x395d2c(0x3e6)](currentMode,_0x54b712[_0x395d2c(0x3e1)])){document['getElementById'](_0x395d2c(0x169))[_0x395d2c(0x2f6)]=stats[_0x395d2c(0x16f)],document[_0x395d2c(0x3fa)](_0x54b712[_0x395d2c(0x3fb)])['textContent']=stats[_0x395d2c(0x1e3)],document['getElementById'](_0x395d2c(0x40a))[_0x395d2c(0x2f6)]=stats[_0x395d2c(0x40a)];const _0x453f2d=stats[_0x395d2c(0x40a)]>0x0?Math[_0x395d2c(0x361)](_0x54b712['GqPmS'](_0x54b712[_0x395d2c(0x19e)](stats[_0x395d2c(0x16f)],stats[_0x395d2c(0x40a)]),0x64)):0x0;document[_0x395d2c(0x3fa)](_0x54b712[_0x395d2c(0x410)])[_0x395d2c(0x2f6)]=_0x54b712[_0x395d2c(0x28d)](_0x453f2d,'%'),stats[_0x395d2c(0x15a)]=questionStates['reduce']((_0x1eb75e,_0x2d6c6a)=>_0x1eb75e+_0x2d6c6a['timeSpent'],0x0);const _0x26a7c0=Math[_0x395d2c(0x21a)](_0x54b712[_0x395d2c(0x2d9)](stats[_0x395d2c(0x15a)],0x3e8)),_0x8aaa64=Math[_0x395d2c(0x21a)](_0x26a7c0/0x3c),_0x31d990=_0x26a7c0%0x3c;document[_0x395d2c(0x3fa)](_0x54b712[_0x395d2c(0x39b)])[_0x395d2c(0x2f6)]=_0x54b712[_0x395d2c(0x344)](_0x54b712[_0x395d2c(0x28d)](_0x8aaa64,':'),_0x31d990[_0x395d2c(0x33e)]()[_0x395d2c(0x26b)](0x2,'0'));}}function _0x3c41(){const _0x44d98e=['solutionVideo','YtIVN','1-b,\x202-a,\x203-d,\x204-c','incorrectResult','WXpBH','rBSWo','YICZt','VOcxn','DQfOP','iubcX','ZuSTP','1-a.\x202-c,\x203-b,\x204-d','createElement','VPpGf','Darifenacin','snypN','nLrjO','<p>The\x20patient\x27s\x20complaints\x20of\u00a0breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting\x20are\x20suggestive\x20of\x20anaphylactic\x20shock.\x20The\x20<strong>drug\u00a0of\x20choice</strong>\x20for\x20anaphylaxis\x20is\x20<strong>intramuscular\x20adrenaline</strong>\x20(<strong>0.5ml\x20in\x201:1000\x20dilution</strong>).\x20Activation\x20of\x20<strong>beta\x202</strong>\x20receptors\x20causes<strong>\x20bronchodilation</strong>.\x20Hence,\x20adrenaline\x20action\x20on\x20the\x20beta\x202\x20receptors\x20improves\x20the\x20breathing\x20difficulty\x20in\x20this\x20patient.\x20Apart\x20from\x20this,\x20beta\x202\x20receptors\x20also\x20inhibit\x20the\x20secretion\x20from\x20mast\x20cells.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<table\x20style=\x22height:\x2099px;\x22\x20width=\x22456\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22><strong>Receptor</strong></td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22><strong>Action</strong></td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22><strong>Use\x20in\x20anaphylaxis\x20treatment\u00a0</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Alpha\x201\x20and\x20Alpha\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Vasoconstriction</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x201</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Cardiac\x20stimulation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Bronchodilation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Reverse\x20bronchoconstriction\u00a0</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>The\x20net\x20effect\x20of\x20adrenaline\x20on\x20BP:\x20Adrenaline\x20rapidly\x20<strong>increases\x20blood\x20pressure</strong>\x20by\x20reversing\x20vasodilation\x20and\x20improving\x20cardiac\x20output.\x20This\x20is\x20critical\x20for\x20preventing\x20shock\x20and\x20ensuring\x20adequate\x20perfusion\x20to\x20vital\x20organs\x20during\x20anaphylaxis.</p>','<p>The\x20advantage\x20of\x20the<strong>&nbsp;\x27Z-track\x20technique\x27&nbsp;</strong>for\x20intramuscular\x20administration\x20is\x20that\x20it<strong>\x20prevents\x20skin\x20staining.&nbsp;</strong></p>\x0a<p>Z-track\x20technique\x20procedure:&nbsp;</p>\x0a<ol>\x0a<li>Stretch\x20the\x20skin\x20by\x20pulling\x20it\x20laterally\x20away\x20from\x20the\x20intended\x20point\x20of\x20injection.</li>\x0a<li>Insert\x20the\x20needle\x20into\x20the\x20site\x20at\x20a\x2090\x20angle,\x20aspirate\x20by\x20pulling\x20back\x20to\x20see\x20if\x20the\x20needle\x20has\x20a\x20penetrated\x20vessel.</li>\x0a<li>If\x20blood\x20is\x20aspirated\x20withdraw\x20the\x20needle,\x20and\x20repeat\x20the\x20procedure\x20at\x20another\x20site\x20with\x20new\x20equipment\x20and\x20medication.</li>\x0a<li>If\x20no\x20blood\x20is\x20aspirated\x20administer\x20the\x20injection.</li>\x0a<li>Wait\x20for\x2010\x20seconds\x20and\x20then\x20withdraw\x20the\x20needle,\x20and\x20release\x20the\x20skin\x20allowing\x20the\x20displaced\x20tissue\x20to\x20seal\x20the\x20needle\x20track.</li>\x0a</ol>\x0a<p><strong>Advantages:</strong>&nbsp;</p>\x0a<ul>\x0a<li>The\x20\x27Z-track\x27&nbsp;<strong>prevents\x20leakage</strong>\x20of\x20the\x20medication\x20into\x20the\x20subcutaneous\x20tissue\x20and<strong>\x20skin\x20staining\x20</strong>through\x20the\x20tract\x20to\x20the\x20surface\x20of\x20the\x20skin</li>\x0a<li><strong>Pain\x20intensity\x20</strong>is\x20also<strong>\x20reduced</strong>&nbsp;</li>\x0a</ul>','<p>This\x20elderly\x20patient\x20with\x20a\x20swollen,\x20painful\x20big\x20toe\x20and\x20needle-shaped,\x20negatively\x20birefringent\x20crystals\x20on\x20synovial\x20tap\x20has&nbsp;<strong>acute\x20gout.\x20</strong>Due\x20to\x20coexisting\x20<strong>chronic\x20kidney\x20disease,\x20</strong>the\x20drug\x20of\x20choice\x20in\x20him\x20is\x20<strong>intra-articular\x20steroids\x20</strong>like\x20<strong>triamcinolone\x20</strong>or\x20<strong>methylprednisolone.</strong></p>\x0a<p>The\x20drug\x20of\x20choice\x20is\x20an\x20acute\x20attack\x20of\x20gout\x20is\x20<strong>NSAIDs\x20</strong>(Non-steroidal\x20anti-inflammatory\x20drugs)\x20like\x20<strong>indomethacin\x20</strong>or\x20the\x20drug\x20<strong>colchicine,\x20</strong>but\x20they\x20are\x20poorly\x20tolerated\x20and\x20should\x20<strong>not\x20</strong>be\x20used\x20in\x20<strong>elderly\x20</strong>patients\x20<strong>with</strong>\x20<strong>chronic\x20kidney\x20</strong>disease.</p>\x0a<p>Drugs\x20used\x20in\x20the\x20management\x20of\x20gout\x20can\x20be\x20classified\x20as:</p>\x0a<p>Drugs\x20that\x20<strong>relieve\x20inflammation\x20and\x20pain</strong>-\x20These\x20drugs\x20are\x20useful\x20in\x20the\x20management\x20of\x20<strong>acute\x20attacks\x20of\x20gout</strong>.\x20They\x20are:</p>\x0a<ul>\x0a<li><strong>NSAIDs</strong>-\x20They\x20mainly\x20exert\x20their\x20antiinflammatory\x20action\x20by\x20inhibiting\x20cyclooxygenase\x20enzyme\x20(COX).&nbsp;This\x20enzyme\x20converts\x20arachidonic\x20acid\x20to&nbsp;prostanoids,\x20thromboxane\x20A2,\x20and\x20other\x20prostaglandins.&nbsp;</li>\x0a<li><strong>Colchicine</strong>-&nbsp;It\x20arrests\x20the\x20cell\x20division\x20in\x20G<span\x20class=\x22s1\x22>1\x20</span>by\x20interfering\x20with\x20microtubule\x20and\x20spindle\x20formation.\x20This\x20results\x20in\x20decreased\x20neutrophil\x20recruitment,\x20decreased\x20neutrophil\x20motility,\x20and\x20decreased\x20release\x20of\x20chemotactic\x20factors.&nbsp;</li>\x0a<li><strong>Glucocorticoids</strong>-\x20These\x20drugs\x20bind\x20to\x20the\x20nuclear\x20receptors\x20and\x20decrease\x20the\x20transcription\x20of\x20genes\x20for&nbsp;COX-2,\x20inducible\x20NOS\x20(NOS2),\x20inflammatory\x20cytokines,\x20collagenase,\x20etc,\x20that\x20are\x20responsible\x20for\x20inflammation.</li>\x0a</ul>\x0a<p>Drugs\x20that\x20inhibit\x20urate\x20formation-\x20These\x20drugs\x20inhibit\x20urate\x20formation\x20by\x20inhibiting\x20the\x20enzyme\x20xanthine\x20oxidase.\x20Eg.\x20allopurinol\x20and\x20febuxostat</p>\x0a<p>Uricosuric\x20drugs-\x20These\x20drugs\x20increase\x20the\x20excretion\x20of\x20uric\x20acid.\x20Important\x20ones\x20are:</p>\x0a<ul>\x0a<li><strong>Probenecid-</strong>\x20it&nbsp;inhibits\x20the\x20reabsorption\x20of\x20uric\x20acid\x20by\x20inhibiting\x20organic\x20acid\x20transporter\x20(OATs),\x20principally\x20URAT-1.</li>\x0a<li><strong>Benzbromarone</strong>-\x20It\x20increases\x20uric\x20acid\x20secretion\x20by&nbsp;reversibly\x20inhibiting\x20urate&ndash;anion\x20exchanger\x20in\x20the\x20proximal\x20tubule</li>\x0a<li><strong>Lesinurad</strong>-\x20It&nbsp;inhibits\x20the\x20URAT-1\x20and\x20OAT-4\x20transporters,\x20thereby\x20reducing\x20renal\x20uric\x20acid\x20reabsorption.</li>\x0a</ul>\x0a<p>Pegloticase\x20and\x20rasburicase\x20catalyze\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin.\x20This\x20product\x20is\x20soluble\x20and\x20inactive.&nbsp;</p>','IElZH','jdEYa','toString','yXUOo','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','4\x20and\x205','.option-button','Subtotal\x20thyroidectomy','ViQyj','correct_choice_id','Treatment\x20of\x20malaria\x20in\x20children\x20<2\x20years','<p><strong>Oxybutynin</strong>\x20is\x20an\x20antimuscarinic\x20drug\x20indicated\x20in&nbsp;the<strong>\x20overactive\x20bladder\x20</strong>that\x20also\x20exerts\x20a\x20direct\x20spasmolytic\x20action\x20on\x20the\x20smooth\x20muscles\x20of\x20the\x20bladder.&nbsp;</p>\x0a<p>Direct\x20spasmolytic\x20activity\x20is\x20the\x20direct\x20smooth\x20muscle\x20relaxation\x20effect\x20independent\x20of\x20relaxation\x20caused\x20by\x20antimuscarinic\x20action.&nbsp;</p>\x0a<p>The\x20most\x20important\x20adverse\x20effects\x20caused\x20by\x20the\x20use\x20of\x20muscarinic\x20antagonists\x20for\x20an\x20overactive\x20bladder\x20are\x20xerostomia\x20(most\x20common\x20reason\x20for\x20discontinuation),\x20blurred\x20vision,\x20and\x20GI\x20side\x20effects\x20like\x20constipation\x20and\x20dyspepsia\x20(due\x20to\x20<strong>blockade\x20of\x20M1,\x20M2\x20&amp;\x20M3</strong>).\x20Drowsiness,\x20dizziness,\x20and\x20confusion&nbsp;can\x20also\x20occur.</p>\x0a<p>Tolterodine,\x20darifenacin,\x20and\x20solifenacin\x20are\x20antimuscarinic\x20agents\x20but\x20they\x20do\x20not\x20have\x20the\x20additional\x20direct\x20antispasmodic\x20effect.</p>','bMGHN','solutionContainer','Insulin\x20degludec','2857392TtXLeo','Ranitidine','search','https://cdn1.dailyrounds.org/uploads/b0ed7ef4cf7b427aa1e538ade0f69af8.JPEG','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','baaiA','Triamcinolone','wdazE','return\x20(function()\x20','Ciprofloxacin','ZHqno','Hydrochlorthiazide','baaPc','Wgasg','bveMP','Blockade\x20of\x20adenosine\x20receptors','Inhibit\x20funny\x20currents\x20in\x20SA\x20node','XVbwq','Longer\x20duration\x20of\x20action','lFLwz','vrswj','A\x20>\x20B\x20>\x20C','round','AOzgh','paypG','Iewsa','lxkfd','Phenytoin','JhYBZ','Diphenhydramine','index.html','Solifenacin','NKSCv','nidAk','reviewQuestionsContainer','question_video','https://dhmbxeygs57ff.cloudfront.net/uploads/23b7eb6ea07e4ccd8689c15d21f4d601x1280x2717.JPEG','A\x2060-year-old\x20female\x20patient\x20presented\x20with\x20the\x20following\x20finding.\x20Her\x20medical\x20history\x20includes\x20hypertension\x20for\x20which\x20she\x20has\x20been\x20taking\x20regular\x20medications\x20for\x20the\x20past\x203\x20months.\x20Which\x20of\x20the\x20following\x20medication\x20is\x20most\x20likely\x20to\x20be\x20associated\x20with\x20this\x20finding?','DZRmK','vIrHf','RVoFq','wvRPb','T-\x20type\x20calcium\x20channel\x20blocker','Propranolol','navBtn_','fbbIB','IfIcW','FKhIk','kNuVB','Pantoprazole\x2040mg\x20OD\x2030\x20mins\x20before\x20lunch','appendChild','GqSKQ','uDuqo','mYTIm','ksdNW','1,\x202\x20&\x205\x20are\x20correct.','YlneQ','quizHierarchy','dDoJD','tkKEy','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','0|4|1|2|3|5','CnTmP','none','Ceftolozane','WtVth','</span><span>','2,\x203\x20&\x205\x20are\x20correct.','A\x2024-year-old\x20woman\x20was\x20diagnosed\x20with\x20focal\x20seizures\x20and\x20was\x20prescribed\x20ezogabine.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','scoreCircle','Which\x20of\x20the\x20following\x20is\x20true\x20about\x20pegylated-filgrastim?','kwKgP','UcQdL','It\x20is\x20a\x20monoclonal\x20antibody\x20produced\x20by\x20injecting\x20HER-2\x20antigen','lOXZS','RirOp','Lidocaine','RGQia','Propylthiouracil','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','SDmfa','width','The\x20drug\x20of\x20choice\x20for\x20the\x20management\x20of\x20acute\x20\x20alcohol\x20withdrawal\x20is?','KojSy','It\x20is\x20recommended\x20for\x20patients\x20with\x20colorectal\x20cancer','Regular\x20insulin','gRoeP','nav-btn-current','C\x20-\x20Amphotericin','endsWith','XMfWd','SipzO','Thiazide','innerHTML','display','SOitN','CNzBn','bookmarkedQuestions','idKxy','NtRrF','EfgBW','2,\x204\x20and\x205','dFxzC','GpHKl','totalTimeResult','stats','getAttribute','Fnhkj','https://cdn1.dailyrounds.org/uploads/8a4bcdecc8194bae9ef8a680f6175771.JPEG','block','WMuyo','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','bookmarked','GawAG','split','red','mNEVC','rSdOm','nav-btn-correct','solution','WmZkL','fIPEC','YJzmG','review-question\x20','Image\x20of\x20insulin\x20regimen\x20with\x20different\x20preparations\x20of\x20insulin\x20is\x20given\x20below.\x20The\x20yellow\x20curve\x20in\x20the\x20image\x20indicates','ofsyN','CpGDc','DOMContentLoaded','JzCNH','6310lDqRPT','Furosemide','classList','rrRHL','removeItem','timed_exam','Disulfiram','Lorazepam','JrWwn','wyzKS','Alpha\x202','WCFFE','DnLMu','pyRtG','ThEUh','Metronidazole\x20+\x20Paromomycin','solutionImages','VJVLK','fromCharCode','{}.constructor(\x22return\x20this\x22)(\x20)','ewyhA','AkdtP','SmPer','now','Nimodipine','Progress\x20loaded.','aRwQz','canPlayType','vMfFk','completed','zCTTj','vPKGq','Tafenoquine\x20is\x20used\x20in\x20which\x20of\x20the\x20following\x20conditions?','text','questionMedia','JIQYR','currentQuestionIndex','Omeprazole\x2020mg\x20OD\x2030\x20mins\x20before\x20breakfast','KBxIX','Albendazole\x20+\x20Metronidazole','<p>The\x20given\x20scenario\x20and\x20the\x20ECG\x20findings\x20(<strong>rapid\x20asynchronous\x20complexes</strong>\x20and\x20an\x20<strong>undulating</strong>\x20<strong>baseline</strong>)\x20point\x20towards\x20a\x20diagnosis\x20of\x20<strong>torsades\x20de\x20pointes.</strong>\u00a0<strong>Lidocaine</strong>\x20use\x20is\x20unlikely\x20to\x20cause\x20this\x20condition.</p>\x0a<p><strong>Lidocaine</strong>\x20belongs\u00a0to\x20class\x20IB\x20antiarrhythmics.\u00a0It\x20is\x20considered\x20to\x20have\x20the\x20<strong>least\x20arrhythmogenic</strong>\x20potential\x20among\x20antiarrhythmics.</p>\x0a<p>Among\x20the\x20antiarrhythmics,\x20<strong>class\x20Ia</strong>\x20and\x20<strong>class\x20III</strong>\x20drugs\x20prolong\x20action\x20potential\x20duration\x20and\x20thus\x20<strong>prolong\x20QT\x20interval.</strong>\x20They\x20are\x20also\x20prone\x20to\x20cause\x20torsades\x20de\x20pointes.</p>','JRSXB','yLiOj','HcTvr','nEHzF','NEbOH','getElementById','WFEIG','Chlorthalidone','pikRR','Pantoprazole\x2040mg\x20BD\x20irrespective\x20of\x20meals','IKwlh','cRamy','wlPZV','MmCjT','jLQJV','A\x2050-year-old\x20male\x20diabetic\x20patient\x20was\x20diagnosed\x20with\x20congestive\x20cardiac\x20failure.\x20He\x20was\x20started\x20on\x20digoxin.\x20What\x20will\x20be\x20the\x20therapeutic\x20plasma\x20concentration\x20of\x20this\x20drug?','JPFsL','OZAmD','Not\x20Attempted','OzleO','quhAh','totalAttempted','zVAMZ','vwKPD','\x22\x20data-option-index=\x22','accuracyScore','style','GFwBT','avgTimeResult','<p>Among\x20the\x20given\x20options,\x20ondansetron\x20is\x20the\x20least\x20effective\u00a0in\x20managing\x20motion\x20sickness.</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Ondansetron\x20is\x20a</span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a05\x20HT<sub>3</sub>\x20receptor\x20antagonist</span></strong>.\x20It\x20blocks\x20impulses\x20at\x20the\x20peripheral\x20origin\x20in\x20GIT\x20and\x20does\x20not\x20suppress\x20vomiting\x20caused\x20by\x20motion\x20sickness.\u00a0<span\x20data-preserver-spaces=\x22true\x22>It\x20is\x20most\x20commonly\x20indicated\x20for\x20the\x20treatment\x20of\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>postoperative\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>and\x20<strong>chemotherapy</strong>-<strong>induced</strong></span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0nausea\x20</span></strong>and\x20<strong><span\x20data-preserver-spaces=\x22true\x22>vomiting.\u00a0</span></strong></p>\x0a<p>Drugs\x20used\x20in\x20the\x20treatment\x20of\x20motion\x20sickness\x20are:</p>\x0a<ul>\x0a<li><strong><span\x20data-preserver-spaces=\x22true\x22>Anticholinergic</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0agents\x20(muscarinic\x20receptor\x20antagonists)\x20such\x20as\u00a0<strong>scopolamine</strong>\x20(<strong>hyoscine</strong>)\x20and\x20dicyclomine.</span></li>\x0a<li><strong><span\x20data-preserver-spaces=\x22true\x22>Antihistamines</span></strong>\x20(H1\x20antagonists)<strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>are\x20primarily\x20used\x20for\x20treating\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>motion\x20sickness\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>and</span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0postoperative\x20emesis.\u00a0\u00a0</span></strong></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong><span\x20data-preserver-spaces=\x22true\x22>Scopolamine\x20transdermal\x20patches\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>should\x20be\x20given\u00a0<strong>prophylactically</strong>\u00a0as\x20it\x20is\x20less\x20effective\x20once\x20symptoms\x20start.\x20It\x20is\u00a0<strong>applied\x20behind\x20the\x20ear</strong>\u00a0at\x20least\u00a0<strong>4-12</strong>\u00a0<strong>hours\x20before</strong>\u00a0an\x20anticipated\x20exposure\x20to\x20motion.\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>Dry</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>mouth\u00a0</span></strong>and<strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0sedation</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0are\x20common\x20side\x20effects.</span></span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>First-generation\x20antihistamines\x20such\x20as\x20<strong>promethazine,</strong>\x20dimenhydrinate,\x20chlorpheniramine,\x20<strong>diphenhydramine</strong>,\x20cyclizine,\x20and\x20<strong>meclizine</strong>\x20are\x20effective\x20in\x20controlling\x20nausea\x20and\x20vomiting\x20in\x20motion\x20sickness.\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>Sedation</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0is\x20a\x20common\x20side\x20effect\x20of\x20these\x20drugs.\x20Second-generation\x20antihistamines\x20like\x20cetirizine\x20and\x20fexofenadine\x20are\x20ineffective\x20in\x20the\x20treatment\x20of\x20motion\x20sickness.</span></p>','<p>Statements\x202\x20&amp;\x204\x20are\x20correct\x20regarding\x20clinical\x20trials.&nbsp;<strong>Safety</strong>\x20and<strong>\x20tolerability</strong>\x20are\x20tested\x20in\x20<strong>healthy\x20volunteers</strong>\x20in\x20<strong>phase\x20I\x20</strong>of\x20clinical\x20trials.</p>\x0a<ul>\x0a<li><strong>Statement\x201</strong>-\x20Phases\x20<strong>II</strong>\x20and\x20<strong>III</strong>\x20are\x20randomized\x20controlled\x20trials.</li>\x0a<li><strong>Statement\x203</strong>-\x20Adverse\x20events\x20are\x20determined\x20in\x20phase\x20II<strong>&nbsp;</strong>of\x20clinical\x20trials.\x20Adverse\x20events\x20are\x20confirmed\x20in\x20phase\x20III.</li>\x0a<li><strong>Statement\x205-\x20Phase\x20III\x20</strong>is\x20regarded\x20as\x20a\x20<strong>multisite\x20trial</strong>\x20and\x20phase\x20IV\x20is\x20postmarketing\x20surveillance.</li>\x0a</ul>\x0a<p>The\x20below\x20pearl\x20explains\x20the\x20various\x20phases\x20of\x20clinical\x20trials.</p>','Which\x20of\x20the\x20following\x20antibiotics\x20bind\x20to\x20the\x20subunit\x20of\x20the\x20ribosome\x20marked\x20by\x20the\x20black\x20arrow\x20and\x20inhibits\x20bacterial\x20protein\x20synthesis?','aUcvB','join','Prevent\x20staining\x20of\x20skin','1\x20&\x205\x20are\x20correct.','5\x20only','Potassium\x20channel\x20opener','Cefpodoxime','LOTDa','Radioactive\x20iodine','pathname','Previous\x20progress\x20cleared.','Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20about\x20prasugrel?','RWOrF','yyyvb','test','hKKRA','TiWQg','kmGTn','enkQz','EfkCy','https://cdn1.dailyrounds.org/uploads/00e9fd31a507460192d5b3caf8c74708.PNG','A\x20patient\x20with\x20chronic\x20myeloid\x20leukemia\x20was\x20switched\x20to\x20nilotinib\x20as\x20he\x20showed\x20only\x20partial\x20response\x20to\x20imatinib\x20therapy.\x20What\x20is\x20the\x20mechanism\x20resulting\x20in\x20the\x20loss\x20of\x20response?','rDoJY','ArrowLeft','lQMcq','filter','Methimazole','Celiprolol\x20undergoes\x20hepatic\x20elimination','OLhmg','1-b,\x202-c,\x203-a,\x204-d','KbgIc','statsBar','1|5|4|2|3|0','custom_quiz.html','log','SenzF','WqTYG','Fluoxetine','Increased\x20efflux','Ytcug','Acetazolamide','viTcM','A\x20first-year\x20resident\x20administers\x20an\x20intramuscular\x20injection\x20to\x20a\x20patient\x20by\x20the\x20Z\x20track\x20technique.\x20What\x20is\x20the\x20advantage\x20of\x20this\x20technique?','incorrect','preventDefault','Overexpression\x20of\x20MDR\x20gene','It\x20is\x20an\x20antibody\x20produced\x20entirely\x20from\x20mouse\x20containing\x20no\x20human\x20component','UgiMa','title','data-option-index','isSupported','dBgks','Pilocarpine','GmdhY','nav-btn-incorrect','startAt','FdXQd','fQlWx','5|4|3|2|0|1','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','TNF-alpha\x20antagonist','Nicotinic\x20acid','UCCZD','Scopalamine','<p>The\x20image\x20shows<strong>\x20iris\x20pigmentation</strong>\x20and\x20it\x20is\x20seen\x20with\x20<strong>topical\x20PGF2&alpha;\x20(prostaglandin)\x20analogs\x20</strong>like<strong>\x20latanoprost.</strong></p>\x0a<p>Topical\x20PGF2\x20alpha\x20(prostaglandin)\x20analogs\x20are\x20used\x20as\x20a\x20first-line\x20drug\x20in\x20glaucoma.\x20<strong>Latanoprost</strong>\x20is\x20the<strong>&nbsp;most&nbsp;commonly</strong>\x20used\x20anti-glaucoma\x20medication.\x20Other\x20prostaglandin\x20analogs\x20are\x20travoprost,\x20bimatoprost,\x20tafluprost\x20and\x20unoprostone.</p>\x0a<p>It\x20decreases\x20intra-ocular\x20pressure\x20by\x20enhancing\x20the\x20outflow\x20of\x20aqueous\x20and\x20by\x20altering\x20the\x20ciliary\x20muscle\x20tension.</p>\x0a<p>Other\x20adverse\x20effects\x20are\x20eyelash\x20lengthening,\x20allergic\x20conjunctival\x20hyperemia,\x20and\x20orbital\x20fat\x20atrophy.</p>','<p>The\x20given\x20clinical\x20scenario\x20describes\x20the\x20adverse\x20effects\x20characteristic\x20of&nbsp;<strong>metoclopramide</strong>.\x20The\x20most\x20common\x20adverse\x20effects\x20of\x20metoclopramide\x20involve\x20the\x20central\x20nervous\x20system\x20because\x20it\x20crosses\x20the\x20blood-brain&nbsp;barrier\x20(BBB)\x20and\x20<strong>blocks\x20</strong>the<strong>\x20central\x20D2\x20receptors</strong>.</p>\x0a<p>The\x20adverse\x20effects\x20include:</p>\x0a<ul>\x0a<li>Restlessness</li>\x0a<li>Drowsiness</li>\x0a<li>Insomnia</li>\x0a<li>Anxiety</li>\x0a<li>Agitation&nbsp;</li>\x0a<li><strong>Extrapyramidal\x20effects\x20-\x20</strong>acute\x20reaction\x20with\x20high\x20doses\x20and\x20long-term\x20therapy.\x20(due\x20to&nbsp;central\x20dopamine\x20receptor\x20blockade)\x0a<ul>\x0a<li>Dystonias</li>\x0a<li>Akathisia</li>\x0a<li>Parkinsonian\x20features</li>\x0a<li>Tardive\x20dyskinesia&nbsp;</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Adverse\x20events\x20are\x20more\x20common\x20among\x20the\x20elderly.\x20Long-term\x20use\x20should\x20be\x20avoided\x20unless\x20absolutely\x20necessary.&nbsp;</p>','NrEwm','TJPSJ','0.5-1.4\x20ng/mL','1760496VRhgnH','A\x20-\x20Flucytosine','GXYnV','Tolvaptan','toggle','stringify','Duration\x20of\x20action\x20is\x20shorter\x20than\x20normal\x20filgrastim','<p>The\x20given\x20scenario\x20is\x20suggestive\x20of\x20the\x20<strong>development</strong>\x20of\x20<strong>resistance</strong>\x20to\x20<strong>imatinib,</strong>\x20which\x20is\x20a\x20<strong>tyrosine\x20kinase\x20inhibitor</strong>.\x20This\x20condition\x20arises\x20due\x20to\x20<strong>point\x20mutations</strong>\x20in\x20three\x20separate\x20regions\x20of\x20the\x20<strong>kinase\x20domain</strong>.</p>\x0a<p>The\x20contact\x20points\x20between\x20imatinib\x20and\x20the\x20enzyme\x20become\x20sites\x20of\x20mutations\x20in\x20drug-resistant\x20leukemic\x20cells\x20and\x20hence\x20these\x20<strong>mutations\x20prevent\x20tight\x20binding</strong>\x20of\x20the\x20<strong>drug</strong>\x20and\x20lock\x20the\x20enzyme\x20in\x20its\x20open\x20configuration\x20(the\x20configuration\x20in\x20which\x20it\x20has\x20access\x20to\x20the\x20substrate\x20and\x20is\x20enzymatically\x20active).</p>\x0a<p>Mechanisms\x20other\x20than\x20BCR-ABL\x20kinase\x20mutations\x20play\x20a\x20minor\x20role\x20in\x20resistance\x20to\x20imatinib.\x20They\x20include:</p>\x0a<ul>\x0a<li>Amplification\x20of\x20the\x20wild-type\x20kinase\x20gene\x20has\x20been\x20identified\x20in\x20some\x20cases.</li>\x0a<li>Overexpression\x20of\x20MDR-gene\x20leading\x20to\x20increased\x20drug\x20efflux\x20transporter\x20has\x20been\x20shown\x20experimentally\x20but\x20not\x20implicated\x20in\x20clinical\x20resistance.</li>\x0a</ul>\x0a<p>Nilotinib\x20retains\x20inhibitory\x20activity\x20in\x20the\x20presence\x20of\x20most\x20point\x20mutations\x20that\x20confer\x20resistance\x20to\x20imatinib.</p>','Axdwb','A\x20=\x20B\x20>\x20C','eRtpj','https://cdn1.dailyrounds.org/uploads/93bd46631d294c00acd68ec7cf7bcbfb.JPEG','MEELc','To\x20inhibit\x20the\x20metabolism\x20of\x20levodopa\x20in\x20brain','https://dhmbxeygs57ff.cloudfront.net/uploads/2687fee5df024653908a0728befd85afx1024x683.JPEG','</span></div>','wkvVd','A\x20patient\x20presented\x20to\x20the\x20casualty\x20with\x20signs\x20of\x20dehydration\x20due\x20to\x20severe\x20vomiting.\x20The\x20intern\x20gave\x20the\x20patient\x20a\x20parenteral\x20medication,\x20following\x20which\x20the\x20patient\x20developed\x20grimacing\x20and\x20abnormal\x20posturing.\x20What\x20could\x20have\x20been\x20the\x20inciting\x20drug\x20for\x20this\x20reaction?','KbMQi','zsVzM','MpvYs','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','true','<p><strong>Ranolazine</strong>\x20acts\x20by\u00a0<strong>late\x20sodium\x20current</strong>\u00a0<strong>inhibition\u00a0</strong>in\x20the\x20heart.\u00a0It\x20is\x20used\x20in\x20the\x20prophylaxis\x20of\x20<strong>angina.</strong></p>\x0a<p>Late\x20sodium\x20current\x20(I<sub>Na</sub>)\x20facilitates\x20the\x20entry\x20of\x20calcium\x20via\x20the\x20sodium-calcium\x20exchanger.\x20<strong>Inhibition</strong>\x20of\u00a0<strong>I<sub>Na</sub>,</strong>\x20therefore,\x20reduces\x20the\x20intracellular\x20calcium\x20concentration\x20which\x20in\x20turn\x20reduces\x20the\x20diastolic\x20tension\x20and\x20cardiac\x20contractility.</p>\x0a<p>At\x20higher\x20doses,\x20it\x20may\x20also\x20modify\x20the\x20fatty\x20acid\x20oxidation\x20(<strong>pFOX\x20inhibitor</strong>),\x20which\x20improves\x20the\x20efficiency\x20of\x20cardiac\x20oxygen\x20utilisation\x20but\x20whether\x20this\x20actually\x20occurs\x20at\x20therapeutic\x20doses\x20is\x20still\x20being\x20studied.\x20It\x20also\x20has\x20mild\x20beta-blocking\x20activity.</p>\x0a<p>Ranolazine\x20is\x20the\x20second-line\x20FDA-approved\x20drug\x20for\x20heart\x20failure.\x20Side\x20effects\x20of\x20ranolazine\x20include\x20dizziness,\x20headache,\x20and\x20postural\x20hypotension.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\u00a0<strong>Ivabradine\x20</strong>selectively\x20<strong>blocks\x20the\x20funny\x20current\x20(I<sub>f</sub></strong><strong>)\x20channel\u00a0</strong>involved\x20in\x20the\x20generation\x20of\x20automaticity\x20in\x20the\x20SA\x20node.\x20It\x20reduces\x20heart\x20rate\x20and\x20thereby\x20oxygen\x20demand.\x20It\x20does\x20not\x20have\x20any\x20effect\x20on\x20cardiac\x20contractility.\x20It\x20is\x20an\x20FDA-approved\x20drug\x20for\x20the\x20treatment\x20of\x20<strong>heart\x20failure</strong>.\x20It\x20is\x20also\x20used\x20for\x20treating\x20stable\x20angina.</p>\x0a<p>Option\x20C:\u00a0<strong>Fasudil</strong>\u00a0acts\x20by<strong>\x20inhibiting</strong>\x20smooth\x20muscle\x20<strong>Rho\x20kinase</strong>\x20and\x20reduces\x20coronary\x20vasospasm.</p>\x0a<p>Option\x20D:\u00a0<strong>Nicorandil</strong>\x20acts\x20as\x20an\x20agonist\x20at\x20ATP-sensitive\x20potassium\x20(K<sub>ATP</sub>)\x20channels\x20i.e.\x20<strong>potassium\x20channel\x20opener</strong>.\x20It\x20decreases\x20afterload\x20and\x20preload\x20of\x20the\x20heart\x20by\x20its\x20vasodilatory\x20properties\x20at\x20both\x20arterioles\x20and\x20venules.\x20It\x20is\x20used\x20for\x20the\x20treatment\x20of\x20stable\x20angina.</p>\x0a<p>Note:\x20<strong>Trimetazidine</strong>\x20is\x20a\u00a0<strong>pFOX\x20inhibitor\u00a0</strong>that\x20partially\x20inhibits\x20fatty\x20acid\x20oxidation\x20in\x20the\x20myocardium.\x20Thereby,\x20it\x20decreases\x20the\x20oxygen\x20requirement.\x20It\x20is\x20also\x20used\x20as\x20an\x20anti-anginal\x20agent.</p>','It\x20is\x20not\x20effective\x20in\x20the\x20treatment\x20of\x20severe\x20neutropenia','A\x20>\x20B\x20=\x20C','nqeFC','fGppB','isArray','Indomethacin','2\x20&\x204\x20are\x20correct.','<p>The\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20<strong>drug</strong>-<strong>induced\x20hearing\x20loss</strong>,\x20and\x20<strong>furosemide</strong>\x20is\x20likely\x20to\x20be\x20associated\x20with\x20these\x20side\x20effects,\x20causing\x20<strong>ototoxicity</strong>.</p>\x0a<p><strong>Loop\x20diuretics</strong>\x20have\x20the\x20potential\x20to\x20cause\x20damage\x20to\x20the\x20ears,\x20resulting\x20in\x20symptoms\x20such\x20as\x20ringing\x20in\x20the\x20ears\x20(tinnitus),\x20<strong>hearing\x20impairment</strong>,\x20<strong>dizziness</strong>,\x20and\x20a\x20feeling\x20of\x20fullness\x20in\x20the\x20ears.\x20The\x20risk\x20of\x20ototoxicity\x20is\x20highest\x20when\x20loop\x20diuretics\x20are\x20<strong>administered\x20rapidly</strong>\x20through\x20an\x20<strong>intravenous\x20route</strong>\x20and\x20lowest\x20when\x20taken\x20orally.\x20To\x20prevent\x20ototoxicity,\x20it\x20is\x20important\x20to\x20avoid\x20infusing\x20furosemide\x20at\x20a\x20rate\x20of\x20more\x20than\x204\x20mg/min.</p>\x0a<p><strong>Furosemide</strong>\u00a0is\x20a\u00a0<strong>loop\x20diuretic.\u00a0</strong>It\x20acts\x20by\u00a0<strong>inhibiting</strong>\u00a0the<strong>\u00a0Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>\u00a0symporter\u00a0</strong>in\x20the\x20thick\x20ascending\x20limb\x20of\x20the\x20loop\x20of\x20Henle,\x20resulting\x20in\x20increased\u00a0excretion\x20of\x20sodium,\x20potassium,\u00a0and\u00a0chloride.\u00a0It\x20is\x20used\x20in\x20cases\x20of\x20acute\x20pulmonary\x20oedema,\x20cerebral\x20oedema,\x20hypertension,\x20and\x20hypercalcemia\x20of\x20malignancy.</p>\x0a<p><strong>Hypokalemia,\x20hyperuricemia,\x20hypocalcemia</strong>,\x20and\x20hypomagnesemia\x20are\x20the\x20important\x20side\x20effects.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:<strong>\x20</strong>Thiazides\x20act\x20on\x20the\x20<strong>DCT</strong>.\x20They\x20inhibit\x20Na<sup><span\x20class=\x22s1\x22>+</span></sup>-Cl<sup><span\x20class=\x22s1\x22>\x20</span></sup>symporter\x20present\x20in\x20the\x20distal\x20convoluted\x20tubule.\x20It\x20is\x20used\x20for\x20the\x20treatment\x20of\x20hypertension\x20and\x20chronic\x20oedema.\x20Their\x20adverse\x20effects\x20are\x20as\x20follows:</p>\x0a<ul>\x0a<li>Hypotension</li>\x0a<li>Hyponatremia</li>\x0a<li>Hypokalemia</li>\x0a<li>Hypomagnesemia</li>\x0a<li>Hypochloremia</li>\x0a<li>Hyperuricemia</li>\x0a<li>Hypercalcemia</li>\x0a<li>Decrease\x20glucose\x20tolerance</li>\x0a<li>May\x20increase\x20the\x20lipid\x20levels</li>\x0a</ul>\x0a<p>Option\x20C:<strong>\x20</strong>Carbonic\x20anhydrase\x20inhibitors\x20like\x20<strong>acetazolamide</strong>\u00a0inhibit\x20the\u00a0reabsorption\x20of\x20bicarbonate\x20ions\x20in\x20the\x20proximal\x20convoluted\x20tubule.\x20Used\x20to\x20treat\u00a0<strong>glaucoma</strong>\u00a0and\x20<strong>mountain\x20sickness</strong>\x20and\x20to\x20alkalinize\x20urine.\x20Side\x20effects\x20are\x20acidosis,\x20hypokalaemia,\u00a0fever,\x20rashes,\x20and\u00a0paresthesia.\x20Bone\x20marrow\x20depression\x20is\x20rare\x20but\x20a\x20serious\x20side\x20effect.\x20It\x20is\x20<strong>contraindicated</strong>\x20in\x20<strong>liver\x20disease.</strong></p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20646\x22>Option\x20D:\u00a0Tolvaptan\x20is\x20an\x20orally\x20active\x20nonpeptide\x20<strong>selective\x20V2\x20receptor\x20antagonist</strong>.\u00a0Its\x20main\x20mechanism\x20of\x20action\x20is\x20to\x20enhance\x20the\x20excretion\x20of\x20free\x20water\x20by\x20the\x20kidneys,\x20which\x20helps\x20<strong>restore\x20normal\x20sodium\x20levels</strong>\x20in\x20the\x20blood.\x20It\x20is\x20a\x20new\x20addition\x20to\x20the\x20<strong>treatment</strong>\x20options\x20for\x20<strong>hyponatremia</strong>\x20caused\x20by\x20congestive\x20heart\x20failure,\x20liver\x20cirrhosis,\x20or\x20syndrome\x20of\x20inappropriate\x20antidiuretic\x20hormone\x20secretion\x20(SIADH).\u00a0The\x20most\x20common\x20side\x20effects\x20of\x20this\x20medication\x20include\x20<strong>increased\x20thirst</strong>\x20and\x20a\x20dry\x20sensation\x20in\x20the\x20mouth.\x20Other\x20possible\x20side\x20effects\x20are\x20fever,\x20gastrointestinal\x20disturbances,\x20and\x20<strong>elevated\x20blood\x20sugar\x20levels</strong>.</div>','qAZmb','OusHs','WwNES','Which\x20of\x20the\x20following\x20anti-tubercular\x20drug\x20is\x20not\x20bactericidal?','lUMLJ','40283QfQAIk','<p>Except\x20for\x20nifedipine,\x20all\x20the\x20other\x20drugs\x20(Enalapril,\x20thiazide,\x20furosemide)\x20causes\x20lithium\x20toxicity.</p>\x0a<p><strong>Lithium\x20toxicity\x20</strong>occurs\x20with<strong>\x20concomitant\x20use\x20</strong>of&nbsp;</p>\x0a<ol>\x0a<li><strong>Thiazide\x20diurertics\x20(chlorthalidone)</strong></li>\x0a<li>Angiotensin-converting\x20enzyme\x20inhibitors\x20(enalapril)</li>\x0a<li>Angiotensin\x20II\x20receptor\x20blocker\x20(telmisartan)</li>\x0a<li>Nonsteroidal\x20anti-inflammatory\x20drugs\x20(indomethacin)</li>\x0a<li>Tetracyclines\x20(doxycycline)</li>\x0a<li>Loop\x20diuretics\x20(furosemide)</li>\x0a</ol>\x0a<p>These\x20act\x20by<strong>\x20increasing</strong>\x20the<strong>\x20tubular\x20reabsorption\x20of\x20lithium</strong>,<strong>&nbsp;</strong>resulting\x20in\x20decreased\x20excretion\x20of\x20lithium\x20and\x20thereby\x20increasing\x20the\x20serum\x20lithium\x20levels,\x20causing\x20toxicity.</p>\x0a<p><strong>Lithium\x20toxicity:&nbsp;</strong></p>\x0a<p>Serum\x20lithium\x20level\x20greater\x20than<strong>\x201.5\x20mEq/L</strong>\x20are&nbsp;considered\x20toxic.\x20Acute\x20intoxication\x20is\x20characterized\x20by\x20vomiting,\x20profuse\x20diarrhea,&nbsp;coarse\x20tremor,\x20ataxia,\x20dysarthria,\x20and\x20convulsions.\x20It\x20may\x20progress\x20to\x20cardiac&nbsp;arrhythmias,&nbsp;coma,\x20and\x20death.</p>\x0a<p>Treatment\x20is\x20supportive\x20which\x20includes\x20dialysis,\x20continuous\x20cardiac\x20monitoring,\x20intubation\x20if\x20needed.</p>\x0a<p><strong>Adverse\x20effects\x20of\x20Lithium:</strong></p>\x0a<p>Central\x20nervous\x20system:\x20Lithium\x20at\x20therapeutic\x20levels\x20cause\x20<strong>fine\x20tremors</strong>\x20and\x20at\x20toxic\x20levels\x20cause\x20<strong>coarse\x20tremors.</strong>\x20Incoordination,\x20ataxia,\x20and\x20slurred\x20speech\x20can\x20occur\x20at\x20peak\x20serum\x20concentrations.</p>\x0a<p>Lithium\x20enters\x20into\x20the\x20distal\x20tubular\x20cells\x20in\x20kidney\x20via\x20luminal\x20ENaC.\x20However,\x20it\x20accumulates\x20in\x20the\x20distal\x20tubular\x20cells\x20due\x20to\x20the\x20inability\x20of\x20Na+K+ATPase\x20to\x20secrete\x20lithium\x20via\x20basal\x20membrane.\x20Thereby,\x20lithium\x20inhibits\x20GSK-3&szlig;,\x20leading\x20to\x20vasopressin\x20insensitivity,\x20downregulation\x20of\x20aquaporin-2\x20channels,\x20and\x20<strong>nephrogenic\x20diabetes\x20insipidus.\x20</strong>Patients\x20present\x20with<strong>\x20polyuria\x20and\x20polydipsia.&nbsp;Amiloride\x20</strong>blocks\x20entry\x20of\x20lithium\x20into\x20renal\x20distal\x20tubule\x20ENaCs\x20and\x20is\x20used\x20to\x20treat\x20lithium\x20induced\x20nephrogenic\x20diabetes\x20insipidus.</p>\x0a<p>Lithium\x20therapy\x20is\x20associated\x20with\x20<strong>hypothyroidism\x20</strong>and\x20<strong>hypercalcemia\x20</strong>related\x20to\x20hyperparathyroidism.&nbsp;Lithium\x20therapy\x20causes\x20significant\x20<strong>weight\x20gain.</strong></p>\x0a<p><strong>T\x20wave\x20flattening</strong>\x20in\x20ECG\x20occurs\x20in\x20few\x20patients\x20on\x20lithium.\x20At\x20toxic\x20levels,\x20sinus\x20bradycardia,\x20AV\x20block,\x20and\x20cardiac\x20arrhythmias\x20occur.&nbsp;<strong>Allergic\x20reactions</strong>\x20including\x20dermatitis,\x20folliculitis,\x20and\x20vasculitis\x20can\x20occur\x20with\x20lithium\x20use.</p>\x0a<p>Lithium\x20use\x20in\x20early\x20pregnancy\x20causes\x20<strong>Ebstein\x20anomaly</strong>\x20in\x20the\x20fetus.\x20Fetal\x20lithium\x20exposure\x20is\x20associated\x20with\x20<strong>neonatal\x20goiter,\x20CNS\x20depression,\x20hypotonia\x20(floppy\x20baby\x20syndrome),\x20and\x20cardiac\x20murmur.</strong></p>\x0a<p>Due\x20to\x20all\x20these\x20adverse\x20effects,\x20patients\x20on\x20lithium\x20therapy\x20should\x20have\x20routine\x20monitoring\x20of\x20serum\x20electrolytes,\x20serum\x20calcium,\x20thyroid\x20profile,\x20renal\x20function\x20tests,\x20ECG,\x20and\x20serum\x20lithium\x20levels.</p>','QVqKX','questionIndex','A\x2057-year-old\x20woman\x20diagnosed\x20with\x20breast\x20carcinoma\x20was\x20prescribed\x20trastuzumab.\x20Which\x20of\x20the\x20following\x20statements\x20regarding\x20this\x20drug\x20is\x20true?','<p><strong>IL-17A\x20antagonist</strong>&nbsp;is\x20not\x20used\x20in\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis.</p>\x0a<p>IL-17A\x20antagonists<strong>&nbsp;</strong>(secukinumab,\x20ixekizumab)\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20moderate\x20to\x20severe\x20plaque\x20or\x20scalp\x20<strong>psoriasis</strong>.</p>\x0a<p>All\x20the\x20other\x203\x20are&nbsp;biological\x20<strong>D</strong>isease\x20<strong>M</strong>odifying\x20<strong>A</strong>nti-<strong>R</strong>heumatoid\x20<strong>Drugs</strong>&nbsp;(<strong>DMARDs</strong>)\x20used\x20in\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis.\x20All\x20biological\x20DMARDs\x20<strong>downregulate\x20the\x20immune\x20system</strong>\x20and\x20can\x20lead\x20to\x20adverse\x20effects\x20like\x20<strong>opportunistic\x20infections</strong>\x20and\x20the\x20flaring\x20of\x20latent\x20TB.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:&nbsp;IL-1\x20receptor\x20antagonist\x20-\x20anakinra</p>\x0a<p>Option\x20C:&nbsp;IL-6\x20receptor\x20antagonist\x20-\x20tocilizumab\x20and\x20sarilumab</p>\x0a<p>Option\x20D:&nbsp;TNF&nbsp;&alpha;\x20antagonist\x20-\x20adalimumab,\x20golimumab,\x20etanercept,\x20etc.,</p>','GNeNc','Year\x202021\x20-\x2022','hKNuC','ZYwpY','Cefepime','yeDxF','bookmarkText','vDpTW','1.6-\x202\x20ng/mL','iKKle','tviHb','True\x20statement\x20about\x20teduglutide\x20is\x20:','totalTime','WVqfF','xBBto','Metoclopramide','TGiWO','USdXl','prototype','eXqPF','VWXjW','replace','YbolI','<div\x20class=\x22mt-4\x22><img\x20src=\x22','key','xkEWW','tzQQf','correctCount','EDCDc','etEZe','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','Diltiazem','rNxHd','correctAnswers','markedForReview','Timolol','<p>In\x20the\x20log\x20dose-response\x20curve,\x20the\x20<strong>perpendicular\x20height</strong>\x20represents\x20the\x20drug\x20efficacy.</p>\x0a<p>Therefore,\x20Drug\x20C\x20has\x20the\x20least\x20efficacy.&nbsp;Both\x20Drug\x20A&nbsp;and\x20Drug\x20B\x20have\x20the\x20highest\x20efficacy\x20that\x20is\x20the\x20maximum\x20effect\x20produced\x20by\x20the\x20drug.\x20Thus,\x20in\x20the\x20above\x20image,\x20the\x20efficacy\x20is\x20<strong>Drug\x20A\x20=\x20Drug\x20B\x20&gt;\x20Drug\x20C.</strong></p>\x0a<p>Efficacy:</p>\x0a<ul>\x0a<li>It\x20is\x20defined\x20as\x20the<strong>\x20maximum\x20effect\x20produced</strong>\x20by\x20the\x20drug.</li>\x0a<li>It\x20reflects\x20the\x20capacity\x20of\x20the\x20drug\x20to\x20activate\x20a\x20receptor\x20and\x20produce\x20the\x20response.</li>\x0a<li>In\x20the\x20log\x20dose-response\x20curve,\x20the\x20<strong>perpendicular\x20height</strong>\x20represents\x20the\x20drug\x20efficacy.\x20Thus,\x20in\x20the\x20above\x20image,\x20the\x20efficacy\x20is\x20Drug\x20A\x20=\x20Drug\x20B\x20&gt;\x20Drug\x20C.</li>\x0a</ul>','Omeprazole\x2020mg\x20OD\x2030\x20mins\x20before\x20dinner','target','href','DftSt','Latanoprost','yDKte','pEGLQ','To\x20decrease\x20the\x20plasma\x20half\x20life\x20of\x20levodopa','TvOGK','XjeLX','Bookmarked','It\x20is\x20a\x20reversible\x20inhibitor\x20of\x20ADP\x20receptor','timerContainer','bRtfO','.m3u8','KxUzv','zdiuj','denQJ','JLrIg','Clindamycin','\x20-\x20Brain\x20And\x20Scalpel','study','Added\x20advantage\x20is\x20that\x20it\x20can\x20be\x20taken\x20orally','bXdCa','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','FJuyq','Benzodiazepines','qroFi','wqKVQ','A\x2045-year-old\x20patient\x20with\x20chronic\x20kidney\x20disease\x20developed\x20secondary\x20hyperparathyroidism\x20for\x20which\x20he\x20was\x20treated\x20appropriately,\x20and\x20was\x20started\x20on\x20cinacalcet.\x20Which\x20of\x20the\x20following\x20best\x20describes\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','selected','Naltrexone','toISOString','tNXOG','markReviewBtn','CEtyH','Amplification\x20of\x20wild-type\x20kinase\x20gene','quizFile','pop','https://dhmbxeygs57ff.cloudfront.net/uploads/3fe2da00a2b7445d8a99ec027efeab5ax799x533.JPEG','Meclizine','OwmXi','CiwGq','UQMPd','<p\x20style=\x22text-align:\x20justify;\x22>Patients\x20with\x20sickle\x20cell\x20anemia\x20should\x20not\x20receive\x20pegylated\x20filgrastim\x20as\x20it\x20can&nbsp;trigger\x20a\x20<strong>sickle\x20cell\x20crisis.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Filgrastim&nbsp;</strong>is\x20a\x20recombinant\x20human\x20G-CSF\x20(granulocyte\x20colony-stimulating\x20factor).\x20The\x20pegylated\x20forms\x20of\x20filgrastim,\x20pegfilgrastim,\x20and\x20lipefilgrastim,\x20are\x20longer-acting\x20forms.\x20It\x20is\x20administered\x20subcutaneously\x20or\x20by\x20slow\x20intravenous\x20infusion\x20only.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Indications\x20of\x20recombinant\x20G-CSF:&nbsp;\x20&nbsp;</p>\x0a<ul\x20style=\x22text-align:\x20justify;\x22>\x0a<li>Severe\x20neutropenia\x20after\x20autologous\x20hematopoietic\x20stem\x20cell\x20transplantation</li>\x0a<li>Severe\x20neutropenia\x20after\x20high\x20dose\x20cancer\x20chemotherapy</li>\x0a<li>Severe\x20congenital\x20neutropenias</li>\x0a<li>Neutropenia\x20of\x20patients\x20with\x20<strong>AIDS</strong>\x20receiving\x20<strong>zidovudine</strong></li>\x0a</ul>','apply','An\x20obese\x20male\x20patient\x20has\x20been\x20recently\x20diagnosed\x20with\x20coronary\x20artery\x20disease\x20and\x20hypertension.\x20He\x20is\x20started\x20on\x20atorvastatin.\x20Which\x20of\x20the\x20following\x20additional\x20medication\x20can\x20be\x20safely\x20prescribed\x20to\x20this\x20patient?','GABA\x20transaminase\x20inhibitor','EJENb','seIFi','Its\x20half\x20life\x20is\x206\x20-\x208\x20hours','__proto__','incomplete','ljxHE','<p>Option\x20B\x20is\x20correct.\x20Thiazide,\x20levodopa,\x20and\x20metformin\x20do\x20not\x20require\x20therapeutic\x20drug\x20monitoring.\x20However,\x20phenytoin\x20and\x20lithium\x20will\x20require\x20strict&nbsp;therapeutic\x20drug\x20monitoring\x20because\x20of\x20their\x20narrow\x20therapeutic\x20window.</p>\x0a<p><strong>Therapeutic\x20drug\x20monitoring\x20(TDM)</strong>\x20is\x20individualizing\x20drug\x20dosage\x20by\x20maintaining\x20plasma\x20or\x20blood\x20drug\x20concentrations\x20within\x20a\x20targeted\x20therapeutic\x20range\x20or\x20window.</p>\x0a<p>Indications\x20for\x20TDM:</p>\x0a<ol>\x0a<li>Drugs\x20with\x20low\x20safety\x20margins\x20i.e.\x20narrow\x20therapeutic\x20window\x20(e.g.\x20digoxin,\x20<strong>anticonvulsants</strong>,\x20antiarrhythmics,\x20theophylline,\x20aminoglycosides,\x20lithium,\x20TCAs,\x20immunomodulators)</li>\x0a<li>Drugs\x20with\x20high\x20individual\x20variations\x20(e.g.\x20<strong>lithium</strong>,\x20antidepressants)</li>\x0a<li>Drugs\x20with\x20potential\x20toxicity\x20used\x20in\x20renal\x20failure\x20patients\x20(e.g.\x20aminoglycosides,\x20vancomycin)</li>\x0a<li>Poisoning</li>\x0a<li>Drug\x20therapy\x20failure\x20(e.g.\x20failure\x20of\x20response\x20to\x20antibiotics)</li>\x0a<li>To\x20check\x20patient\x20compliance\x20(e.g.\x20psycho-pharmacological\x20agents)</li>\x0a</ol>\x0a<p>TDM\x20is<strong>\x20not\x20necessary</strong>\x20for</p>\x0a<ol>\x0a<li>Drugs\x20whose\x20response\x20is\x20easily\x20measured\x20(eg.\x20<strong>antihypertensives</strong>,\x20<strong>anti-diabetic\x20agents</strong>,\x20oral\x20anticoagulants,\x20inhalational\x20general\x20anesthesia)</li>\x0a<li>Prodrugs\x20(e.g.<strong>\x20levodopa</strong>)</li>\x0a<li>Drugs\x20that\x20have\x20long-lasting\x20effects\x20-Hit\x20and\x20run\x20drugs\x20e.g.\x20reserpine,\x20guanethidine,\x20monoamine\x20oxidase\x20inhibitors,\x20omeprazole)</li>\x0a<li>Irreversible\x20action\x20of\x20drugs\x20(eg.\x20organophosphates,\x20phenoxybenzamine)</li>\x0a</ol>','<p><strong>Option\x20B\x20</strong>is<strong>\x20correctly\x20matched.</strong></p>\x0a<table\x20style=\x22height:\x2061px;\x20width:\x20285px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x20text-align:\x20center;\x22><strong>Drug\u00a0</strong></td>\x0a<td\x20style=\x22width:\x20135.414px;\x20text-align:\x20center;\x22><strong>Antidote</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>1</strong>.\x20Heparin</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>b</strong>.\x20Protamine\x20sulfate</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>2</strong>.\x20Dabigatran</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>c</strong>.\x20Idarucizumab</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>3</strong>.\x20Warfarin</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>a</strong>.\u00a0Vitamin\x20K</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>4</strong>.\x20Rivaroxaban</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>d</strong>.\x20Andexanet\x20alfa</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>Heparin\x20-\x20Protamine\x20sulfate(1-b)\x20:</p>\x0a<p><strong>Protamine\x20sulfate</strong>\x20is\x20indicated\x20for\x20the\x20reversal\x20of<strong>\x20heparin\x20overdose</strong>.\x20It\x20binds\x20to\x20<strong>long\x20heparin\x20molecules</strong>\x20with\x20high\x20affinity\x20and\x20neutralizes\x20anticoagulant\x20activity.\x20Therefore,\x20it\x20<strong>completely\x20reverses</strong>\x20the\x20action\x20of\x20unfractionated\x20heparin\x20but\x20only\x20<strong>partially\x20reverses\x20the\x20action</strong>\x20of\x20low-molecular-weight\x20heparin\x20(LMWH).\x20It\x20has\x20no\x20effect\x20on\x20fondaparinux.</p>\x0a<p>Dabigatran\x20-\x20Idarucizumab\x20(2-c)\x20:</p>\x0a<p><strong>Idarucizumab</strong>\u00a0is\x20a\x20monoclonal\x20antibody\x20that\x20specifically\x20acts\x20as\x20a\x20<strong>reversal\x20agent\x20</strong>for<strong>\x20dabigatran</strong>.\x20It\x20has\x20a\x20350\x20times\x20higher\x20affinity\x20for\x20dabigatran\x20than\x20dabigatran\x20for\x20thrombin.\x20Hence,\x20it\x20forms\x20a\x20complex\x20with\x20dabigatran,\x20which\x20is\x20excreted\x20by\x20the\x20kidneys.</p>\x0a<p>Warfarin\x20-\x20Vitamin\x20K\x20(3-a)\x20:</p>\x0a<p><strong>Vitamin\x20K</strong>\x20is\x20given\x20orally\x20as\x20well\x20as\x20intravenously\x20to\x20treat\x20<strong>warfarin\x20toxicity</strong>.\x20It\x20causes\x20the\x20reversal\x20of\x20anticoagulation\x20effects\x20of\x20warfarin\x20by\x20synthesis\x20of\x20vitamin\x20Kdependent\x20coagulation\x20factors\x20(II,\x20VII,\x20IX,\x20X).</p>\x0a<p>Rivaroxaban\x20-\x20Andexanet\x20alfa\x20(4-d)\x20:</p>\x0a<p><strong>Andexanet\x20alfa</strong>\x20is\x20a\u00a0recombinant\x20analog\x20of\x20factor\x20Xa\x20and\x20is\x20used\x20as\x20a\x20<strong>reversal\x20agent</strong>\x20for\u00a0<strong>oral\x20factor\x20Xa\x20inhibitors</strong>\u00a0like\x20rivaroxaban,\x20edoxaban,\x20and\x20apixaban.\u00a0It\x20rapidly\x20reverses\x20the\x20action\x20of\x20these\x20drugs\x20and\x20restores\x20thrombin\x20generation.\x20It\x20is\x20given\x20intravenously.</p>\x0a<p>Note:</p>\x0a<div>\x0a<p><strong>Ciraparantag\u00a0</strong>is\x20considered\x20a\x20potential\x20<strong>reversal\x20agent\x20agains</strong>t\x20<strong>all\x20direct\x20</strong><strong>anticoagulants,\u00a0</strong>including\x20dabigatran,\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban,\x20as\x20well\x20as\x20heparin\x20and\x20LMWH.\x20This\x20drug\x20is\x20in\x20the\x20early\x20stages\x20of\x20development.</p>\x0a</div>','qyGJv','sZwvY','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','NLxtp','HvHkF','Xpaco','YKZPl','iVLfB','Atropine','bind','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Point\x20mutations\x20in\x20kinase\x20domain','xXWrB','14fQpBNk','jnMiI','xsOsl','error','No\x20questions\x20available\x20for\x20this\x20quiz.','A\x20schizophrenic\x20patient\x20was\x20initiated\x20on\x20haloperidol\x20therapy.\x20Two\x20days\x20later,\x20he\x20presented\x20to\x20the\x20hospital\x20with\x20a\x20deviation\x20of\x20eyes,\x20inability\x20to\x20open\x20mouth,\x20and\x20torticollis.\x20What\x20is\x20the\x20first-line\x20management\x20of\x20this\x20case?','<p><strong>Teduglutide\x20</strong>is\x20a<strong>\x20GLP-2\x20analogue.</strong></p>\x0a<p>It\x20has\x20been\x20recently\x20approved\x20for\x20the\x20<strong>treatment\x20of\x20short\x20bowel\x20syndrome.&nbsp;</strong>Teduglutide\x20binds\x20to\x20enteric\x20neurons\x20and\x20endocrine\x20cells,\x20stimulating\x20the\x20release\x20of\x20a\x20number\x20of\x20hormones\x20such\x20as\x20insulin-like\x20growth\x20factor,\x20this\x20<strong>stimulates\x20mucosal\x20epithelial\x20growth</strong>\x20and\x20enhances\x20fluid\x20absorption.</p>\x0a<p>The\x20drug\x20has\x20a<strong>&nbsp;t1/2\x20of\x201&ndash;2\x20hours&nbsp;</strong>and\x20is&nbsp;<strong>administered\x20subcutaneously</strong>&nbsp;once\x20daily.\x20It\x20can\x20potentially\x20cause<strong>&nbsp;bowel\x20cancer,&nbsp;</strong>therefore\x20it\x20is\x20not\x20recommended\x20for\x20patients\x20with\x20active\x20malignancies.</p>\x0a<p>Note:\x20GLP-1\x20analogs\x20are\x20used\x20for\x20the\x20treatment\x20of\x20Type\x20II\x20diabetes\x20mellitus.&nbsp;</p>','skkbk','Nadolol\x20has\x20longest\x20half\x20life','kxvGq','WaKIR','lodSE','nav-btn-answered','(((.+)+)+)+$','A\x20patient\x20with\x20chronic\x20angina\x20was\x20prescribed\x20a\x20new\x20drug,\x20ranolazine.\x20This\x20drug\x20acts\x20by\x20which\x20of\x20the\x20following\x20mechanism?','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','MAGGR','Treatment\x20of\x20severe\x20falciparum\x20malaria','Match\x20the\x20following\x20pairs\x20of\x20drugs\x20with\x20their\x20antidotes.','Tetracycline','xaHkh','closest','<p><strong>Ezogabine\x20</strong>is\x20a\x20<strong>potassium\x20channel\x20opener.</strong></p>\x0a<p><strong>Ezogabine</strong>\x20(retigabine)\x20acts\x20by\x20<strong>opening</strong>\x20<strong>neuronal</strong>\x20<strong>potassium\x20channels</strong>.\x20By\x20opening\x20the\x20K<sup>+</sup>\x20channels,\x20it\x20stabilizes\x20the\x20resting\x20membrane\x20potential\x20and\x20reduces\x20the\x20excitability\x20of\x20the\x20nerve\x20membrane.</p>\x0a<p>It\x20is\x20used\x20as\x20an\x20adjunctive\x20treatment\x20for\x20focal\x20seizures.</p>\x0a<p>Serious\x20side\x20effects\x20associated\x20with\x20long-term\x20therapy\x20include\x20<strong>retinal\x20abnormalities</strong>\x20causing\x20visual\x20defects,\x20skin\x20discoloration,\x20QT\x20prolongation,\x20and\x20neuropsychiatric\x20symptoms.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Vigabatrin</strong>\x20irreversibly\x20<strong>inhibits&nbsp;GABA\x20transaminase</strong>,\x20which\x20degrades\x20GABA.\x20Thereby,\x20resulting\x20in\x20increased\x20levels\x20of\x20extracellular\x20GABA\x20at\x20its\x20receptor\x20and\x20enhanced\x20inhibitory\x20GABAergic\x20transmission.</p>\x0a<p>It\x20is\x20indicated\x20in\x20<strong>refractory\x20focal\x20seizures</strong>\x20with\x20impaired\x20awareness\x20and<strong>\x20infantile\x20spasms&nbsp;</strong>in\x20tuberous\x20sclerosis.\x20Vigabatrin\x20is\x20associated\x20with\x20progressive\x20and\x20permanent\x20bilateral\x20<strong>visual\x20loss.</strong></p>\x0a<p>Option\x20C:\x20<strong>Ethosuximide\x20inhibits\x20</strong>the\x20<strong>T-type\x20calcium\x20currents</strong>\x20in\x20thalamic\x20neurons.\x20It\x20is\x20the\x20first-line\x20agent\x20for\x20the\x20treatment\x20of\x20generalized\x20<strong>absence\x20seizures.</strong></p>\x0a<p>Option\x20D:&nbsp;<strong>Tiagabine\x20inhibits</strong>\x20the\x20<strong>GABA\x20transporter\x20GAT-1</strong>\x20and\x20thereby\x20reduces&nbsp;GABA\x20uptake\x20into\x20neurons\x20and\x20glia\x20and\x20prolongs\x20the\x20action\x20of&nbsp;GABA\x20in\x20the\x20synapse.\x20It\x20is\x20also\x20used\x20an\x20adjunct\x20therapy\x20for\x20<strong>focal\x20seizures.</strong></p>','lPBGq','YSskR','<p><strong>Amphotericin\x20B\x20</strong>is\x20an<strong>\x20amphipathic\x20molecule</strong>\x20and\x20incorporates\x20itself\x20in\x20the\x20cell\x20membrane\x20by\x20actively\x20binding\x20to\x20<strong>ergosterol</strong>\x20(as\x20shown\x20in\x20the\x20image\x20by\x20\x27<strong>C</strong>\x27).\x20This\x20results\x20in\x20the\x20formation\x20of\x20<strong>amphotericin-induced\x20pores</strong>\x20which\x20cause\x20leakage\x20of\x20the\x20intracellular\x20contents\x20ultimately\x20resulting\x20in\x20cell\x20death.</p>\x0a<p>It\x20is\x20a\x20<strong>broad-spectrum\x20antifungal</strong>\x20that\x20can\x20be\x20used\x20against<em>\x20Candida\x20albicans,\x20Cryptococcus\x20neoformans,\x20Blastomyces\x20dermatitidis,\x20Histoplasma\x20capsulatum,\x20Sporothrix\x20schenckii,&nbsp;</em><em>Coccidioides\x20immitis,\x20Aspergillus.</em></p>\x0a<p><strong>Amphotericin\x20B</strong>\x20also\x20has\x20<strong>antiprotozoal</strong>\x20action\x20along\x20with\x20antifungal\x20properties\x20and\x20is\x20effective\x20against\x20<strong><em>Leishmania</em></strong><em>.</em></p>\x0a<p><strong>Adverse\x20effects</strong>\x20of\x20amphotericin\x20B\x20include:</p>\x0a<ul>\x0a<li>Infusion-related\x20fever\x20and\x20chills</li>\x0a<li><strong>Azotemia/nephrotoxicity</strong>-\x20all\x20lipid\x20formulations\x20of\x20amphotericin\x20B\x20are\x20less\x20nephrotoxic\x20than\x20conventional\x20amphotericin\x20B</li>\x0a<li><strong>Renal\x20tubular\x20acidosis&nbsp;</strong></li>\x0a<li>Renal\x20wasting\x20of\x20potassium\x20and\x20magnesium</li>\x0a<li>Hypochromic\x20normocytic\x20anemia-\x20due\x20to\x20decreased\x20erythropoietin\x20production\x20from\x20the\x20kidney.</li>\x0a</ul>','1,\x202\x20and\x203','ApZMY','ohTYM','xWoAk','kLzWF','HHTfh','Pharmacology\x20Test','YBkQb','Chlorpropamide','evuhz','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','correctResult','questionNav','cFwon','questions','Correct','cVXtl','incorrectAnswers','EjDea','cnepg','BqqgC','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','4OZhsoa','quizSidebar','choices','<p\x20style=\x22text-align:\x20left;\x22>Theophylline\x20enhances\x20the\x20effect\x20of\x20corticosteroids\x20by\x20activation\x20of\x20histone\x20deacetylase.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Theophylline\x20activates\x20<strong>histone\x20deacetylase-2</strong>.\x20The\x20recruitment\x20of\x20histone\x20deacetylase-2\x20by\x20glucocorticoid\x20receptors\x20(GRs)\x20switches\x20off\x20inflammatory\x20genes.\x20Through\x20this\x20mechanism,\x20theophylline\x20enhances<strong>\x20</strong>the\x20anti-inflammatory<strong>\x20</strong>effects\x20of\x20corticosteroids.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Theophylline\x20is\x20a\x20methylxanthine\x20drug\x20used\x20in\x20the\x20management\x20of\x20asthma\x20and\x20chronic\x20obstructive\x20pulmonary\x20disease.\x20Its\x20other\x20mechanisms\x20of\x20action\x20are\x20as\x20follows:</p>\x0a<ul\x20style=\x22text-align:\x20left;\x22>\x0a<li>Inhibits<strong>\u00a0</strong>phosphodiesterase<strong>\x20</strong>non-selectively,\x20(<strong>PDE3,\x20</strong>PDE4,\x20and\x20PDE5)\x20thereby,\x20increasing\x20cellular\x20cAMP\x20and\x20cGMP,\u00a0causing\x20bronchodilation</li>\x0a<li>Adenosine\x20causes\x20bronchoconstriction\x20by\x20releasing\x20histamine\x20and\x20leukotrienes.\x20Theophylline\x20antagonizes\x20adenosine<strong>\x20</strong>receptors\u00a0causing\x20bronchodilation</li>\x0a<li>Increases\x20<strong>IL-10\x20release</strong>,\x20which\x20has\x20an\x20anti-inflammatory\x20effect</li>\x0a<li>Decreases\x20gene\x20transcription\x20of\x20pro-inflammatory\x20cytokines</li>\x0a<li>Promotes\x20apoptosis\x20of\x20granulocytes,\u00a0reducing\x20the\x20inflammatory\x20load\x20in\x20the\x20airways</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20left;\x22>Theophylline\x20is\x20mainly\x20metabolized\x20by\x20the\x20enzyme\x20CYP1A2\x20enzyme.<strong>\u00a0</strong>Various\u00a0<strong>drug\x20interactions\x20</strong>of\x20theophylline\u00a0include:</p>\x0a<ul\x20style=\x22text-align:\x20left;\x22>\x0a<li>Increased\x20clearance\x20(CYP1A2\x20enzyme\x20induction)\x20by\u00a0smoking,\u00a0phenytoin,\u00a0<strong>rifampicin</strong>,\x20and\x20phenobarbitone.</li>\x0a<li>Decreased\x20clearance\x20(CYP1A2\x20enzyme\x20inhibition)\x20by\x20<strong>erythromycin</strong>,\x20cimetidine,\x20ciprofloxacin,\u00a0<strong>oral\x20contraceptives</strong>,\x20and\x20allopurinol.</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20left;\x22>Important\x20side\x20effects\x20of\x20this\x20drug\x20due\x20to\x20PDE4\x20antagonism\x20are\x20nausea,\x20vomiting,\x20and\x20<strong>gastric\x20discomfort</strong>,\x20and\x20those\x20due\x20to\x20adenosine\x20A1\x20receptor\x20antagonism\x20are\x20diuresis,\x20<strong>cardiac\x20arrhythmias</strong>,\x20and\x20seizures.\u00a0</p>','application/vnd.apple.mpegurl','rkVWj','Metronidazole\x20+\x20Tinidazole','TTwbr','Labetalol\x20has\x20both\x20alpha\x20and\x20beta\x20blocking\x20action','uJhFe','UMkrU','performanceModal','<p>The\x20yellow\x20curve\x20in\x20the\x20image\x20has\x20a\x20duration\x20of\x20action\x20of\x20around\x2011-\x2012\x20hours.\x20Therefore,\x20it\x20indicates\x20<strong>NPH\x20insulin.</strong></p>\x0a<p>The\x20image\x20shows\x20an\x20insulin\x20regimen\x20consisting\x20of\x20a\x20twice-daily\x20injection\x20of\x20<strong>NPH\x20insulin</strong>\x20(yellow\x20line)\x20providing\x20basal\x20insulin\x20coverage\x20and\x20<strong>regular</strong>\x20<strong>insulin</strong>\x20(blue\x20dashed\x20line)\x20or\x20an\x20<strong>insulin</strong>\x20<strong>analog</strong>\x20(glulisine,\x20apart,\x20and\x20lispro\x20in\x20red)\x20providing\x20mealtime\x20insulin\x20coverage.</p>\x0a<p>Duration\x20of\x20NPH\x20insulin\x20is\x20around\x2010-16\x20hours,\x20insulin\x20degludec\x20is\x2024-42\x20hours,\x20regular\x20insulin\x20is\x204-6\x20hours\x20and\x20insulin\x20glulisine\x20is\x20around\x203-4\x20hours.</p>\x0a<p>Other\x20commonly\x20used\x20insulin\x20regimens\x20are\x20shown\x20in\x20the\x20following\x20image.\x20The\x20letter\x20B\x20indicates\x20breakfast,\x20L\x20indicates\x20lunch,\x20S\x20indicates\x20supper\x20and\x20HS\x20indicates\x20bedtime.</p>','accuracy','xRJWd','mtcLJ','userHistory','tfwfX','\x22\x20data-src=\x22','A\x202-year-old\x20child\x20diagnosed\x20with\x20bronchial\x20asthma\x20requires\x20bronchodilator\x20therapy.\x20Which\x20of\x20the\x20following\x20device\x20will\x20you\x20prescribe\x20for\x20this\x20child,\x20to\x20avoid\x20oropharyngeal\x20adverse\x20effects?','gYJIe','You\x20are\x20an\x20intern\x20posted\x20in\x20the\x20surgery\x20department.\x20Your\x20consultant\x20asks\x20you\x20to\x20prescribe\x20a\x20drug\x20for\x20a\x20patient\x20complaining\x20of\x20heartburn.\x20What\x20will\x20you\x20prescribe?','explanation_audio_hin','not_attempted','status','qwUyw','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','Vincristine','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','Dose\x20adjustment\x20is\x20needed\x20in\x20renal\x20impairment','Rifapentin','MMUqj','YCMwI','BqvjL','Kanamycin','pihBA','question_audio','fWZIw','progressBar','It\x20should\x20not\x20be\x20administered\x20in\x20sickle\x20cell\x20patients','Senna','DFfDC','808164raxUWS','qNJMC','loadSource','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','className','zINbQ','https://cdn1.dailyrounds.org/uploads/89e772c50ff7432f87e42692044f9fab.JPEG','https://cdn1.dailyrounds.org/uploads/9d49df501d8440d3bbffd6ee3c455cc4.JPEG','floor','Omeprazole','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','ArrowRight','EGgop','<p><strong>Tetracycline</strong>\x20binds\x20to\x20the\x20<strong>30S</strong>\x20subunit\x20of\x20the\x20ribosome\x20and\x20<strong>inhibits</strong>\x20bacterial\x20<strong>protein\x20synthesis.</strong></p>\x0a<p>Protein\x20synthesis\x20is\x20important\x20for\x20maintaining\x20certain\x20vital\x20functions\x20in\x20bacteria.\x20Hence\x20by\x20interrupting\x20the\x20protein\x20synthesis,\x20they\x20act\x20as\x20<strong>bacteriostatic\x20agents</strong>.</p>\x0a<p>Antibacterial\x20which\x20binds\x20to\x20the<strong>\x2030s\x20subunit\x20of\x2070s\x20ribosome.</strong></p>\x0a<ul>\x0a<li>Tetracyclines</li>\x0a<li>Aminoglycosides</li>\x0a</ul>\x0a<p>Antibacterials\x20that\x20bind\x20to\x20<strong>50s\x20subunit\x20of\x2070s\x20ribosome.</strong></p>\x0a<ul>\x0a<li>Macrolides</li>\x0a<li>Clindamycin</li>\x0a<li>Streptogramins</li>\x0a<li>Chloramphenicol</li>\x0a<li>Linezolid</li>\x0a</ul>','Vitamin\x20D3\x20analog','Atenolol','cATMS','dfJxy','Atenolol\x20is\x20longer\x20acting\x20than\x20metoprolol','Interleukin-10\x20release','tcvYb','Increase\x20absorption\x20rate','eAVcU','eigrH','<p>The\x20image\x20shows<strong>\x20pitting\x20pedal\x20edema</strong>\x20in\x20a\x20hypertensive\x20patient.\x20<strong>Calcium\x20channel\x20blockers\x20(CCBs)</strong>\x20like\x20<strong>amlodipine</strong>\x20are\x20most\x20likely\x20to\x20be\x20associated\x20with\x20peripheral\x20edema.</p>\x0a<p>The\x20frequency\x20of\x20CCB-\x20induced\x20peripheral\x20edema\x20is\x20both\x20<strong>drug-specific</strong>\x20(i.e\x20more\x20potent\x20drugs\x20like\x20amlodipine\x20will\x20be\x20associated\x20with\x20higher\x20rates\x20of\x20developing\x20edema)\x20and\x20<strong>dose-dependent</strong>\x20(i.e\x20incidence\x20of\x20edema\x20increases\x20with\x20an\x20increase\x20in\x20drug\x20dosage\x20and\x20chronicity\x20of\x20its\x20usage).\x20It\x20is\x20more\x20common\x20among\x20<strong>females.</strong></p>\x0a<p>CCB-induced\x20peripheral\x20edema\x20occurs\x20due\x20to\x20a\x20disproportionate\x20decrease\x20in\x20the&nbsp;arteriolar\x20resistance\x20than\x20in\x20the\x20venous\x20circulation,\x20resulting\x20in\x20increased&nbsp;hydrostatic\x20pressure\x20in\x20the\x20precapillary\x20circulation.\x20This\x20leads\x20to\x20a\x20fluid\x20shift&nbsp;into\x20the\x20interstitial\x20compartment\x20causing\x20edema.</p>\x0a<p>Treatment:</p>\x0a<ul>\x0a<li>Dose\x20reduction.</li>\x0a<li>Interclass\x20switching\x20of\x20CCB\x20-\x20switch\x20to\x20non-dihydropyridines\x20like\x20verapamil,\x20and\x20diltiazem.</li>\x0a<li>Addition\x20of\x20a\x20venodilator\x20-\x20ACE\x20inhibitor,\x20ARBs,\x20Nitrates.</li>\x0a<li>Others\x20-\x20compression\x20stockings,\x20avoiding\x20prolonged\x20upright\x20position.</li>\x0a<li>Definitive\x20treatment\x20would\x20be\x20discontinuation\x20of\x20the\x20CCB\x20and\x20switching\x20to\x20another\x20class\x20of\x20antihypertensives.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Common\x20side\x20effects\x20of\x20<strong>ACE\x20inhibitors</strong>\x20like\x20<strong>enalapril\x20</strong>include\x20hypotension,\x20hyperkalemia,\x20dry\x20cough,\x20rashes,\x20urticaria,\x20dysgeusia,\x20gastrointestinal\x20upset,\x20headache,\x20and\x20dizziness.</p>\x0a<p>Option\x20B:<strong>&nbsp;Telmisartan</strong>,\x20an\x20angiotensin\x20receptor\x20blocker\x20(<strong>ARBs)</strong>,\x20causes\x20adverse\x20effects\x20such\x20as\x20hypotension,\x20hyperkalemia,\x20headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>\x0a<p>Option\x20D:\x20Adverse\x20effects\x20of\x20<strong>thiazide\x20diuretics</strong>\x20like\x20<strong>hydrochlorothiazide</strong>\x20are\x20hypokalemia,\x20hyponatremia,\x20hyperglycemia,\x20hyperuricemia,\x20hypercalcemia,\x20rashes,&nbsp;headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>','location','Docusates','answered','submitSection','A\x20young\x20woman\x20is\x20taking\x20regular\x20oral\x20contraceptive\x20pills.\x20Additional\x20contraceptive\x20measures\x20will\x20be\x20required\x20if\x20there\x20is\x20concomitant\x20use\x20of:','solutionAudio','njTwp','LbQPs','ODRUq','RWgux','NAxPV','CvsWC','GOmpF','Bookmark','A\x2065-year-old\x20man\x20with\x20a\x20history\x20of\x20chronic\x20kidney\x20disease\x20and\x20creatinine\x20of\x204.1mg/dl,\x20\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20severe\x20pain\x20in\x20his\x20great\x20toe\x20for\x20the\x20past\x203\x20hours.\x20On\x20examination,\x20his\x20big\x20toe\x20of\x20the\x20right\x20foot\x20is\x20red\x20and\x20tender.\x20Joint\x20aspiration\x20shows\x20no\x20white\x20cells\x20but\x20shows\x20needle-shaped\x20negatively\x20birefringent\x20crystals.\x20What\x20is\x20the\x20drug\x20of\x20choice\x20in\x20this\x20patient?','wnAcC','IL-6\x20receptor\x20antagonist','includes','wghYX','cnGNx','2\x20hours','UpOLh','Late\x20sodium\x20current\x20inhibition','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','explanation_video','kQEgF','trace','add','WMMOn','<p>Prasugrel\x20is\x20<strong>contraindicated</strong>\x20in&nbsp;cerebrovascular\x20accidents\x20as\x20it&nbsp;is\x20associated\x20with\x20higher\x20rates\x20of\x20fatal\x20and\x20life-threatening\x20bleeding.&nbsp;</p>\x0a<p>Option\x20A:\x20It\x20is\x20an\x20<strong>irreversible</strong>\x20inhibitor\x20of\x20the\x20ADP\x20(P2Y<sub>12</sub>)\x20receptor\x20of\x20platelets.</p>\x0a<p>Option\x20B:\x20It\x20has\x20a\x20<strong>faster</strong>\x20onset\x20of\x20action\x20and\x20produces&nbsp;greater\x20inhibition\x20of\x20platelets\x20than\x20clopidogrel.&nbsp;</p>\x0a<p>Option\x20D:\x20<strong>Dose\x20adjustment</strong>&nbsp;is<strong>\x20not\x20needed</strong>\x20in\x20moderate\x20hepatic\x20and\x20renal\x20impairment.&nbsp;</p>','incorrectCount','Isoniazid','VkLCK','Procainamide','bHKBx','vkuuR','fQqsG','To\x20promote\x20the\x20metabolism\x20of\x20levodopa\x20in\x20periphery','setItem','VgBII','720760TcrYjj','yGeRS','BDGtZ','AvJZp','<p>Cinacalcet\x20is\x20a\x20<strong>calcimimetic</strong>\x20agent.</p>\x0a<p>It\x20<strong>activates</strong>\x20the\x20calcium-sensing\x20receptor\x20<strong>(CaSR)</strong>\x20in\x20the\x20parathyroids\x20and\x20blocks\x20PTH\x20secretion.</p>\x0a<p>Cinacalcet\x20is\x20a\x20<strong>type\x20II\x20calcimimetic\x20agent</strong>\x20,\x20it\x20means\x20that\x20it\x20needs\x20either\x20Ca<sup>2+</sup>\x20or\x20some\x20other\x20agonist\x20to\x20activate\x20CaSR.</p>\x0a<p>It\x20is\x20indicated\x20for\x20<strong>secondary\x20hyperparathyroidism</strong>\x20due\x20to\x20chronic\x20kidney\x20disease\x20and\x20tumor\x20of\x20parathyroid\x20gland.</p>\x0a<p>Type\x20I\x20calcimimetic\x20agents\x20are\x20those\x20which\x20can\x20activate\x20CaSR\x20directly\x20such\x20as\x20aminoglycoside\x20and\x20polylysine.</p>','Bisacodyl','XgeIH','lYsat','sgapT','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Has\x20a\x20slower\x20onset\x20of\x20action\x20than\x20clopidogrel','tIUOg','SFTMh','ktmGn','xYnND','sohvY','referrer','questionStates','NhbjI','toLowerCase','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','TiTeW','GjJiN','dYoYi','padStart','timeSpent','pharmacology-test-8fc397a1.html','strokeDasharray','A\x2058-year-old\x20man\x20was\x20treated\x20with\x20a\x20diuretic\x20for\x20heart\x20failure.\x20He\x20now\x20presents\x20with\x20complaints\x20of\x20hearing\x20impairment\x20and\x20dizziness.\x20Which\x20diuretic\x20is\x20likely\x20to\x20be\x20associated\x20with\x20these\x20side\x20effects?','0.1-0.3\x20ng/mL','It\x20is\x20a\x20polyclonal\x20antibody','kMjeY','markReviewText','QpQOJ','getItem','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','AMyfd','Rbdrc','nav-btn-marked-review','A\x20patient\x20is\x20given\x20200mg\x20of\x20a\x20drug\x20and\x20150\x20mg\x20of\x20the\x20drug\x20is\x20excreted\x20in\x204\x20hours.\x20If\x20the\x20elimination\x20of\x20the\x20drug\x20follows\x20first-order\x20kinetics,\x20calculate\x20its\x20half-life?','6-mercaptopurine','map','querySelectorAll','RcDEl','correct','bookmarkBtn','wlgKO','FhcCS','<p><strong>Topiramate</strong>\x20can\x20be\x20used\x20in\x20this\x20patient\x20to\x20<strong>prevent\x20migraine</strong>\x20attacks.</p>\x0a<p>In\x20patients\x20with&nbsp;<strong>&ge;4\x20attacks\x20</strong>of\x20migraine\x20in\x20a<strong>\x20month</strong>,\x20<strong>prophylactic</strong>\x20medications\x20can\x20be\x20used.\x20The\x20various\x20FDA-approved\x20drugs\x20include\x20<strong>propranolol,</strong>\x20timolol,\x20rimegepant,\x20sodium\x20valproate,\x20<strong>topiramate,</strong>\x20eptinezumab,\x20erenumab,\x20fremanezumab,\x20and\x20galcanezumab.</p>\x0a<p>Drugs\x20used\x20for\x20<strong>prophylaxis</strong>\x20of\x20migraine:</p>\x0a<ul>\x0a<li>Beta\x20blockers:\x20Propranolol,\x20metoprolol,\x20timolol,\x20atenolol</li>\x0a<li>Antidepressants:\x20Amitriptyline,\x20nortriptyline,\x20imipramine</li>\x0a<li>Anticonvulsants:\x20Valproate,\x20<strong>topiramate</strong></li>\x0a<li>Serotonin\x20antagonist:\x20Methysergide</li>\x0a<li>Angiotensin\x20II\x20receptor\x20blocker:\x20Candesartan</li>\x0a<li>Angiotensin-converting\x20enzyme\x20inhibitor:\x20Lisinopril</li>\x0a<li>Calcium\x20channel\x20blockers:\x20Flunarizine</li>\x0a</ul>\x0a<p>Other\x20modalities\x20of\x20preventive\x20treatment:</p>\x0a<ul>\x0a<li><strong>Onabotulinum\x20toxin\x20type\x20A</strong>\x20is\x20used\x20in\x20the\x20prevention\x20of\x20<strong>chronic\x20migraine</strong></li>\x0a<li>Neuromodulation:\x20A\x20single-pulse\x20transcranial\x20magnetic\x20stimulation\x20(sTMS)&nbsp;is\x20delivered\x20with\x20a\x20hand-held\x20device\x20(FDA\x20approved)\x20that\x20creates\x20a\x20fluctuating\x20magnetic\x20field\x20which\x20triggers\x20an\x20electric\x20current\x20that\x20modifies\x20cortical\x20excitability.</li>\x0a</ul>\x0a<p><strong>No\x20role\x20in\x20prophylaxis\x20:</strong></p>\x0a<ul>\x0a<li>Calcium\x20channel\x20blockers:\x20Verapamil,\x20nimodipine,\x20diltiazem.&nbsp;</li>\x0a<li>&alpha;2\x20adrenergic\x20agonist:\x20Clonidine.&nbsp;</li>\x0a<li>Selective\x20serotonin\x20reuptake\x20inhibitors:\x20Fluoxetine.</li>\x0a</ul>','GlLKv','Oxybutynin','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','<p><strong>Tafenoquine</strong>\x20is\x20used\x20in\x20the\x20<strong>radical\x20cure\x20of\x20Plasmodium\x20vivax</strong>.\x20Total\x20eradication\x20of\x20plasmodium\x20species\x20which\x20includes\x20clinical\x20curative\x20and\x20hypnozoites\x20phase\x20are\x20called\x20radical\x20cure.</p>\x0a<p>Primaquine\x20and\x20tafenoquine\x20(derivative\x20of\x20primaquine)\x20have\x20very\x20high\x20activity\x20against\x20the\x20<strong>latent\x20tissue\x20forms\x20(hypnozoites)</strong>\x20of\x20the\x20species.\x20It\x20is\x20primarily\x20used\x20for\x20the&nbsp;chemoprophylaxis\x20and\x20radical\x20cure\x20of\x20P.\x20vivax\x20and\x20P.\x20ovale&nbsp;infections.</p>','<p><strong>Thioacetazone</strong>&nbsp;is\x20not\x20a\x20bactericidal\x20drug,\x20it\x20is\x20<strong>bacteriostatic.</strong></p>\x0a<p>Thioacetazone\x20is\x20never\x20used\x20alone.\x20It\x20is\x20only\x20used\x20as\x20a\x20combination\x20with\x20first-line\x20TB\x20medications,\x20such\x20as\x20isoniazid\x20and\x20rifampicin.\x20It\x20is\x20used\x20primarily\x20to\x20prevent\x20the\x20development\x20of\x20bacteria\x20that\x20are\x20resistant\x20to\x20first-line\x20drugs\x20and\x20to\x20treat\x20patients\x20infected\x20with\x20<strong>drug-resistant\x20TB</strong>.</p>\x0a<p>It\x20should\x20<strong>never\x20</strong>be\x20used\x20in<strong>\x20HIV\x20patients</strong>\x20as\x20it&nbsp;can\x20cause\x20severe\x20and\x20fatal\x20skin\x20reactions.\x20Side-effects&nbsp;include\x20gastrointestinal\x20disturbances,\x20blurring\x20of\x20vision,&nbsp;hemolytic\x20anemia\x20and\x20urticaria.</p>\x0a<p><strong>Isoniazid</strong>\x20is\x20a\x20first-line\x20bactericidal\x20drug\x20that\x20is\x20active\x20against\x20both\x20intracellular\x20and&nbsp;extracellular\x20bacilli.</p>\x0a<p><strong>Rifapentin</strong>&nbsp;is\x20a\x20rifampin\x20congener\x20having\x20a\x20similar&nbsp;mechanism\x20of\x20action.\x20It\x20is\x20a\x20bactericidal\x20drug\x20having\x20a\x20longer\x20half-life\x20than\x20rifampin.</p>\x0a<p><strong>Kanamycin</strong>\x20is&nbsp;bactericidal\x20and\x20is\x20active\x20against\x20bacilli&nbsp;resistant\x20to\x20streptomycin,\x20INH,\x20and\x20cycloserine.</p>','UnOEG','Disopyramide','No\x20solution\x20available.','hIuqC','nmlmF','You\x20are\x20posted\x20as\x20an\x20intern\x20in\x20the\x20medicine\x20ward\x20where\x20your\x20consultant\x20asks\x20you\x20to\x20make\x20a\x20list\x20of\x20all\x20the\x20patients\x20who\x20require\x20strict\x20therapeutic\x20drug\x20monitoring.\x20All\x20the\x20following\x20patients\x20will\x20be\x20included\x20in\x20your\x20list,\x20except\x20______.','An\x20elderly\x20patient\x20is\x20brought\x20to\x20the\x20emergency\x20room\x20in\x20a\x20drowsy\x20state\x20after\x20taking\x20an\x20overdose\x20of\x20his\x20sleeping\x20pills.\x20His\x20medical\x20history\x20includes\x20insomnia\x20for\x20which\x20he\x20was\x20on\x20alprazolam.\x20Which\x20of\x20the\x20following\x20medication\x20will\x20you\x20administer\x20to\x20this\x20patient?','ktXPa','hidden','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','currentMode','23967oxvmwH','IcHTH','To\x20reduce\x20the\x20systemic\x20side\x20effects\x20of\x20levodopa','timeDisplay','Desmopressin','vocnl','prevBtn','Marrow','A\x2040-year-old\x20man\x20was\x20treated\x20for\x20a\x20high-grade\x20soft-tissue\x20sarcoma\x20with\x20radiotherapy.\x20Since\x20he\x20was\x20not\x20responding,\x20he\x20was\x20shifted\x20to\x20chemotherapy.\x20After\x20initiating\x20chemotherapy,\x20he\x20developed\x20erythematous\x20rashes\x20over\x20the\x20areas\x20where\x20radiotherapy\x20was\x20administered\x20earlier.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20likely\x20to\x20cause\x20this\x20condition?','<p>The\x20most\x20appropriate\x20treatment\x20for&nbsp;<strong>lithium-induced\x20nephrogenic\x20diabetes\x20insipidus\x20</strong>(NDI)<strong>&nbsp;</strong>is&nbsp;<strong>amiloride.</strong></p>\x0a<p>Lithium&nbsp;is\x20a\x20<strong>mood\x20stabilizer</strong>\x20with\x20a\x20very\x20narrow\x20therapeutic\x20index\x20hence\x20regular\x20determination\x20of\x20serum\x20concentrations\x20is\x20important.\x20Its\x20use\x20is\x20approved\x20by\x20FDA\x20in\x20acute\x20mania\x20and\x20the\x20prevention\x20of\x20recurrences\x20of\x20bipolar\x20illness\x20in\x20adults\x20or\x20adolescents.</p>\x0a<p>Important\x20side\x20effects\x20of\x20lithium\x20are-</p>\x0a<ul>\x0a<li><strong>Fine&nbsp;</strong>tremors\x20in&nbsp;<strong>therapeutic\x20dose</strong></li>\x0a<li><strong>Nephrogenic\x20diabetes\x20insipidus</strong></li>\x0a<li>Hypothyroidism</li>\x0a<li>T\x20wave\x20flattening</li>\x0a<li\x20aria-level=\x221\x22>CNS\x20toxicity\x20manifests\x20as\x20coarse\x20tremors,\x20giddiness,\x20ataxia,\x20motor\x20incoordination,\x20nystagmus,\x20mental\x20confusion,\x20slurred\x20speech,\x20and\x20hyperreflexia.</li>\x0a</ul>\x0a<p>The\x20development\x20of\x20NDI\x20is\x20related\x20to\x20the\x20accumulation\x20of\x20Li<sup>+</sup>\x20in<strong>\x20distal\x20tubular\x20cells</strong>\x20and\x20subsequent\x20inhibition\x20of\x20GSK-3&beta;,\x20leading\x20to\x20<strong>vasopressin\x20insensitivity\x20</strong>and\x20downregulation\x20of<strong>\x20aquaporin-2\x20channels.</strong>\x20Amiloride\x20is\x20a\x20<strong>potassium-sparing\x20diuretic</strong>\x20that\x20<strong>blocks\x20entry\x20of\x20Li<sup>+</sup></strong>\x20into<strong>&nbsp;</strong>collecting\x20duct\x20cells&nbsp;and\x20thus\x20can\x20be\x20used\x20to\x20treat\x20lithium-induced\x20NDI.</p>','iozQs','div','notAttemptedResult','border-red-500','question_images','https://dhmbxeygs57ff.cloudfront.net/uploads/dcf1afee41f64b98a0129246c3cb0a72x720x404.JPEG','CeetA','questionReviewSection','nlXJx','Amlodipine','studyModeLegend','A\x20patient\x20presents\x20with\x20an\x20amoebic\x20liver\x20abscess.\x20He\x20does\x20not\x20have\x20any\x20diarrhea\x20or\x20blood\x20in\x20his\x20stool.\x20His\x20only\x20complaint\x20is\x20vague\x20abdominal\x20pain.\x20On\x20examination\x20of\x20stool,\x20cysts\x20of\x20Entamoeba\x20histolytica\x20are\x20present.\x20How\x20would\x20you\x20treat\x20this\x20patient?','XWvIQ','optionsContainer','explanation_audio_eng','JgcKj','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','MNTJZ','omLNo','DimTa','hivHd','ayTWK','CiclI','HIitm','Domperidone','strokeDashoffset','WpvoV','border-green-500','jsKVy','fVRBJ','Febuxostat','iboaa','A\x20patient\x20on\x20lithium\x20therapy\x20was\x20started\x20on\x20a\x20drug\x20for\x20hypertension.\x20After\x20few\x20days,\x20he\x20developed\x20coarse\x20tremors\x20and\x20other\x20symptoms\x20suggestive\x20of\x20lithium\x20toxicity.\x20Which\x20of\x20the\x20following\x20anti-hypertensive\x20drug\x20is\x20least\x20likely\x20to\x20be\x20the\x20cause\x20of\x20this\x20toxicity?','FbiCT','bktjz','A\x20patient\x20with\x20bronchial\x20asthma\x20was\x20treated\x20with\x20regular\x20inhaled\x20corticosteroids.\x20He\x20is\x20now\x20commenced\x20on\x20theophylline\x20as\x20an\x20add-on\x20therapy.\x20By\x20which\x20of\x20the\x20following\x20mechanism\x20does\x20this\x20drug\x20enhance\x20the\x20effect\x20of\x20corticosteroids?','-600\x20text-white\x22>','ccSpS','reload','No\x20solution\x20provided','dkjuI','Reduce\x20allergic\x20manifestations','Cyclophosphamide','info','AuZfg','customQuizData','UxeMS','gSJdR','GLmss','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','MzEXo','PYQlZ','<p>The\x20rationale\x20behind\x20the\x20combination\x20therapy\x20of<strong>\x20levodopa</strong>\x20with\x20a\x20peripheral\x20DOPA\x20decarboxylase\x20inhibitor\x20like\x20<strong>carbidopa\x20(co-careldopa)</strong>\x20is\x20that\x20inhibition\x20of\x20the\x20metabolism&nbsp;of\x20levodopa\x20(i.e.\x20conversion\x20of\x20levodopa\x20into\x20dopamine)\x20in\x20the\x20peripheral\x20circulation\x20<strong>decreases\x20the\x20systemic\x20side\x20effects</strong>\x20of&nbsp;levodopa,\x20like\x20vomiting.</p>\x0a<p>Peripheral\x20dopa\x20decarboxylase\x20inhibitors\x20(carbidopa)\x20do\x20not\x20cross\x20the\x20blood-brain\x20barrier.\x20Therefore,\x20they\x20only\x20<strong>inhibit\x20</strong>the<strong>\x20conversion\x20of\x20levodopa</strong>\x20into\x20dopamine\x20in\x20the<strong>\x20periphery</strong>\x20and\x20<strong>not\x20in\x20the\x20brain</strong>.\x20This\x20leads\x20to\x20the\x20increased\x20plasma\x20half-life\x20of\x20levodopa,\x20and\x20therefore,\x20lower\x20doses\x20of\x20levodopa\x20can\x20be\x20prescribed.</p>\x0a<p>Benefits\x20of\x20combination\x20therapy:</p>\x0a<ul>\x0a<li>This\x20therapy\x20inhibits\x20the\x20metabolism\x20of\x20levodopa\x20in\x20the\x20periphery,\x20leading\x20to\x20<strong>increased\x20plasma\x20half-life</strong>\x20of\x20levodopa.</li>\x0a<li>Combination\x20therapy\x20reduces\x20adverse\x20effects\x20like\x20gastrointestinal\x20side\x20effects,\x20orthostatic\x20hypotension,\x20and\x20cardiac\x20arrhythmias.</li>\x0a<li>This\x20therapy\x20allows\x20for\x20increased\x20availability\x20of\x20levodopa\x20in\x20the\x20brain.</li>\x0a<li>Fluctuation\x20in\x20motor\x20control,\x20where\x20the\x20patient\x20is\x20alternately\x20well\x20and\x20disabled,\x20occurs\x20on\x20prolonged\x20therapy\x20with\x20levodopa.\x20This\x20type\x20of\x20\x22<strong>on-off</strong>\x22\x20effect\x20is\x20<strong>reduced</strong>\x20in\x20combination\x20therapy\x20because\x20of\x20sustained\x20dopamine\x20levels\x20in\x20the\x20brain.</li>\x0a<li><strong>Pyridoxine</strong>\x20enhances\x20the\x20peripheral\x20metabolism\x20of\x20levodopa.\x20Hence,\x20combination\x20therapy\x20with\x20carbidopa\x20nullifies\x20the\x20interaction\x20of\x20pyridoxine\x20with\x20levodopa\x20metabolism.</li>\x0a<li><strong>&nbsp;</strong>A<strong>\x20higher&nbsp;degree\x20of\x20improvement</strong>\x20is\x20seen&nbsp;in\x20combination\x20therapy\x20than\x20in\x20monotherapy\x20with\x20levodopa.</li>\x0a</ul>\x0a<p>Demerits\x20of\x20combination\x20therapy:</p>\x0a<p>This\x20therapy\x20decreases\x20the\x20concentration\x20of\x20levodopa\x20in\x20the\x20periphery,\x20but\x20increases\x20the\x20concentration\x20of\x20levodopa\x20reaching\x20the\x20brain.<strong>\x20Involuntary\x20movements\x20</strong>and\x20<strong>behavioral\x20adverse\x20effects</strong>\x20like\x20confusion,\x20hallucinations,&nbsp;nightmares,\x20and\x20delusions\x20are\x20<strong>not\x20reduced\x20</strong>after\x20the\x20addition\x20of\x20carbidopa<strong>.\x20</strong>In\x20fact,\x20they\x20are\x20<strong>increased</strong>&nbsp;in\x20patients\x20who\x20are\x20taking\x20levodopa\x20<strong>with\x20peripheral\x20carboxylase</strong>\x20inhibitors.<strong>&nbsp;</strong>This\x20is\x20because\x20<strong>higher</strong>\x20levels\x20of\x20<strong>dopamine</strong>\x20are\x20formed\x20in\x20CNS.</p>','explanationVideoPlayer','Thioacetazone','A\x2030-year-old\x20female\x20patient\x20had\x206\x20attacks\x20of\x20migraine\x20in\x20the\x20last\x20month\x20and\x20was\x20treated\x20for\x20the\x20same.\x20She\x20is\x20not\x20able\x20to\x20tolerate\x20the\x20pain\x20during\x20attacks\x20and\x20came\x20to\x20the\x20hospital\x20asking\x20for\x20medication\x20that\x20can\x20prevent\x20these\x20attacks\x20in\x20the\x20future.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20in\x20this\x20patient?','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','Beta\x202','length','SCfIN','eMQWJ','Quinidine','parse','UFTnE','MhWcn','<p><strong>Phenytoin&nbsp;</strong>is\x20an\x20<strong>enzyme\x20inducer\x20</strong>and\x20can\x20cause\x20increased\x20metabolism\x20of\x20oral\x20contraceptive\x20pills\x20(OCPs)\x20leading\x20to\x20<strong>contraceptive\x20failure</strong>.\x20Hence,\x20additional&nbsp;contraceptive\x20measures\x20will\x20be\x20required\x20if\x20there\x20is\x20concomitant\x20use\x20of\x20phenytoin\x20with\x20OCPs.</p>\x0a<p>Ciprofloxacin,\x20omeprazole,\x20and\x20grapefruit\x20juice\x20are&nbsp;<strong>enzyme\x20inhibitors</strong>\x20that\x20inhibit\x20the\x20degradation\x20of\x20OCPs\x20and\x20<strong>increase</strong>\x20their\x20<strong>duration</strong>\x20of\x20<strong>action.</strong></p>\x0a<p><strong>CYP450\x20enzyme\x20inducers:</strong></p>\x0a<ul>\x0a<li>Carbamazepine</li>\x0a<li>Cigarette\x20smoking</li>\x0a<li>Rifampicin</li>\x0a<li>Alcohol\x20(chronic)</li>\x0a<li><strong>Phenytoin</strong></li>\x0a<li>Phenobarbitone</li>\x0a</ul>\x0a<p><strong>CYP\x20450\x20enzyme\x20inhibitors:</strong></p>\x0a<ul>\x0a<li>Sodium\x20valproate</li>\x0a<li>SSRIs\x20-\x20fluoxetine,\x20fluvoxamine,\x20paroxetine,\x20sertraline</li>\x0a<li>Azole\x20antifungals\x20-\x20ketoconazole,\x20itraconazole,\x20fluconazole</li>\x0a<li>Erythromycin,\x20clarithromycin</li>\x0a<li><strong>Ciprofloxacin</strong></li>\x0a<li><strong>Omeprazole</strong></li>\x0a<li><strong>Grapefruit\x20juice</strong>&nbsp;</li>\x0a</ul>','wMLQO','HBPWX','exception','border-gray-600','modeModal','IfgHC','notAttempted','CUbiO','not-attempted','C\x20>\x20A\x20=\x20B','name','https://dhmbxeygs57ff.cloudfront.net/uploads/17fa4dd02dcc4822a252ebcf7c1c3e11x1280x884.JPEG','1-c.\x202-a,\x203-b,\x204-d','Match\x20the\x20following\x20antiretroviral\x20drugs\x20with\x20their\x20important\x20adverse\x20effects.','table','src','jxInT','remove','2555192rlffdq','constructor','Colchicine','console','textContent','addEventListener','contains','<p><strong>Lactulose</strong>\x20is\x20safe\x20to\x20use\x20in\x20pregnant\x20women\x20with\x20constipation.</p>\x0a<p><strong>Constipation\x20in\x20pregnancy:</strong></p>\x0a<p>Constipation\x20is\x20a\x20common\x20occurrence\x20in\x20pregnancy\x20because\x20of\x20dietary\x20alterations,\x20anatomic\x20impingement\x20of\x20a\x20large\x20uterus\x20on\x20the\x20rectosigmoid,\x20fluid\x20shifts,\x20decreased\x20exercise\x20levels,\x20and\x20reduced\x20mobility.\x20Pregnancy\x20and\x20pregnancy-related\x20constipation\x20increases\x20the\x20risk\x20for\x20developing\x20haemorrhoids.</p>\x0a<p>Treatment\x20options\x20include</p>\x0a<ul>\x0a<li>Dietary\x20changes\x20-\x20increased\x20water\x20intake,\x20increased\x20fibre\x20in\x20diet</li>\x0a<li>Gentle\x20exercises</li>\x0a<li>Laxatives\x20-\x20<strong>Lactulose,\x20</strong>an\x20osmotic\x20purgative,<strong>&nbsp;</strong>and\x20<strong>Ispaghula,</strong>\x20a\x20bulk\x20forming\x20agent,\x20are\x20safe\x20to\x20use\x20in\x20pregnancy.&nbsp;</li>\x0a</ul>\x0a<p>Senna,\x20bisacodyl,\x20docusates\x20and\x20saline\x20laxatives&rsquo;\x20<strong>safety</strong>\x20is\x20<strong>unknown</strong>\x20and\x20hence\x20it\x20is\x20better\x20to\x20<strong>avoid</strong>\x20them.</p>','<p>The<strong>\x20therapeutic\x20plasma\x20concentration</strong>\x20of\x20digoxin\x20is\x20<strong>0.5-1.4\x20ng/ml.</strong></p>\x0a<p><strong>Digoxin\x20</strong>is\x20a<strong>\x20cardiac\x20glycoside</strong>&nbsp;with\x20a\x20<strong>narrow\x20therapeutic\x20index</strong>\x20and\x20is\x20used\x20in\x20the\x20management\x20of\x20heart\x20failure.\x20It\x20<strong>inhibits\x20the&nbsp;Na<span\x20class=\x22s1\x22>+</span>/K<span\x20class=\x22s1\x22>+&nbsp;</span>ATPase</strong>\x20pump\x20in\x20the\x20myocardium\x20leading\x20to\x20increased\x20accumulation\x20of\x20intracellular\x20sodium.\x20Increased\x20intracellular\x20sodium\x20prevents\x20the\x20efflux\x20of\x20calcium\x20ions.\x20This\x20results\x20in\x20<strong>increased\x20intracellular\x20calcium</strong>\x20which\x20increases\x20the\x20contractility\x20of\x20the\x20muscle.</p>\x0a<p>Pharmacokinetics\x20of\x20digoxin:</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Oral\x20absorption</td>\x0a<td>60&ndash;80%</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Plasma\x20t&frac12;\x20</strong></td>\x0a<td><strong>40\x20hr</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Therapeutic\x20conc.</strong></td>\x0a<td><strong>0.5&ndash;1.4\x20ng/ml</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Toxic\x20conc.</strong></td>\x0a<td><strong>&gt;\x202\x20ng/ml</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Daily\x20maintenance\x20dose</td>\x0a<td>0.125&ndash;0.5\x20mg</td>\x0a</tr>\x0a<tr>\x0a<td>Route\x20of\x20elimination\x20&nbsp;</td>\x0a<td>Renal\x20excretion</td>\x0a</tr>\x0a<tr>\x0a<td>Route\x20of\x20administration</td>\x0a<td>Oral,\x20IV</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Clinical\x20features\x20of\x20digoxin\x20toxicity:</strong></p>\x0a<ul>\x0a<li>CNS\x20manifestations\x20-\x20Drowsiness,\x20neuralgia,\x20headache,\x20confusion,\x20or\x20giddiness</li>\x0a<li>Ophthalmic\x20manifestations\x20-\x20Visual\x20aberration\x20is\x20an\x20early\x20indication\x20of\x20digitalis\x20toxicity.\x20Yellow-green\x20distortion\x20is\x20the\x20most\x20common.\x20Yellow\x20halos\x20around\x20lights\x20(<strong>xanthopsia</strong>)\x20are\x20seen.\x20Visual\x20acuity\x20is\x20reduced.</li>\x0a<li>Gastrointestinal\x20manifestations-\x20Nausea,\x20vomiting,\x20anorexia,\x20diarrhea,\x20abdominal\x20pain.</li>\x0a<li>Cardiac&nbsp;manifestations\x20-&nbsp;Palpitations,\x20dyspnea,\x20syncope,\x20hypotension.&nbsp;The\x20most\x20serious\x20side\x20effect\x20of\x20digoxin\x20is\x20<strong>arrhythmia</strong>.\x20They\x20can\x20present\x20as&nbsp;extreme\x20bradycardia,\x20atrial\x20fibrillation,\x20ventricular\x20extrasystoles,\x20bigeminy,\x20ventricular\x20tachycardia,\x20and\x20fibrillation.</li>\x0a</ul>\x0a<p>Digoxin\x20should\x20be\x20discontinued\x20whenever\x20toxicity\x20is\x20suspected.&nbsp;An\x20effective\x20<strong>antidote</strong>\x20for\x20digoxin\x20toxicity\x20is\x20<strong>digibind</strong>,\x20which\x20is\x20an\x20anti-digoxin\x20antibody.\x20Arrhythmias\x20should\x20be\x20treated.</p>','forEach','OTvWL','video[data-src]','WoGPA','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','A\x2030-year-old\x20female\x20patient\x20with\x20early\x20morning\x20stiffness\x20and\x20chronic\x20pain\x20over\x20small\x20joints\x20was\x20diagnosed\x20with\x20rheumatoid\x20arthritis.\x20She\x20has\x20been\x20on\x20drugs\x20for\x20the\x20past\x20few\x20years,\x20without\x20any\x20improvement.\x20Now,\x20it\x20has\x20been\x20decided\x20to\x20start\x20her\x20on\x20biological\x20agents.\x20Which\x20of\x20the\x20following\x20will\x20not\x20be\x20used\x20in\x20this\x20patient?','lDOoc','Which\x20of\x20the\x20following\x20statements\x20are\x20correct\x20regarding\x20the\x20clinical\x20trials?','pxvuX','Which\x20of\x20the\x20following\x20drugs\x20cannot\x20be\x20used\x20for\x20pneumonia\x20caused\x20by\x20Pseudomonas?','get','button','PvdbX','WPEzT','pGOik','lTuZW','GnIDt','explanation_images','A\x2023-year-old\x20pregnant\x20woman\x20presented\x20with\x20features\x20suggestive\x20of\x20thyrotoxicosis.\x20Which\x20of\x20the\x20following\x20is\x20not\x20a\x20treatment\x20option\x20for\x20her\x20condition?','YsEID','Dantrolene','Thiazides','QYRRk','3|1|2|5|4|0','It\x20is\x20contraindicated\x20in\x20cerebrovascular\x20accidents','selectedAnswer','fill','IySdU','timed_study','flex','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','questionText','totalQuestionsResult','https://dhmbxeygs57ff.cloudfront.net/uploads/322b8f3ab83e486784da84d544735a56x1280x1147.JPEG','HLHMp','STgnz','aiVUR','XtapY','ZwnQe','KXMHe','>\x202\x20ng/mL','push','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','PTH\x20preparation','<p><strong>Doxorubicin</strong>&nbsp;can\x20result\x20in\x20a\x20<strong>radiation\x20recall\x20reaction</strong>&nbsp;where\x20erythema\x20and\x20desquamation\x20of\x20skin\x20are\x20observed\x20at\x20sites\x20of\x20previous\x20radiation\x20injury.&nbsp;</p>\x0a<div\x20class=\x22ng-star-inserted\x22>\x0a<div\x20class=\x22table-responsive\x20font-weight-light\x20answer-scroll\x20ng-star-inserted\x22>\x0a<p>Radiation\x20recall\x20syndrome\x20is\x20an\x20acute\x20inflammatory\x20response\x20confined\x20to\x20the\x20areas\x20that\x20are\x20previously\x20irradiated,\x20which\x20can\x20be\x20triggered\x20by\x20the\x20administration\x20of\x20chemotherapeutic\x20agents.\x20Studies\x20show\x20that\x20the\x20common\x20drugs\x20causing\x20this\x20phenomenon\x20are:</p>\x0a<ul>\x0a<li\x20aria-level=\x221\x22><strong>Doxorubicin</strong></li>\x0a<li\x20aria-level=\x221\x22>Docetaxel\x20and\x20paclitaxel</li>\x0a<li\x20aria-level=\x221\x22>Gemcitabine\x20and\x20capecitabine</li>\x0a</ul>\x0a<p><strong>Radiation\x20sensitization\x20-&nbsp;</strong>This\x20is&nbsp;<strong>more\x20common</strong>&nbsp;than\x20radiation\x20recall.\x20This\x20is\x20a\x20period\x20of\x20enhanced\x20sensitivity\x20in\x20the\x20days\x20after\x20irradiation\x20when\x20the\x20reaction\x20to\x20systemically\x20administered\x20drugs\x20and\x20the\x20time\x20interval\x20between\x20the\x20end\x20of\x20radiation\x20and\x20chemotherapy\x20is<strong>&nbsp;&lt;7\x20days</strong>.\x20Such\x20reactions\x20can\x20be\x20considered\x20radiation\x20enhancement\x20or\x20sensitization.&nbsp;</p>\x0a<p><strong>Radiation\x20recall\x20-&nbsp;</strong>This\x20is&nbsp;<strong>less</strong>&nbsp;common\x20than\x20radiation\x20sensitization.\x20When\x20the\x20time\x20interval\x20between\x20the\x20end\x20of\x20radiation\x20and\x20chemotherapy\x20is&nbsp;<strong>&gt;7</strong>&nbsp;<strong>days</strong>,\x20months,\x20or\x20even&nbsp;<strong>years</strong>.</p>\x0a<p\x20dir=\x22ltr\x22>The\x20major\x20side\x20effects\x20of\x20doxorubicin\x20are:&nbsp;</p>\x0a<ul>\x0a<li\x20dir=\x22ltr\x22\x20role=\x22presentation\x22><strong>Myelosuppression&nbsp;</strong></li>\x0a<li\x20dir=\x22ltr\x22\x20role=\x22presentation\x22><strong>Cardiomyopathy.</strong></li>\x0a</ul>\x0a</div>\x0a</div>\x0a<div\x20class=\x22row\x20mt-3\x22>\x0a<div\x20class=\x22col-auto\x22>&nbsp;</div>\x0a</div>'];_0x3c41=function(){return _0x44d98e;};return _0x3c41();}function setupVideo(_0x1cc8df,_0x5e9e97){const _0x50081e=_0x5b771a,_0x33b4a9={'YSskR':function(_0xfdc70a,_0x26b8bf){return _0xfdc70a(_0x26b8bf);},'GsGdu':_0x50081e(0x202),'ofsyN':function(_0x3480f2){return _0x3480f2();},'kMjeY':_0x50081e(0x1ec),'WMPnY':function(_0x94993,_0x4f3909){return _0x94993===_0x4f3909;},'QmqmX':_0x50081e(0x223)};if(Hls[_0x50081e(0x447)]()){const _0x26b538=new Hls();_0x26b538[_0x50081e(0x214)](_0x5e9e97),_0x26b538['attachMedia'](_0x1cc8df);}else _0x1cc8df[_0x50081e(0x3e7)](_0x33b4a9[_0x50081e(0x272)])&&(_0x33b4a9['WMPnY'](_0x33b4a9['QmqmX'],_0x50081e(0x23e))?_0x33b4a9[_0x50081e(0x1d0)](_0x1cfe14,_0x33b4a9['GsGdu'])&&_0x33b4a9[_0x50081e(0x3c8)](_0x1f9e2e):_0x1cc8df['src']=_0x5e9e97);}function displayQuestion(){const _0x24894c=_0x5b771a,_0x31a1c0={'cFwon':function(_0x2adfc5,_0x2494ca){return _0x2adfc5!==_0x2494ca;},'yyyvb':function(_0xadae6c,_0x9019c6){return _0xadae6c===_0x9019c6;},'KojSy':_0x24894c(0x440),'MmCjT':_0x24894c(0x1ff),'lQMcq':function(_0xb8b103){return _0xb8b103();},'WCFFE':function(_0x5a2460,_0x20f7d3){return _0x5a2460===_0x20f7d3;},'lxkfd':_0x24894c(0x260),'YBkQb':function(_0x71eb97,_0x3bd293){return _0x71eb97+_0x3bd293;},'bMGHN':_0x24894c(0x191),'pikRR':function(_0x566adb,_0x38ceca){return _0x566adb+_0x38ceca;},'ifCAf':'Option\x20','iubcX':_0x24894c(0x342),'MMUqj':function(_0x2da98e,_0x3543ad){return _0x2da98e(_0x3543ad);},'mtcLJ':_0x24894c(0x446),'UxeMS':function(_0x52a939,_0x2a5fb3){return _0x52a939===_0x2a5fb3;},'IElZH':_0x24894c(0x31a),'XjeLX':_0x24894c(0x1bc),'ewyhA':function(_0x5170e9,_0x1a9eb7){return _0x5170e9/_0x1a9eb7;},'bHKBx':function(_0x258b1e,_0x49521d){return _0x258b1e+_0x49521d;},'GpHKl':_0x24894c(0x20e),'VPpGf':_0x24894c(0x29a),'TTwbr':function(_0x303cc3,_0xcbdebf){return _0x303cc3===_0xcbdebf;},'GjJiN':'No\x20question\x20text\x20available','eUunY':function(_0x23ac78,_0x7241dd){return _0x23ac78===_0x7241dd;},'WmZkL':'IuqLW','JhYBZ':_0x24894c(0x3ee),'YCMwI':_0x24894c(0x2ab),'kLzWF':_0x24894c(0x22d),'AvJZp':'timed_study','XVXTd':function(_0x1ddb9b,_0x2f6fd8){return _0x1ddb9b===_0x2f6fd8;},'tfQWi':_0x24894c(0x289),'lAGhv':_0x24894c(0x406),'ujPys':function(_0x2886a9){return _0x2886a9();}};if(!questionsData||_0x31a1c0[_0x24894c(0x2cc)](questionsData[_0x24894c(0x2d8)],0x0)){document['getElementById'](_0x31a1c0[_0x24894c(0x33c)])[_0x24894c(0x3a8)]=_0x31a1c0[_0x24894c(0x17c)];return;};const _0xe8c225=questionsData[currentQuestionIndex];questionStartTime=Date[_0x24894c(0x3e3)](),selectedOption=questionStates[currentQuestionIndex][_0x24894c(0x314)];const _0x2300c7=_0x31a1c0[_0x24894c(0x3e0)](_0x31a1c0[_0x24894c(0x24d)](currentQuestionIndex,0x1),questionsData[_0x24894c(0x2d8)])*0x64;document['getElementById'](_0x31a1c0[_0x24894c(0x3b2)])['style'][_0x24894c(0x39c)]=_0x31a1c0[_0x24894c(0x3fd)](_0x2300c7,'%'),document['getElementById']('currentQuestion')[_0x24894c(0x2f6)]=_0x31a1c0[_0x24894c(0x3fd)](currentQuestionIndex,0x1),_0x31a1c0[_0x24894c(0x42d)](updateQuestionNav),document[_0x24894c(0x3fa)](_0x31a1c0[_0x24894c(0x335)])['disabled']=_0x31a1c0[_0x24894c(0x1ef)](currentQuestionIndex,0x0),document[_0x24894c(0x3fa)](_0x24894c(0x349))[_0x24894c(0x3ce)]['add']('hidden'),document[_0x24894c(0x3fa)](_0x31a1c0['IElZH'])['innerHTML']=_0xe8c225['text']||_0x31a1c0[_0x24894c(0x269)];let _0x265475='';if(_0xe8c225[_0x24894c(0x20c)])_0x265475+=_0x24894c(0x204)+_0xe8c225['question_audio']+_0x24894c(0x3ba);if(_0xe8c225[_0x24894c(0x36e)])_0x265475+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0xe8c225[_0x24894c(0x36e)]+_0x24894c(0x39a);if(_0xe8c225[_0x24894c(0x2a2)]){if(_0x31a1c0['eUunY'](_0x31a1c0[_0x24894c(0x3c3)],_0x24894c(0x320))){const _0x5cc843=_0x1fd93b[_0x3006e9];_0x31a1c0[_0x24894c(0x1df)](_0x5cc843[_0x24894c(0x314)],null)&&(_0x31a1c0[_0x24894c(0x422)](_0x20232b['choices'][_0x5cc843[_0x24894c(0x314)]]['id'],_0x162075[_0x24894c(0x345)])?(_0x5681db++,_0x5cc843[_0x24894c(0x200)]='correct'):(_0x3fe282++,_0x5cc843[_0x24894c(0x200)]=_0x31a1c0[_0x24894c(0x39e)]));}else _0xe8c225[_0x24894c(0x2a2)]['forEach'](_0x530ccd=>{const _0x3b7cdc=_0x24894c;if(_0x530ccd)_0x265475+=_0x3b7cdc(0x2ff)+_0x530ccd+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});}document[_0x24894c(0x3fa)](_0x31a1c0[_0x24894c(0x367)])['innerHTML']=_0x265475;const _0xe1c0fb=document[_0x24894c(0x3fa)](_0x31a1c0[_0x24894c(0x208)]);_0xe1c0fb[_0x24894c(0x3a8)]='',_0xe1c0fb[_0x24894c(0x3ce)][_0x24894c(0x2f1)](_0x31a1c0[_0x24894c(0x1d6)]),_0xe8c225[_0x24894c(0x1ea)]&&Array[_0x24894c(0x13f)](_0xe8c225[_0x24894c(0x1ea)])&&(_0xe8c225[_0x24894c(0x1ea)][_0x24894c(0x2fb)]((_0x1dd9d6,_0x26598d)=>{const _0x3817eb=_0x24894c;if(_0x31a1c0[_0x3817eb(0x3d7)](_0x31a1c0[_0x3817eb(0x365)],_0x31a1c0[_0x3817eb(0x365)])){const _0x164ec5=String['fromCharCode'](_0x31a1c0[_0x3817eb(0x1d9)](0x41,_0x26598d)),_0x3b174b=selectedOption===_0x26598d,_0x64ae85=document[_0x3817eb(0x334)](_0x3817eb(0x29f));_0x64ae85[_0x3817eb(0x3a8)]=_0x3817eb(0x267)+(_0x3b174b?_0x31a1c0[_0x3817eb(0x348)]:'')+_0x3817eb(0x40d)+_0x26598d+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x164ec5+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x1dd9d6[_0x3817eb(0x3ed)]||_0x31a1c0[_0x3817eb(0x3fd)](_0x31a1c0['ifCAf'],_0x31a1c0[_0x3817eb(0x1d9)](_0x26598d,0x1)))+_0x3817eb(0x242),_0xe1c0fb[_0x3817eb(0x37d)](_0x64ae85);}else _0xf1692a[_0x59b407][_0x3817eb(0x200)]===_0x31a1c0[_0x3817eb(0x402)]&&(_0x52da94[_0x17f110][_0x3817eb(0x200)]='answered',_0x37c954[_0x3817eb(0x40a)]++,_0x19386c[_0x3817eb(0x2e6)]--),_0x31a1c0[_0x3817eb(0x42d)](_0x547ac5);}),_0xe1c0fb['addEventListener']('click',function(_0x12f0c3){const _0x566cb=_0x24894c,_0x5a747b=_0x12f0c3['target'][_0x566cb(0x1cd)](_0x31a1c0[_0x566cb(0x331)]);if(_0x5a747b){const _0x3c4673=_0x31a1c0[_0x566cb(0x207)](parseInt,_0x5a747b['getAttribute'](_0x31a1c0[_0x566cb(0x1f7)]));_0x31a1c0[_0x566cb(0x207)](selectOption,_0x3c4673);}})),_0x31a1c0[_0x24894c(0x42d)](updateBookmarkButton),_0x31a1c0[_0x24894c(0x42d)](updateMarkReviewButton),(currentMode===_0x31a1c0[_0x24894c(0x256)]||_0x31a1c0[_0x24894c(0x422)](currentMode,_0x24894c(0x3d1)))&&!isQuizCompleted&&(_0x31a1c0['XVXTd'](_0x31a1c0['tfQWi'],_0x31a1c0['lAGhv'])?_0x31a1c0[_0x24894c(0x42d)](_0x5e1cc1):_0x31a1c0['ujPys'](startTimer));}function selectOption(_0x5baa84){const _0x2720a6=_0x5b771a,_0xbd7555={'EGgop':'selected','cATMS':function(_0x39c06f,_0x4e694d){return _0x39c06f===_0x4e694d;},'JRSXB':function(_0x58482f){return _0x58482f();},'DFfDC':_0x2720a6(0x2ab),'qwUyw':_0x2720a6(0x22d),'ouUMB':function(_0x2e8c74,_0x2c7dbc){return _0x2e8c74-_0x2c7dbc;},'pihBA':_0x2720a6(0x188),'ThEUh':function(_0x1214b1,_0x5c79a4){return _0x1214b1===_0x5c79a4;},'ODRUq':'timed_study','kmGTn':function(_0x1648cd,_0x57405f){return _0x1648cd!==_0x57405f;},'xWoAk':_0x2720a6(0x1f9),'dBgks':_0x2720a6(0x1ff),'hKNuC':function(_0xe4fbb8){return _0xe4fbb8();}},_0x25ec53=document[_0x2720a6(0x3fa)](_0xbd7555[_0x2720a6(0x211)]);if(_0x25ec53[_0x2720a6(0x3ce)][_0x2720a6(0x2f8)](_0xbd7555[_0x2720a6(0x201)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x2720a6(0x26c)]+=_0xbd7555['ouUMB'](Date[_0x2720a6(0x3e3)](),questionStartTime),questionStartTime=Date[_0x2720a6(0x3e3)]()),selectedOption=_0x5baa84,questionStates[currentQuestionIndex]['selectedAnswer']=_0x5baa84,document[_0x2720a6(0x27d)](_0x2720a6(0x342))[_0x2720a6(0x2fb)]((_0x547dd4,_0x50a0e2)=>{const _0x274603=_0x2720a6;_0x547dd4[_0x274603(0x3ce)][_0x274603(0x45e)](_0xbd7555[_0x274603(0x21e)],_0xbd7555[_0x274603(0x222)](_0x50a0e2,_0x5baa84));}),_0xbd7555[_0x2720a6(0x222)](currentMode,_0xbd7555[_0x2720a6(0x20b)])||_0xbd7555[_0x2720a6(0x3da)](currentMode,_0xbd7555[_0x2720a6(0x233)])?_0xbd7555['JRSXB'](processAnswer):_0xbd7555[_0x2720a6(0x426)](_0xbd7555[_0x2720a6(0x1d5)],_0x2720a6(0x3d9))?(_0xbd7555[_0x2720a6(0x222)](questionStates[currentQuestionIndex]['status'],_0xbd7555[_0x2720a6(0x448)])&&(questionStates[currentQuestionIndex][_0x2720a6(0x200)]=_0xbd7555[_0x2720a6(0x201)],stats[_0x2720a6(0x40a)]++,stats[_0x2720a6(0x2e6)]--),updateQuestionNav()):_0xbd7555[_0x2720a6(0x3f5)](_0x224dab),_0xbd7555[_0x2720a6(0x150)](saveProgress);}function processAnswer(){const _0x224937=_0x5b771a,_0x49c34={'GOmpF':function(_0x356da4,_0x15dd53){return _0x356da4===_0x15dd53;},'WaKIR':function(_0x1d91b5,_0x2ae4ad){return _0x1d91b5===_0x2ae4ad;},'enkQz':function(_0x149556,_0x2b098c){return _0x149556===_0x2b098c;},'xYnND':'not_attempted','pGOik':'correct','XSSxB':_0x224937(0x440),'wtHPb':function(_0x2bcc50){return _0x2bcc50();}},_0x317f60=questionsData[currentQuestionIndex],_0x514977=_0x317f60[_0x224937(0x345)];if(_0x49c34[_0x224937(0x237)](selectedOption,null))return;const _0x4a9d64=_0x317f60[_0x224937(0x1ea)][selectedOption],_0x25cb5b=_0x49c34[_0x224937(0x1c2)](_0x4a9d64['id'],_0x514977);if(_0x49c34[_0x224937(0x427)](questionStates[currentQuestionIndex][_0x224937(0x200)],_0x49c34[_0x224937(0x261)])){stats[_0x224937(0x40a)]++,stats[_0x224937(0x2e6)]--;if(_0x25cb5b)stats[_0x224937(0x16f)]++;else stats[_0x224937(0x1e3)]++;}questionStates[currentQuestionIndex][_0x224937(0x200)]=_0x25cb5b?_0x49c34[_0x224937(0x309)]:_0x49c34['XSSxB'],updateStats(),showInlineFeedback(_0x25cb5b),_0x49c34['wtHPb'](updateQuestionNav);}function showInlineFeedback(_0x1ad14d){const _0x1f9c46=_0x5b771a,_0x487535={'THNDk':_0x1f9c46(0x276),'vDpTW':function(_0x7f6bf6,_0x21fb7b){return _0x7f6bf6===_0x21fb7b;},'eRtpj':_0x1f9c46(0x1f2),'vocnl':'selected','tNXOG':function(_0x2c0d49,_0x15016d){return _0x2c0d49===_0x15016d;},'skkbk':function(_0x22ca66,_0x1fec25){return _0x22ca66===_0x1fec25;},'YKZPl':_0x1f9c46(0x440),'rDoJY':function(_0x2addd9,_0x32e35e){return _0x2addd9!==_0x32e35e;},'zVAMZ':_0x1f9c46(0x2ab),'MzEXo':_0x1f9c46(0x22d)};if(_0x487535[_0x1f9c46(0x42b)](currentMode,_0x1f9c46(0x188))&&currentMode!=='timed_study')return;const _0x334b80=document[_0x1f9c46(0x3fa)](_0x487535[_0x1f9c46(0x40b)]),_0x275916=_0x334b80[_0x1f9c46(0x27d)](_0x1f9c46(0x342)),_0x12f1c0=questionsData[currentQuestionIndex],_0x42f54b=_0x12f1c0['correct_choice_id'];let _0x2a246e=_0x12f1c0[_0x1f9c46(0x1ea)]['findIndex'](_0x2937d0=>_0x2937d0['id']===_0x42f54b);_0x334b80['classList'][_0x1f9c46(0x246)](_0x487535[_0x1f9c46(0x2d0)]),_0x275916[_0x1f9c46(0x2fb)]((_0x2c5ea7,_0x440ee1)=>{const _0xbb1558=_0x1f9c46,_0x379ca1={'quhAh':_0x487535['THNDk'],'ZwnQe':function(_0x3f5c0b){return _0x3f5c0b();}};if(_0x487535[_0xbb1558(0x155)](_0x487535[_0xbb1558(0x464)],_0x487535['eRtpj'])){_0x2c5ea7['classList'][_0xbb1558(0x2f1)](_0x487535[_0xbb1558(0x299)]);if(_0x487535[_0xbb1558(0x194)](_0x440ee1,_0x2a246e))_0x2c5ea7[_0xbb1558(0x3ce)][_0xbb1558(0x246)]('correct');else{if(_0x487535[_0xbb1558(0x1bf)](_0x440ee1,selectedOption)&&!_0x1ad14d)_0x2c5ea7[_0xbb1558(0x3ce)][_0xbb1558(0x246)](_0x487535[_0xbb1558(0x1b1)]);}}else _0x488bd1(_0x379ca1[_0xbb1558(0x409)])&&(_0x5740d1=0x0,_0x379ca1[_0xbb1558(0x321)](_0x37cd80),_0x379ca1[_0xbb1558(0x321)](_0x1ccac6));}),showSolution();}function showSolution(){const _0x507c2f=_0x5b771a,_0x2fdc84={'eAVcU':_0x507c2f(0x342),'dkjuI':function(_0x1b12f3,_0x31c91e){return _0x1b12f3(_0x31c91e);},'VgBII':_0x507c2f(0x446),'qAZmb':function(_0x4ce578){return _0x4ce578();},'qroFi':_0x507c2f(0x2e4),'VOcxn':_0x507c2f(0x38a),'ksdNW':_0x507c2f(0x444),'rkVWj':_0x507c2f(0x188),'jLQJV':function(_0x3b13ff,_0x5d946d){return _0x3b13ff!==_0x5d946d;},'HLHMp':_0x507c2f(0x317),'VDjBk':'solutionText','BYGMi':_0x507c2f(0x2c5),'FKhIk':_0x507c2f(0x328),'jdEYa':_0x507c2f(0x2d3),'rUmYy':_0x507c2f(0x374),'wnAcC':'hidden','DZRmK':_0x507c2f(0x181),'rNxHd':function(_0x10e512,_0x5b4739,_0x3db1cb){return _0x10e512(_0x5b4739,_0x3db1cb);},'XVbwq':_0x507c2f(0x230),'XNgoa':function(_0x5dda74,_0x54a39d){return _0x5dda74!==_0x54a39d;},'CEtyH':_0x507c2f(0x284),'WMMOn':_0x507c2f(0x3dc),'PYQlZ':_0x507c2f(0x349)};if(currentMode!==_0x2fdc84[_0x507c2f(0x1ed)]&&_0x2fdc84[_0x507c2f(0x403)](currentMode,_0x2fdc84[_0x507c2f(0x31d)]))return;const _0x555fdc=questionsData[currentQuestionIndex];document['getElementById'](_0x2fdc84['VDjBk'])[_0x507c2f(0x3a8)]=_0x555fdc[_0x507c2f(0x3c2)]||_0x2fdc84['BYGMi'];const _0x30c742=document['getElementById'](_0x2fdc84[_0x507c2f(0x37a)]),_0x46351b=document[_0x507c2f(0x3fa)](_0x2fdc84[_0x507c2f(0x33d)]),_0x5a3db6=_0x555fdc['explanation_video'];if(_0x5a3db6){if(_0x2fdc84['jLQJV'](_0x507c2f(0x379),_0x2fdc84['rUmYy'])){_0x30c742[_0x507c2f(0x3ce)][_0x507c2f(0x2f1)](_0x2fdc84[_0x507c2f(0x23a)]);if(_0x5a3db6[_0x507c2f(0x23c)](_0x2fdc84[_0x507c2f(0x371)]))_0x2fdc84[_0x507c2f(0x16e)](setupVideo,_0x46351b,_0x5a3db6);else _0x46351b[_0x507c2f(0x2ef)]=_0x5a3db6;}else{const _0x17a6d8=_0x2cb1c2[_0x507c2f(0x174)][_0x507c2f(0x1cd)](_0x2fdc84[_0x507c2f(0x228)]);if(_0x17a6d8){const _0x1fc6d4=_0x2fdc84[_0x507c2f(0x2c6)](_0x310102,_0x17a6d8[_0x507c2f(0x3b5)](_0x2fdc84[_0x507c2f(0x252)]));_0x2fdc84[_0x507c2f(0x2c6)](_0x5357cd,_0x1fc6d4);}}}else _0x30c742[_0x507c2f(0x3ce)]['add'](_0x2fdc84[_0x507c2f(0x23a)]);const _0x19cdff=document[_0x507c2f(0x3fa)](_0x2fdc84[_0x507c2f(0x35c)]);_0x19cdff[_0x507c2f(0x3a8)]='';_0x555fdc[_0x507c2f(0x2ac)]&&(_0x19cdff[_0x507c2f(0x3a8)]+=_0x507c2f(0x215)+_0x555fdc[_0x507c2f(0x2ac)]+_0x507c2f(0x3ba));if(_0x555fdc['explanation_audio_hin']){if(_0x2fdc84['XNgoa'](_0x2fdc84[_0x507c2f(0x196)],_0x507c2f(0x284))){if(_0x3e5f6e){const _0x5f0435=_0x47071b[_0x507c2f(0x1a0)](_0x4b1102,arguments);return _0x7cdfa7=null,_0x5f0435;}}else _0x19cdff['innerHTML']+=_0x507c2f(0x2ae)+_0x555fdc[_0x507c2f(0x1fe)]+_0x507c2f(0x3ba);}const _0x5a5dfb=document['getElementById'](_0x2fdc84[_0x507c2f(0x247)]);_0x5a5dfb['innerHTML']='',_0x555fdc[_0x507c2f(0x30c)]&&_0x555fdc[_0x507c2f(0x30c)]['forEach'](_0x4c6c68=>{const _0x41f215=_0x507c2f,_0x2d367d={'jnMiI':function(_0x23dce3){const _0x792fb2=_0x2fff;return _0x2fdc84[_0x792fb2(0x143)](_0x23dce3);},'jDxRn':_0x2fdc84[_0x41f215(0x18e)],'mNEVC':_0x2fdc84[_0x41f215(0x32f)]};if(_0x2fdc84[_0x41f215(0x381)]!==_0x2fdc84['ksdNW'])_0x2d367d[_0x41f215(0x1b9)](_0x372c99)?(_0x300aa8['getElementById'](_0x2d367d['jDxRn'])[_0x41f215(0x40f)]['display']=_0x2d367d[_0x41f215(0x3bf)],_0x2d367d[_0x41f215(0x1b9)](_0x1f051c)):(_0x2d367d[_0x41f215(0x1b9)](_0x4c417d),_0x5d1007[_0x41f215(0x3fa)]('modeModal')[_0x41f215(0x40f)][_0x41f215(0x3a9)]=_0x41f215(0x318));else{if(_0x4c6c68)_0x5a5dfb[_0x41f215(0x3a8)]+=_0x41f215(0x165)+_0x4c6c68+_0x41f215(0x450);}}),document[_0x507c2f(0x3fa)](_0x2fdc84[_0x507c2f(0x2d1)])[_0x507c2f(0x3ce)][_0x507c2f(0x2f1)](_0x2fdc84['wnAcC']);}function submitQuiz(){const _0x1be3dd=_0x5b771a,_0x114efa={'CiclI':_0x1be3dd(0x330),'WMuyo':'correct','xBBto':_0x1be3dd(0x440),'oCLHL':function(_0x5e2a82,_0x22c6b3){return _0x5e2a82(_0x22c6b3);},'RcDEl':function(_0x37e180,_0x5d724b){return _0x37e180(_0x5d724b);},'cvLGQ':_0x1be3dd(0x325),'ohTYM':function(_0x2be5d4,_0x488b21){return _0x2be5d4-_0x488b21;},'wlPZV':'quizPerformanceData','JIcUw':function(_0x2ac228,_0x205c81){return _0x2ac228-_0x205c81;},'VJVLK':function(_0x55eb78,_0x59a175){return _0x55eb78+_0x59a175;}};if(timer)_0x114efa['oCLHL'](clearInterval,timer);if(!_0x114efa[_0x1be3dd(0x27e)](confirm,_0x114efa['cvLGQ']))return;isQuizCompleted=!![];let _0x4d2af4=0x0,_0x5d5744=0x0;const _0x475d0b=_0x114efa[_0x1be3dd(0x1d4)](Date[_0x1be3dd(0x3e3)](),quizStartTime);questionsData[_0x1be3dd(0x2fb)]((_0x30b9d6,_0x5e58e6)=>{const _0x322b8d=_0x1be3dd;if('DQfOP'===_0x114efa[_0x322b8d(0x2b4)]){const _0x69adfd=questionStates[_0x5e58e6];_0x69adfd['selectedAnswer']!==null&&(_0x30b9d6[_0x322b8d(0x1ea)][_0x69adfd[_0x322b8d(0x314)]]['id']===_0x30b9d6[_0x322b8d(0x345)]?(_0x4d2af4++,_0x69adfd['status']=_0x114efa[_0x322b8d(0x3b9)]):(_0x5d5744++,_0x69adfd[_0x322b8d(0x200)]=_0x114efa[_0x322b8d(0x15c)]));}else _0x334275[_0x1591af[_0x322b8d(0x14b)]][_0x322b8d(0x3bb)]=!![];});const _0x40343c=JSON[_0x1be3dd(0x2dc)](localStorage[_0x1be3dd(0x275)](_0x114efa[_0x1be3dd(0x401)]))||[];_0x40343c[_0x1be3dd(0x324)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x1be3dd(0x3e3)](),'totalTime':_0x475d0b,'stats':{'correct':_0x4d2af4,'incorrect':_0x5d5744,'notAttempted':_0x114efa['JIcUw'](questionsData[_0x1be3dd(0x2d8)],_0x114efa[_0x1be3dd(0x3dd)](_0x4d2af4,_0x5d5744))}}),localStorage['setItem'](_0x114efa[_0x1be3dd(0x401)],JSON[_0x1be3dd(0x45f)](_0x40343c)),stats['correctAnswers']=_0x4d2af4,stats['incorrectAnswers']=_0x5d5744,markQuizAsCompleted(),showPerformanceAnalysis(_0x4d2af4,_0x5d5744,_0x114efa['ohTYM'](questionsData['length'],_0x4d2af4+_0x5d5744),_0x475d0b);}function showPerformanceAnalysis(_0x27223a,_0x3a72a2,_0x475421,_0x16f482){const _0x11a357=_0x5b771a,_0x144cd5={'nlXJx':_0x11a357(0x1f3),'LbQPs':function(_0x51e2dd,_0x424df3){return _0x51e2dd>_0x424df3;},'GNeNc':function(_0x5333c1,_0xbe1b0f){return _0x5333c1+_0xbe1b0f;},'RWgux':function(_0x22daf9,_0x5c6ec7){return _0x22daf9*_0x5c6ec7;},'GlGBQ':_0x11a357(0x390),'hWnYh':function(_0x538846,_0xeb6324){return _0x538846-_0xeb6324;},'BqvjL':function(_0x2d272d,_0x487257){return _0x2d272d/_0x487257;},'MhWcn':_0x11a357(0x40e),'ulSXD':_0x11a357(0x31b),'yLiOj':_0x11a357(0x1dd),'ONdwM':_0x11a357(0x32b),'etEZe':_0x11a357(0x2a0),'qNJMC':function(_0x3ab2a8,_0x3811ba){return _0x3ab2a8/_0x3811ba;},'HIitm':function(_0x40680d,_0x47e690){return _0x40680d%_0x47e690;},'IJcMl':_0x11a357(0x3b3),'VWXjW':function(_0x3b2957,_0x33247f){return _0x3b2957/_0x33247f;},'xXWrB':_0x11a357(0x291)},_0x3c7ec9=document['getElementById'](_0x144cd5[_0x11a357(0x2a6)]),_0x29f1ce=_0x144cd5[_0x11a357(0x232)](_0x144cd5[_0x11a357(0x14e)](_0x27223a,_0x3a72a2),0x0)?Math[_0x11a357(0x361)](_0x27223a/(_0x27223a+_0x3a72a2)*0x64):0x0,_0x420912=_0x144cd5['RWgux'](_0x144cd5[_0x11a357(0x234)](0x2,Math['PI']),0x41),_0x4838c6=document[_0x11a357(0x3fa)](_0x144cd5['GlGBQ']);_0x4838c6['style'][_0x11a357(0x26e)]=_0x420912+'\x20'+_0x420912,_0x4838c6[_0x11a357(0x40f)][_0x11a357(0x2b7)]=_0x144cd5['hWnYh'](_0x420912,_0x144cd5[_0x11a357(0x209)](_0x29f1ce,0x64)*_0x420912),document['getElementById'](_0x144cd5[_0x11a357(0x2de)])[_0x11a357(0x2f6)]=_0x29f1ce+'%',document[_0x11a357(0x3fa)](_0x144cd5['ulSXD'])[_0x11a357(0x2f6)]=questionsData[_0x11a357(0x2d8)],document['getElementById'](_0x144cd5[_0x11a357(0x3f6)])[_0x11a357(0x2f6)]=_0x27223a,document[_0x11a357(0x3fa)](_0x144cd5['ONdwM'])[_0x11a357(0x2f6)]=_0x3a72a2,document[_0x11a357(0x3fa)](_0x144cd5[_0x11a357(0x16b)])['textContent']=_0x475421;const _0x26fa3d=Math[_0x11a357(0x21a)](_0x144cd5['BqvjL'](_0x16f482,0xea60)),_0x20cb9d=Math['floor'](_0x144cd5[_0x11a357(0x213)](_0x144cd5[_0x11a357(0x2b5)](_0x16f482,0xea60),0x3e8));document['getElementById'](_0x144cd5['IJcMl'])[_0x11a357(0x2f6)]=_0x26fa3d+':'+_0x20cb9d['toString']()['padStart'](0x2,'0');const _0x37fa52=_0x144cd5[_0x11a357(0x209)](_0x16f482,questionsData[_0x11a357(0x2d8)]),_0x234172=Math[_0x11a357(0x21a)](_0x144cd5[_0x11a357(0x209)](_0x37fa52,0xea60)),_0x2ac007=Math[_0x11a357(0x21a)](_0x144cd5[_0x11a357(0x162)](_0x144cd5['HIitm'](_0x37fa52,0xea60),0x3e8));document[_0x11a357(0x3fa)](_0x11a357(0x411))[_0x11a357(0x2f6)]=_0x234172+':'+_0x2ac007[_0x11a357(0x33e)]()['padStart'](0x2,'0'),_0x3c7ec9[_0x11a357(0x3ce)][_0x11a357(0x2f1)](_0x144cd5[_0x11a357(0x1b7)]);}function closePerformanceModal(){const _0x64bf8c=_0x5b771a,_0x47185a={'fGppB':_0x64bf8c(0x1f3)};document[_0x64bf8c(0x3fa)](_0x47185a[_0x64bf8c(0x13e)])['classList'][_0x64bf8c(0x246)](_0x64bf8c(0x291));}function reviewQuestions(){const _0x1bc8ad=_0x5b771a,_0x4397f8={'bveMP':function(_0x355a15){return _0x355a15();},'omLNo':function(_0x229c23,_0x18e9e4){return _0x229c23===_0x18e9e4;},'FhcCS':_0x1bc8ad(0x2e3),'jsKVy':_0x1bc8ad(0x2a1),'Iewsa':function(_0x1d68e8,_0x4f36fe){return _0x1d68e8!==_0x4f36fe;},'MAGGR':_0x1bc8ad(0x278),'XgeIH':'nUYRi','peQSc':_0x1bc8ad(0x407),'yKkEL':function(_0x5c7ff1,_0x207c30){return _0x5c7ff1!==_0x207c30;},'dFxzC':_0x1bc8ad(0x1e4),'hIuqC':'Correct','RWOrF':'Incorrect','BDGtZ':function(_0x32b01f,_0x3157a0){return _0x32b01f+_0x3157a0;},'TiWQg':_0x1bc8ad(0x27f),'UCCZD':'green','GLmss':_0x1bc8ad(0x3be),'tkKEy':'gray','MpvYs':_0x1bc8ad(0x28b),'IKwlh':_0x1bc8ad(0x2a5),'ugMFo':_0x1bc8ad(0x291),'ZYwpY':_0x1bc8ad(0x36d)};document[_0x1bc8ad(0x3fa)](_0x4397f8[_0x1bc8ad(0x3ff)])[_0x1bc8ad(0x3ce)][_0x1bc8ad(0x2f1)](_0x4397f8['ugMFo']);const _0x1d130c=document[_0x1bc8ad(0x3fa)](_0x4397f8[_0x1bc8ad(0x151)]);_0x1d130c[_0x1bc8ad(0x3a8)]='',questionsData[_0x1bc8ad(0x2fb)]((_0x1b82f7,_0x37b2c9)=>{const _0x2cc330=_0x1bc8ad,_0x396a85={'ysNol':function(_0x2092d3,_0x36ba61){const _0xe8e48a=_0x2fff;return _0x4397f8[_0xe8e48a(0x2b0)](_0x2092d3,_0x36ba61);},'zCTTj':_0x4397f8[_0x2cc330(0x282)],'yDKte':_0x2cc330(0x2b9),'NtRrF':_0x4397f8[_0x2cc330(0x2ba)],'WqTYG':function(_0x214d34){const _0x7a79f=_0x2cc330;return _0x4397f8[_0x7a79f(0x359)](_0x214d34);},'FcQBp':'index.html'};if(_0x4397f8[_0x2cc330(0x364)](_0x4397f8[_0x2cc330(0x1c8)],_0x4397f8[_0x2cc330(0x259)])){const _0x492de3=questionStates[_0x37b2c9],_0xb0d037=_0x1b82f7[_0x2cc330(0x345)];let _0x11df3e=_0x2cc330(0x2e8),_0x396c74=_0x4397f8['peQSc'];if(_0x4397f8['yKkEL'](_0x492de3['selectedAnswer'],null)){const _0xb1cdc=_0x1b82f7[_0x2cc330(0x1ea)][_0x492de3[_0x2cc330(0x314)]];_0x4397f8[_0x2cc330(0x2b0)](_0xb1cdc['id'],_0xb0d037)?_0x4397f8[_0x2cc330(0x3b1)]!==_0x4397f8[_0x2cc330(0x3b1)]?_0x4397f8[_0x2cc330(0x359)](_0x505b6c):(_0x11df3e=_0x2cc330(0x27f),_0x396c74=_0x4397f8[_0x2cc330(0x28c)]):(_0x11df3e='incorrect',_0x396c74=_0x4397f8[_0x2cc330(0x421)]);}const _0x12ad87=document['createElement'](_0x2cc330(0x29f));_0x12ad87[_0x2cc330(0x216)]=_0x2cc330(0x3c6)+_0x11df3e;let _0x28e103=(_0x1b82f7[_0x2cc330(0x1ea)]||[])[_0x2cc330(0x27c)]((_0xa79d2c,_0x1f5991)=>{const _0x57ab46=_0x2cc330,_0x46cb34=_0x396a85['ysNol'](_0x492de3[_0x57ab46(0x314)],_0x1f5991),_0x486a31=_0xa79d2c['id']===_0xb0d037;let _0x4577b3=_0x396a85[_0x57ab46(0x3ea)];if(_0x486a31)_0x4577b3=_0x396a85[_0x57ab46(0x178)];else{if(_0x46cb34)_0x4577b3=_0x396a85[_0x57ab46(0x3ae)];}return _0x57ab46(0x1e7)+_0x4577b3+_0x57ab46(0x2d6)+String[_0x57ab46(0x3de)](0x41+_0x1f5991)+_0x57ab46(0x38d)+_0xa79d2c[_0x57ab46(0x3ed)]+_0x57ab46(0x469);})['join']('');const _0x40f97c=_0x1b82f7[_0x2cc330(0x243)]?_0x2cc330(0x387)+_0x37b2c9+_0x2cc330(0x1fa)+_0x1b82f7[_0x2cc330(0x243)]+_0x2cc330(0x16c):'';let _0x195af='';if(_0x1b82f7[_0x2cc330(0x2ac)])_0x195af+=_0x2cc330(0x18b)+_0x1b82f7[_0x2cc330(0x2ac)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x1b82f7[_0x2cc330(0x1fe)])_0x195af+=_0x2cc330(0x1ad)+_0x1b82f7[_0x2cc330(0x1fe)]+_0x2cc330(0x3ba);let _0x217dbc=(_0x1b82f7[_0x2cc330(0x30c)]||[])['map'](_0x25cf28=>_0x25cf28?_0x2cc330(0x165)+_0x25cf28+_0x2cc330(0x450):'')[_0x2cc330(0x416)]('');_0x12ad87['innerHTML']=_0x2cc330(0x46f)+_0x4397f8[_0x2cc330(0x255)](_0x37b2c9,0x1)+_0x2cc330(0x1dc)+(_0x11df3e===_0x4397f8[_0x2cc330(0x425)]?_0x4397f8[_0x2cc330(0x453)]:_0x4397f8[_0x2cc330(0x2b0)](_0x11df3e,_0x2cc330(0x440))?_0x4397f8[_0x2cc330(0x2ce)]:_0x4397f8[_0x2cc330(0x386)])+_0x2cc330(0x2c2)+_0x396c74+_0x2cc330(0x2cf)+_0x1b82f7[_0x2cc330(0x3ed)]+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>'+_0x28e103+_0x2cc330(0x292)+(_0x1b82f7[_0x2cc330(0x3c2)]||_0x4397f8[_0x2cc330(0x46e)])+_0x2cc330(0x25c)+_0x40f97c+_0x2cc330(0x319)+_0x195af+_0x2cc330(0x319)+_0x217dbc+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x1d130c[_0x2cc330(0x37d)](_0x12ad87);}else{if(!_0x41846f)_0x396a85[_0x2cc330(0x439)](_0x2ed9c9);_0x21a594['location'][_0x2cc330(0x175)]=_0x2c222e[_0x2cc330(0x263)]||_0x396a85['FcQBp'];}}),_0x4397f8['bveMP'](initializeReviewVideos);}function initializeReviewVideos(){const _0x228c39=_0x5b771a,_0x57bf4e={'rSdOm':_0x228c39(0x3e5),'HFkiu':function(_0xcdb881,_0x189672){return _0xcdb881===_0x189672;},'OusHs':'tuZCD','JIQYR':_0x228c39(0x2fd)};document[_0x228c39(0x27d)](_0x57bf4e[_0x228c39(0x3ef)])[_0x228c39(0x2fb)](_0x2b9d66=>{const _0x29d309=_0x228c39,_0xc2f5bf={'FnpuK':_0x29d309(0x435),'Jllaj':_0x57bf4e[_0x29d309(0x3c0)]};if(_0x57bf4e['HFkiu'](_0x57bf4e[_0x29d309(0x144)],_0x29d309(0x3e2))){const _0x233cf8=_0xc2f5bf['FnpuK'][_0x29d309(0x3bd)]('|');let _0x51bd71=0x0;while(!![]){switch(_0x233cf8[_0x51bd71++]){case'0':return!![];case'1':_0x1d5e3a=_0x26a8e8[_0x29d309(0x264)];continue;case'2':_0x45bdf1=_0x4b5642[_0x29d309(0x293)];continue;case'3':_0x5cc445[_0x29d309(0x437)](_0xc2f5bf['Jllaj']);continue;case'4':_0x1d8a4b=_0x3a229c[_0x29d309(0x3f0)];continue;case'5':_0x614a21=_0x2168cb[_0x29d309(0x3b4)];continue;}break;}}else{const _0x1fe149=_0x2b9d66['dataset'][_0x29d309(0x2ef)];if(_0x1fe149&&_0x1fe149[_0x29d309(0x23c)](_0x29d309(0x181)))setupVideo(_0x2b9d66,_0x1fe149);else _0x1fe149&&(_0x2b9d66[_0x29d309(0x2ef)]=_0x1fe149);}});}function retakeQuiz(){const _0x5ef4a8=_0x5b771a,_0x594128={'wkvVd':function(_0x5b6d9a,_0x305559){return _0x5b6d9a(_0x305559);},'HBPWX':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','YlneQ':function(_0x12b5d1,_0x240cc0){return _0x12b5d1!==_0x240cc0;},'OTvWL':'CFYbZ','vrswj':'custom_quiz.html','Tznwm':_0x5ef4a8(0x2cb)};_0x594128[_0x5ef4a8(0x46a)](confirm,_0x594128[_0x5ef4a8(0x2e1)])&&(_0x594128[_0x5ef4a8(0x383)](_0x594128[_0x5ef4a8(0x2fc)],_0x594128[_0x5ef4a8(0x2fc)])?_0x56f0e3=_0x5ded79:(window['location'][_0x5ef4a8(0x41e)]['endsWith'](_0x594128[_0x5ef4a8(0x35f)])&&localStorage[_0x5ef4a8(0x3d0)](_0x594128['Tznwm']),clearProgress(),location[_0x5ef4a8(0x2c4)]()));}function loadBookmarkedQuestions(){const _0x57f806=_0x5b771a,_0x11ee54={'ccSpS':function(_0x25f01d,_0xe697c5){return _0x25f01d===_0xe697c5;},'hivHd':_0x57f806(0x27f),'mzhOx':_0x57f806(0x3c1),'JgcKj':function(_0x44c696,_0x2fafec){return _0x44c696===_0x2fafec;},'STgnz':'incorrect','fWZIw':_0x57f806(0x44b),'ZwILj':function(_0x3ac63b,_0x45875c){return _0x3ac63b<_0x45875c;},'bRtfO':_0x57f806(0x355)},_0x38d9ca=JSON['parse'](localStorage['getItem'](_0x57f806(0x3ac)))||[];_0x38d9ca[_0x57f806(0x2fb)](_0x5a6f29=>{const _0x48ec8f=_0x57f806;if(_0x5a6f29[_0x48ec8f(0x198)][_0x48ec8f(0x23c)](quizName[_0x48ec8f(0x266)]()[_0x48ec8f(0x163)](/ /g,'-'))){if(_0x11ee54['ZwILj'](_0x5a6f29['questionIndex'],questionsData[_0x48ec8f(0x2d8)])){if(_0x11ee54[_0x48ec8f(0x2c3)](_0x11ee54[_0x48ec8f(0x180)],'AmwtS')){if(_0x11ee54[_0x48ec8f(0x2c3)](_0x30fc90[_0x48ec8f(0x200)],_0x11ee54[_0x48ec8f(0x2b2)]))_0x538068=_0x11ee54['mzhOx'];else{if(_0x11ee54[_0x48ec8f(0x2ad)](_0x113beb['status'],_0x11ee54[_0x48ec8f(0x31e)]))_0x931f3f=_0x11ee54[_0x48ec8f(0x20d)];else _0x14a967=_0x48ec8f(0x340);}}else questionStates[_0x5a6f29[_0x48ec8f(0x14b)]][_0x48ec8f(0x3bb)]=!![];}}});}function toggleBookmark(){const _0x4972f9=_0x5b771a,_0xf94dbf={'Wgasg':_0x4972f9(0x3ac),'RXgsT':function(_0x5c5e28){return _0x5c5e28();},'XWvIQ':function(_0x557702){return _0x557702();}},_0x56a2da=!questionStates[currentQuestionIndex][_0x4972f9(0x3bb)];questionStates[currentQuestionIndex]['bookmarked']=_0x56a2da;let _0x424a2b=JSON['parse'](localStorage['getItem'](_0xf94dbf['Wgasg']))||[];if(_0x56a2da){const _0x110e48={'quizName':quizName,'quizFile':window[_0x4972f9(0x22b)][_0x4972f9(0x41e)][_0x4972f9(0x3bd)]('/')[_0x4972f9(0x199)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x424a2b[_0x4972f9(0x324)](_0x110e48);}else _0x424a2b=_0x424a2b['filter'](_0x1a11e1=>!(_0x1a11e1[_0x4972f9(0x198)][_0x4972f9(0x23c)](quizName[_0x4972f9(0x266)]()[_0x4972f9(0x163)](/ /g,'-'))&&_0x1a11e1[_0x4972f9(0x14b)]===currentQuestionIndex));localStorage['setItem'](_0xf94dbf[_0x4972f9(0x358)],JSON['stringify'](_0x424a2b)),_0xf94dbf['RXgsT'](updateBookmarkButton),_0xf94dbf[_0x4972f9(0x2aa)](updateQuestionNav);}function updateBookmarkButton(){const _0x1ec117=_0x5b771a,_0x3e01f0={'wghYX':_0x1ec117(0x280),'VkCEn':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','Orkxg':_0x1ec117(0x1b5),'MAbdc':_0x1ec117(0x17d),'yGeRS':_0x1ec117(0x238)},_0x31b4b4=document['getElementById'](_0x3e01f0[_0x1ec117(0x23d)]),_0x1904d8=document[_0x1ec117(0x3fa)](_0x1ec117(0x154)),_0x19672b=questionStates[currentQuestionIndex][_0x1ec117(0x3bb)];_0x31b4b4[_0x1ec117(0x216)]=_0x19672b?_0x3e01f0['VkCEn']:_0x3e01f0['Orkxg'],_0x1904d8[_0x1ec117(0x2f6)]=_0x19672b?_0x3e01f0['MAbdc']:_0x3e01f0[_0x1ec117(0x254)];}function toggleMarkForReview(){const _0xa0c010=_0x5b771a,_0xbcb7c0={'viTcM':function(_0x57e26b){return _0x57e26b();},'FbiCT':function(_0x1b9aa8){return _0x1b9aa8();}};questionStates[currentQuestionIndex][_0xa0c010(0x170)]=!questionStates[currentQuestionIndex][_0xa0c010(0x170)],_0xbcb7c0[_0xa0c010(0x43e)](updateMarkReviewButton),_0xbcb7c0[_0xa0c010(0x2bf)](updateQuestionNav);}function updateMarkReviewButton(){const _0x4bd92c=_0x5b771a,_0x36adad={'SFTMh':_0x4bd92c(0x195),'aUcvB':_0x4bd92c(0x21c),'lOXZS':_0x4bd92c(0x286),'hKKRA':'Marked','DimTa':'Mark\x20for\x20Review'},_0x3db387=document['getElementById'](_0x36adad[_0x4bd92c(0x25f)]),_0x35112e=document[_0x4bd92c(0x3fa)](_0x4bd92c(0x273)),_0x3f8210=questionStates[currentQuestionIndex]['markedForReview'];_0x3db387[_0x4bd92c(0x216)]=_0x3f8210?_0x36adad[_0x4bd92c(0x415)]:_0x36adad[_0x4bd92c(0x395)],_0x35112e[_0x4bd92c(0x2f6)]=_0x3f8210?_0x36adad[_0x4bd92c(0x424)]:_0x36adad[_0x4bd92c(0x2b1)];}function previousQuestion(){const _0x26ec73=_0x5b771a,_0x86286d={'lDOoc':_0x26ec73(0x181),'opyzN':function(_0xf1f0d3,_0x9b89b8,_0x434ac6){return _0xf1f0d3(_0x9b89b8,_0x434ac6);},'EfkCy':_0x26ec73(0x2fd),'VIewZ':_0x26ec73(0x291),'DZtqJ':function(_0xe3387c,_0x2ef737){return _0xe3387c>_0x2ef737;},'JPFsL':function(_0x493c33,_0xe6b852){return _0x493c33!==_0xe6b852;},'WZoDs':_0x26ec73(0x184),'CeetA':function(_0xfe167,_0x257381){return _0xfe167!==_0x257381;},'RGQia':_0x26ec73(0x3af),'CvsWC':function(_0x24de44,_0x3a4af2){return _0x24de44-_0x3a4af2;},'AOzgh':function(_0x5ac090){return _0x5ac090();}};if(_0x86286d['DZtqJ'](currentQuestionIndex,0x0)){if(_0x86286d[_0x26ec73(0x405)](_0x26ec73(0x184),_0x86286d['WZoDs'])){const _0x5c34dc={'SjvBQ':_0x86286d[_0x26ec73(0x301)],'UFTnE':function(_0x395262,_0x29180a,_0xfeb848){return _0x86286d['opyzN'](_0x395262,_0x29180a,_0xfeb848);}};_0x5b9f29[_0x26ec73(0x27d)](_0x86286d[_0x26ec73(0x428)])[_0x26ec73(0x2fb)](_0x43a513=>{const _0x285a80=_0x26ec73,_0x8889e3=_0x43a513['dataset']['src'];if(_0x8889e3&&_0x8889e3[_0x285a80(0x23c)](_0x5c34dc['SjvBQ']))_0x5c34dc[_0x285a80(0x2dd)](_0xd1ad6a,_0x43a513,_0x8889e3);else _0x8889e3&&(_0x43a513[_0x285a80(0x2ef)]=_0x8889e3);});}else questionStartTime&&(_0x86286d[_0x26ec73(0x2a4)](_0x86286d[_0x26ec73(0x398)],_0x86286d['RGQia'])?_0x16e1e9[_0x26ec73(0x3ce)][_0x26ec73(0x246)](_0x86286d['VIewZ']):questionStates[currentQuestionIndex][_0x26ec73(0x26c)]+=_0x86286d[_0x26ec73(0x236)](Date[_0x26ec73(0x3e3)](),questionStartTime)),currentQuestionIndex--,_0x86286d['AOzgh'](displayQuestion),_0x86286d[_0x26ec73(0x362)](saveProgress);}}function nextQuestion(){const _0x2f6a05=_0x5b771a,_0x5f19d7={'qArPH':function(_0x459f1d,_0x29d0cb){return _0x459f1d!==_0x29d0cb;},'YUOXv':_0x2f6a05(0x1c4),'zINbQ':function(_0x4b3f9f,_0x4303f2){return _0x4b3f9f>_0x4303f2;},'PvdbX':function(_0xdca8c9,_0x46fa5e){return _0xdca8c9+_0x46fa5e;},'CiwGq':function(_0x383fa6,_0x103303){return _0x383fa6/_0x103303;},'fbbIB':function(_0x4f3f6f,_0x542072){return _0x4f3f6f*_0x542072;},'JzCNH':_0x2f6a05(0x390),'seIFi':function(_0x201b48,_0x3b90da){return _0x201b48-_0x3b90da;},'pxvuX':function(_0x595909,_0x47f5da){return _0x595909/_0x47f5da;},'lodSE':_0x2f6a05(0x1dd),'KXMHe':_0x2f6a05(0x32b),'YwNTZ':_0x2f6a05(0x3b3),'Ytcug':'avgTimeResult','tviHb':function(_0x3dc140,_0x298332){return _0x3dc140-_0x298332;},'bktjz':function(_0x1e0425,_0x520b96){return _0x1e0425<_0x520b96;},'dDoJD':function(_0x2220fb,_0x3b701a){return _0x2220fb-_0x3b701a;},'uJhFe':function(_0x3bca50){return _0x3bca50();},'UBkzC':function(_0x391448,_0xa1740f){return _0x391448===_0xa1740f;},'HcTvr':'timed_exam','EDCDc':function(_0x39e5af,_0x45b530){return _0x39e5af(_0x45b530);},'WPEzT':function(_0xe7411a,_0xc77cd1){return _0xe7411a!==_0xc77cd1;},'HNYaE':_0x2f6a05(0x1e5),'FkfEh':_0x2f6a05(0x14a),'lFLwz':function(_0xece704,_0x396cc0){return _0xece704(_0x396cc0);},'cRamy':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','kwKgP':function(_0xde160c,_0x135af0){return _0xde160c!==_0x135af0;},'NhbjI':_0x2f6a05(0x1d7),'IfgHC':function(_0x568ba2){return _0x568ba2();}};questionStartTime&&(questionStates[currentQuestionIndex][_0x2f6a05(0x26c)]+=_0x5f19d7[_0x2f6a05(0x158)](Date[_0x2f6a05(0x3e3)](),questionStartTime));if(_0x5f19d7[_0x2f6a05(0x2c0)](currentQuestionIndex,_0x5f19d7[_0x2f6a05(0x385)](questionsData[_0x2f6a05(0x2d8)],0x1)))currentQuestionIndex++,_0x5f19d7[_0x2f6a05(0x1f1)](displayQuestion),saveProgress();else{if(_0x5f19d7['UBkzC'](currentMode,_0x2f6a05(0x423))||currentMode===_0x5f19d7[_0x2f6a05(0x3f7)])_0x5f19d7[_0x2f6a05(0x16a)](confirm,_0x2f6a05(0x202))&&_0x5f19d7['uJhFe'](submitQuiz);else{if(_0x5f19d7[_0x2f6a05(0x308)](_0x5f19d7['HNYaE'],_0x5f19d7['FkfEh'])){if(_0x5f19d7[_0x2f6a05(0x35e)](confirm,_0x5f19d7[_0x2f6a05(0x400)])){if(_0x5f19d7[_0x2f6a05(0x392)](_0x5f19d7[_0x2f6a05(0x265)],_0x5f19d7[_0x2f6a05(0x265)])){if(_0x5f19d7['qArPH'](_0x301410[_0x2f6a05(0x314)],null))_0x19271b=_0x5f19d7['YUOXv'];else _0x257619=_0x2f6a05(0x340);}else currentQuestionIndex=0x0,_0x5f19d7[_0x2f6a05(0x2e5)](displayQuestion),saveProgress();}}else{const _0x49ce06=_0x420930['getElementById']('performanceModal'),_0xa5c453=_0x5f19d7[_0x2f6a05(0x217)](_0x5f19d7[_0x2f6a05(0x307)](_0x182385,_0x20fcec),0x0)?_0x585760['round'](_0x5f19d7[_0x2f6a05(0x19d)](_0x53b5fd,_0x5f19d7[_0x2f6a05(0x307)](_0xa69ae3,_0x4b6a13))*0x64):0x0,_0x4653c2=_0x5f19d7[_0x2f6a05(0x378)](_0x5f19d7['fbbIB'](0x2,_0x368c2b['PI']),0x41),_0x42f6d5=_0x48a4ff[_0x2f6a05(0x3fa)](_0x5f19d7[_0x2f6a05(0x3cb)]);_0x42f6d5[_0x2f6a05(0x40f)][_0x2f6a05(0x26e)]=_0x4653c2+'\x20'+_0x4653c2,_0x42f6d5[_0x2f6a05(0x40f)][_0x2f6a05(0x2b7)]=_0x5f19d7[_0x2f6a05(0x1a4)](_0x4653c2,_0x5f19d7[_0x2f6a05(0x378)](_0x5f19d7[_0x2f6a05(0x303)](_0xa5c453,0x64),_0x4653c2)),_0x53db82[_0x2f6a05(0x3fa)]('accuracyScore')[_0x2f6a05(0x2f6)]=_0xa5c453+'%',_0x35d8e8[_0x2f6a05(0x3fa)](_0x2f6a05(0x31b))[_0x2f6a05(0x2f6)]=_0x4e85a9[_0x2f6a05(0x2d8)],_0x35e5ff[_0x2f6a05(0x3fa)](_0x5f19d7[_0x2f6a05(0x1c3)])[_0x2f6a05(0x2f6)]=_0x1b6448,_0x29d52d[_0x2f6a05(0x3fa)](_0x5f19d7[_0x2f6a05(0x322)])[_0x2f6a05(0x2f6)]=_0x10099b,_0x2cd4f8['getElementById'](_0x2f6a05(0x2a0))[_0x2f6a05(0x2f6)]=_0x39f5ab;const _0x18bded=_0x20f018['floor'](_0x5f19d7[_0x2f6a05(0x303)](_0x6b1a05,0xea60)),_0x4698e6=_0xcc069d[_0x2f6a05(0x21a)](_0x5f19d7[_0x2f6a05(0x303)](_0x8da6c7%0xea60,0x3e8));_0x3a04f1[_0x2f6a05(0x3fa)](_0x5f19d7['YwNTZ'])[_0x2f6a05(0x2f6)]=_0x18bded+':'+_0x4698e6[_0x2f6a05(0x33e)]()[_0x2f6a05(0x26b)](0x2,'0');const _0x48f1db=_0x5f19d7['pxvuX'](_0x223885,_0x1a0209['length']),_0x1133a7=_0x528f54[_0x2f6a05(0x21a)](_0x48f1db/0xea60),_0x5cc932=_0x1c1178['floor'](_0x48f1db%0xea60/0x3e8);_0x2b86c6[_0x2f6a05(0x3fa)](_0x5f19d7[_0x2f6a05(0x43c)])['textContent']=_0x1133a7+':'+_0x5cc932[_0x2f6a05(0x33e)]()[_0x2f6a05(0x26b)](0x2,'0'),_0x49ce06[_0x2f6a05(0x3ce)][_0x2f6a05(0x2f1)](_0x2f6a05(0x291));}}}}function startTimer(){const _0x23cad9=_0x5b771a,_0x1035ea={'rBSWo':function(_0x2e3734){return _0x2e3734();},'sZwvY':function(_0x23d7b7,_0x158cd7){return _0x23d7b7-_0x158cd7;},'tIUOg':function(_0x20afa2){return _0x20afa2();},'paypG':function(_0x5ae5de){return _0x5ae5de();},'YFKeK':function(_0x37de4a,_0x48f6a5){return _0x37de4a===_0x48f6a5;},'ORHVL':_0x23cad9(0x24e),'kxvGq':_0x23cad9(0x277),'GmdhY':function(_0x5ca4c9,_0x298bae){return _0x5ca4c9<=_0x298bae;},'WtVth':function(_0x566d14,_0x5df366){return _0x566d14!==_0x5df366;},'eigrH':_0x23cad9(0x466),'ZuSTP':_0x23cad9(0x268),'CHkpg':function(_0x2df872,_0x343d04){return _0x2df872===_0x343d04;},'DnLMu':_0x23cad9(0x3d1),'BmTCo':_0x23cad9(0x30a),'kQEgF':_0x23cad9(0x396),'QpQOJ':function(_0x3d90ef,_0x2cf398){return _0x3d90ef(_0x2cf398);},'SipzO':function(_0xd4789e,_0x2e368c,_0x26bbf0){return _0xd4789e(_0x2e368c,_0x26bbf0);}};if(timer)_0x1035ea[_0x23cad9(0x274)](clearInterval,timer);timeRemaining=0x78,updateTimerDisplay(),timer=_0x1035ea[_0x23cad9(0x3a6)](setInterval,()=>{const _0xfa75ae=_0x23cad9;if(_0x1035ea['YFKeK'](_0x1035ea['ORHVL'],_0x1035ea[_0xfa75ae(0x1c1)])){_0x4c2f6d[_0xfa75ae(0x40a)]++,_0x3868a4['notAttempted']--;if(_0x23ea4b)_0x103d94['correctAnswers']++;else _0x5453e7[_0xfa75ae(0x1e3)]++;}else timeRemaining--,_0x1035ea[_0xfa75ae(0x363)](updateTimerDisplay),_0x1035ea[_0xfa75ae(0x44a)](timeRemaining,0x0)&&(_0x1035ea[_0xfa75ae(0x38c)](_0x1035ea[_0xfa75ae(0x229)],_0x1035ea[_0xfa75ae(0x332)])?(clearInterval(timer),_0x1035ea['CHkpg'](currentMode,_0x1035ea[_0xfa75ae(0x3d8)])?_0x1035ea[_0xfa75ae(0x38c)](_0x1035ea['BmTCo'],_0x1035ea[_0xfa75ae(0x244)])?_0x1035ea[_0xfa75ae(0x363)](submitQuiz):_0x1035ea[_0xfa75ae(0x32d)](_0x5d16fb):nextQuestion()):(_0x283f86&&(_0x1243b3[_0x5d7115]['timeSpent']+=_0x1035ea[_0xfa75ae(0x1ac)](_0x456221[_0xfa75ae(0x3e3)](),_0x317d26)),_0x26638b--,_0x1035ea[_0xfa75ae(0x25e)](_0x4ba9aa),_0x1035ea['paypG'](_0x5c4060)));},0x3e8);}function updateTimerDisplay(){const _0x3415c5=_0x5b771a,_0x34f839={'fQqsG':function(_0x10df46,_0x3891f1){return _0x10df46/_0x3891f1;},'eMQWJ':function(_0x125c34,_0x3b9879){return _0x125c34%_0x3b9879;},'CNzBn':function(_0x549ad3,_0x2c4fa8){return _0x549ad3+_0x2c4fa8;}},_0x4cef33=Math[_0x3415c5(0x21a)](_0x34f839[_0x3415c5(0x24f)](timeRemaining,0x3c)),_0x1f03a7=_0x34f839[_0x3415c5(0x2da)](timeRemaining,0x3c);document['getElementById'](_0x3415c5(0x297))[_0x3415c5(0x2f6)]=_0x34f839[_0x3415c5(0x3ab)](_0x34f839[_0x3415c5(0x3ab)](_0x4cef33,':'),_0x1f03a7[_0x3415c5(0x33e)]()[_0x3415c5(0x26b)](0x2,'0'));}function toggleSidebar(){const _0x4a0d8f=_0x5b771a,_0x3f60d3={'ARpMG':'open'};document[_0x4a0d8f(0x3fa)](_0x4a0d8f(0x1e9))[_0x4a0d8f(0x3ce)][_0x4a0d8f(0x45e)](_0x3f60d3['ARpMG']);}document[_0x5b771a(0x2f7)](_0x5b771a(0x3ca),()=>{const _0x2b858c=_0x5b771a,_0x1b52c5={'KxUzv':_0x2b858c(0x3ac),'mYTIm':'custom_quiz.html','zsVzM':_0x2b858c(0x2cb),'GqSKQ':function(_0x1692e7){return _0x1692e7();},'Xpaco':function(_0x9ce155,_0x5abd03){return _0x9ce155===_0x5abd03;},'wqKVQ':_0x2b858c(0x30b),'ljxHE':_0x2b858c(0x2e4),'MzdNm':function(_0x2f6afd,_0x2c7009){return _0x2f6afd!==_0x2c7009;},'BqqgC':_0x2b858c(0x2b3),'aiVUR':_0x2b858c(0x318),'XgFag':function(_0x433344){return _0x433344();}};if(resume){if(_0x1b52c5[_0x2b858c(0x1b0)]('GnIDt',_0x1b52c5[_0x2b858c(0x18f)])){if(loadProgress())document[_0x2b858c(0x3fa)](_0x1b52c5['ljxHE'])[_0x2b858c(0x40f)][_0x2b858c(0x3a9)]='none',_0x1b52c5['GqSKQ'](initializeQuiz);else{if(_0x1b52c5['MzdNm'](_0x2b858c(0x13d),_0x1b52c5[_0x2b858c(0x1e6)]))_0x1b52c5[_0x2b858c(0x37e)](clearProgress),document[_0x2b858c(0x3fa)](_0x1b52c5[_0x2b858c(0x1a8)])[_0x2b858c(0x40f)][_0x2b858c(0x3a9)]=_0x1b52c5[_0x2b858c(0x31f)];else{const _0x18bdb1=!_0x386fa5[_0x5ddbdc][_0x2b858c(0x3bb)];_0xc8e506[_0x3c1045][_0x2b858c(0x3bb)]=_0x18bdb1;let _0x3f7b90=_0x310a27['parse'](_0x1d96e6['getItem'](_0x1b52c5[_0x2b858c(0x182)]))||[];if(_0x18bdb1){const _0x46c0b8={'quizName':_0x29383a,'quizFile':_0x3baffc['location'][_0x2b858c(0x41e)]['split']('/')[_0x2b858c(0x199)](),'questionIndex':_0x2b0360,'question':_0x3ead4a[_0x5f4e21],'hierarchy':_0x4e2c2f,'timestamp':_0x26bd28[_0x2b858c(0x3e3)]()};_0x3f7b90[_0x2b858c(0x324)](_0x46c0b8);}else _0x3f7b90=_0x3f7b90[_0x2b858c(0x42e)](_0x1c649d=>!(_0x1c649d[_0x2b858c(0x198)][_0x2b858c(0x23c)](_0x31a3cb[_0x2b858c(0x266)]()['replace'](/ /g,'-'))&&_0x1c649d[_0x2b858c(0x14b)]===_0x32d0bd));_0x161124[_0x2b858c(0x251)](_0x1b52c5[_0x2b858c(0x182)],_0x4b1042['stringify'](_0x3f7b90)),_0x17d1d3(),_0x1f0f0e();}}}else{const _0x461d9b=_0x5928b6['constructor'][_0x2b858c(0x160)][_0x2b858c(0x1b4)](_0x15c2f3),_0x4f9f59=_0x522ff3[_0x260fc6],_0x444aa7=_0x4360ea[_0x4f9f59]||_0x461d9b;_0x461d9b[_0x2b858c(0x1a6)]=_0x4b1116[_0x2b858c(0x1b4)](_0x4c66a0),_0x461d9b['toString']=_0x444aa7[_0x2b858c(0x33e)]['bind'](_0x444aa7),_0x119c4c[_0x4f9f59]=_0x461d9b;}}else!window[_0x2b858c(0x22b)][_0x2b858c(0x41e)][_0x2b858c(0x3a4)](_0x2b858c(0x436))?_0x2b858c(0x3cf)!==_0x2b858c(0x462)?(_0x1b52c5[_0x2b858c(0x37e)](clearProgress),document[_0x2b858c(0x3fa)](_0x1b52c5[_0x2b858c(0x1a8)])[_0x2b858c(0x40f)][_0x2b858c(0x3a9)]=_0x1b52c5[_0x2b858c(0x31f)]):(_0xcd875a[_0x2b858c(0x22b)]['pathname'][_0x2b858c(0x3a4)](_0x1b52c5[_0x2b858c(0x380)])&&_0x48a1f4[_0x2b858c(0x3d0)](_0x1b52c5[_0x2b858c(0x46d)]),_0x1b52c5[_0x2b858c(0x37e)](_0x779942),_0x122676[_0x2b858c(0x2c4)]()):_0x1b52c5['XgFag'](initializeQuiz);}),document[_0x5b771a(0x2f7)]('keydown',function(_0x522290){const _0x3f4c1e=_0x5b771a,_0x3f4055={'ZkTNt':_0x3f4c1e(0x191),'vPKGq':function(_0x263b38,_0xad910){return _0x263b38===_0xad910;},'vMfFk':function(_0x3a526f,_0x4b1d76){return _0x3a526f!==_0x4b1d76;},'RVoFq':'none','JrWwn':_0x3f4c1e(0x1f3),'NLxtp':function(_0xd2dd79,_0x2f7371){return _0xd2dd79>=_0x2f7371;},'snypN':function(_0x3c897e,_0x11141d){return _0x3c897e<=_0x11141d;},'Fnhkj':function(_0x5e1bf8,_0xea7ecc){return _0x5e1bf8(_0xea7ecc);},'jBqwY':'.option-button','WpvoV':function(_0xcf0a9e,_0x2d8bc5){return _0xcf0a9e<_0x2d8bc5;},'nidAk':function(_0x2aab27,_0x58e461){return _0x2aab27===_0x58e461;},'fIPEC':_0x3f4c1e(0x42c),'WoGPA':function(_0x4b15ca,_0x4fbe9e){return _0x4b15ca===_0x4fbe9e;},'CUbiO':function(_0x5c3102,_0x34a1bf){return _0x5c3102===_0x34a1bf;},'YJzmG':_0x3f4c1e(0x21d),'yeDxF':function(_0x49a312,_0x471a56){return _0x49a312===_0x471a56;},'baaiA':function(_0x9b823f,_0x34cf6a){return _0x9b823f===_0x34cf6a;},'baaPc':'study','DftSt':function(_0x5b746e,_0x55d8da){return _0x5b746e===_0x55d8da;},'nLrjO':function(_0x18a40e,_0x2aa870){return _0x18a40e===_0x2aa870;},'njTwp':'test','xsSAc':_0x3f4c1e(0x3d1),'NKSCv':function(_0x4fca8c,_0x26dc85){return _0x4fca8c===_0x26dc85;}};if(_0x3f4055[_0x3f4c1e(0x3e8)](document[_0x3f4c1e(0x3fa)](_0x3f4c1e(0x2e4))[_0x3f4c1e(0x40f)]['display'],_0x3f4055[_0x3f4c1e(0x373)]))return;if(_0x3f4055[_0x3f4c1e(0x3eb)](document[_0x3f4c1e(0x3fa)](_0x3f4055[_0x3f4c1e(0x3d4)])['classList']['contains'](_0x3f4c1e(0x291)),![]))return;if(_0x3f4055[_0x3f4c1e(0x1ae)](_0x522290[_0x3f4c1e(0x166)],'1')&&_0x3f4055[_0x3f4c1e(0x337)](_0x522290[_0x3f4c1e(0x166)],'4')){const _0x1e9684=_0x3f4055[_0x3f4c1e(0x3b6)](parseInt,_0x522290[_0x3f4c1e(0x166)])-0x1,_0x17ff32=document[_0x3f4c1e(0x27d)](_0x3f4055['jBqwY']);if(_0x3f4055[_0x3f4c1e(0x2b8)](_0x1e9684,_0x17ff32['length']))selectOption(_0x1e9684);}else{if(_0x3f4055[_0x3f4c1e(0x36c)](_0x522290[_0x3f4c1e(0x166)],_0x3f4055[_0x3f4c1e(0x3c4)]))_0x3f4055[_0x3f4c1e(0x2fe)](_0x3f4c1e(0x352),'iZEwL')?_0x47276d[_0x3f4c1e(0x3ce)][_0x3f4c1e(0x45e)](_0x3f4055['ZkTNt'],_0x3f4055['vPKGq'](_0x5c9d3a,_0x44797f)):previousQuestion();else{if(_0x3f4055[_0x3f4c1e(0x2e7)](_0x522290[_0x3f4c1e(0x166)],_0x3f4055[_0x3f4c1e(0x3c5)])||_0x3f4055[_0x3f4c1e(0x2fe)](_0x522290[_0x3f4c1e(0x166)],'\x20'))_0x522290[_0x3f4c1e(0x441)](),nextQuestion();else{if(_0x3f4055[_0x3f4c1e(0x153)](_0x522290['key']['toLowerCase'](),'b')&&(_0x3f4055[_0x3f4c1e(0x350)](currentMode,_0x3f4055[_0x3f4c1e(0x357)])||_0x3f4055[_0x3f4c1e(0x176)](currentMode,_0x3f4c1e(0x317))))toggleBookmark();else{if(_0x3f4055[_0x3f4c1e(0x338)](_0x522290[_0x3f4c1e(0x166)][_0x3f4c1e(0x266)](),'m')&&(_0x3f4055[_0x3f4c1e(0x2e7)](currentMode,_0x3f4055[_0x3f4c1e(0x231)])||_0x3f4055[_0x3f4c1e(0x350)](currentMode,_0x3f4055['xsSAc'])))toggleMarkForReview();else _0x3f4055[_0x3f4c1e(0x36b)](_0x522290[_0x3f4c1e(0x166)][_0x3f4c1e(0x266)](),'s')&&(currentMode===_0x3f4c1e(0x423)||currentMode===_0x3f4c1e(0x3d1))&&submitQuiz();}}}}});</script>

</body></html>